residency program in cardiothoracic surgery · the training program in thoracic surgery ......

Duke Residency Program in

Cardiothoracic Surgery

Candidate Guide 2016-2017

TABLE OF CONTENTS

Welcome…………………………………………………………………………………………………………………….. 1

History of Duke University Medical Center……………………………………………………………………. 2

Duke Surgery Department Chairmen……………………………………………………………………………. 5

History of Cardiothoracic Surgery at Duke…………………………………………………………………….. 7

The Training Program in Thoracic Surgery……………………………………………………………………. 10

Cardiothoracic Clinical Programs…………………………………………………………………………………. 12

Affiliated Institutions………………………………………………………………………………………………….. 12

Division of Cardiothoracic and Vascular Faculty Members……………………………………………… 14

Current Residents……………………………………………………………………………………………………….. 22

Resident Publications………………………………………………………………………………………………….. 28

Resident Presentations at National Meetings…………………………………………………………………. 48

Graduates………………………………………………………………………………………………………………….. 57

Duke Graduate Medical Education

Employment Requirements…………………………………………………………………………………. 60

Requirement and Standards………………………………………………………………………………… 61

Stipends…………………………………………………………………………………………………………….

64

Sample of Agreement of Appointment…………………………………………………………………… 65

Program and GME Benefits…………………………………………………………………………………. 69

1

Dear Applicant: We would like to welcome you to Durham on behalf of the Division of Cardiothoracic Surgery. We are grateful for your interest in the Residency Program in Thoracic Surgery at Duke and hope that over the course of your interview experience, you come away with shared enthusiasm about our Program.

This brochure has been provided to assist you in this most important process of selecting a Training Program. Within the pages you will find information regarding the history of Duke's medical campus and the Department of Surgery as well as summaries regarding current faculty and residents, recent graduates, and hospitals.

It is our educational mission to train cardiothoracic surgeons who are of the highest clinical caliber and who are committed to careers in which they will continue to advance the field of surgery through research, education, and leadership activities. We are dedicated to providing an environment in which exceptional individuals of diverse backgrounds are welcome and positioned to succeed.

There are clearly a number of factors to be considered when choosing a training program. It is our opinion that one of the most important is the track record of recent graduates. Our program is intentionally broad-based and has produced graduates with a wide variety of clinical and research interests. As you will find in the summaries enclosed, Duke graduates obtain the most highly sought-after academic jobs and specialty training fellowship programs.

We encourage you to take the opportunity to truly explore the opportunities present at Duke. If we can provide any further information to assist you in this process, please do not hesitate to contact any one of us.

Sincerely yours,

Peter K. Smith, M.D. Thomas A. D’Amico, M.D. Professor of Surgery Professor of Surgery Chief, Division of Cardiothoracic Surgery Program Director, Thoracic Surgery

Betty C. Tong, M.D., M.H.S. John C. Haney, M.D., M.P.H. Associate Professor of Surgery Assistant Professor of Surgery Associate Program Director, Thoracic Surgery Assistant Program Director,

Thoracic Surgery

2

Duke University Medical Center History 1891 Trinity College President, John Franklin Crowell, made public a plan for starting a medical college with a teaching hospital at Trinity College.

1924

James B. Duke established The Duke Endowment and directs that part of his $40 million gift be used to transform Durham's Trinity College into Duke University.

1925

James B. Duke makes an additional bequest to establish the Duke School of Medicine, Duke School of Nursing, and Duke Hospital, with the goal of improving health care in the Carolinas and nationwide.

1927

Construction begins on the Medical School and Duke Hospital.

1929

Three thousand applicants apply to the new medical school. Seventy first- and third-year students are selected, including four women.

1930

Duke Hospital opens July 20, 1930, attracting 25,000 visitors.

Classes began in Hospital Administration, Dietetics, and Medical Technology on August 15th.

The eighteen third-year and thirty first-year medical students began classes on October 2nd.

1931

The Duke School of Nursing's first class of twenty-four undergraduate students began classes on January 2nd.

Dedication ceremony for Duke Medical School and Hospital is held on April 20th.

Private Diagnostic Clinics were organized September 15th.

Duke Hospital Main Entrance, Circa 1940

3

Duke University Medical Center History (continued)

1940

First wing added to Duke Hospital.

The 65th General Hospital was authorized as an affiliated unit of the Duke University School of Medicine on October 17th.

1957

Outpatient and Private Diagnostic Clinic plus Hanes and Reed private floors and operating rooms were opened.

The original Medical School and Hospital were renamed "Duke University Medical Center."

1966

New Hospital Entrance, the Woodhall Building, was opened.

1980

The new $94.5 million, 616-bed Duke Hospital was opened, bringing the total number of patient beds to more than 1,000.

1998

The Duke University Health System - an integrated academic health care system serving a broad area of central North Carolina - was officially created as Duke established partnerships with Durham Regional Hospital, Raleigh Community Hospital, and other regional health care providers. DUHS today includes three hospitals, ambulatory care and surgery clinics, primary care medical practice clinics, home health services, hospice services, physician practice affiliations, managed care providers and other related facilities and services.

2007

Future Duke University Health System expansion included the development of the Hospital Addition for Surgery Building.

2009

Duke University Health System (DUHS) moved forward with the construction of a dedicated, state-of-the-art Cancer Center and the new Duke Medicine Pavilion, a major expansion of surgery and critical care services at Duke University Hospital (DUH).

2012

On February 27, 2012, a new landmark opened its doors on Duke’s medical center campus—the seven-story, 267,000-square-foot Duke Cancer Institute. More than just state-of-the-art space, it’s an environment designed to transform the experience of every patient welcomed inside. The new Cancer Institute consolidates outpatient cancer services and clinical research from across the campus into a patient-centered, multidisciplinary center.

2013

The Duke Medicine Pavilion at Duke University Hospital, opened in July 2013. The Pavilion is an eight-story building of approximately 580,000 square feet, and includes 16 new operating suites, 96 critical care beds and 64 intermediate care beds. The operating suites feature the latest in surgical technologies, as well as intraoperative CT and MRI scanners. The 64 new intermediate care beds allow for optimal transition of patients from intensive care beds to standard hospital rooms.

The expanded Duke clinical facilities serve as a state-of-the-art training and education facility for the nearly 900 residents and fellows at Duke who comprise one of the largest training programs in the United States.

4

This major expansion project follows on several recent significant capital projects throughout Duke Medicine, including renovations at Duke Raleigh and Duke Regional hospitals, and the opening of several new clinics in Wake County (Brier Creek, Morrisville, Knightdale, and North Raleigh).

Duke Medicine Pavilion at Duke University Hospital, 2013.

5

Duke Surgery

Department Chairmen The rich history and high standards that bore Duke University are also deeply rooted within the Department of Surgery. Duke Hospital’s first dean, Dr. Wilburt Davison, appointed a Johns Hopkins surgeon, Dr. J. Deryl Hart, to be Professor of Surgery and the first Chairman of the Department in 1930 (Dr. Hart had the unique privilege of having been selected by Dr. William Stewart Halsted to join the surgical training program at Johns Hopkins University). After stepping down as Chairman in 1960, Dr. Hart served as President of Duke University. During his tenure as Chairman, Dr. Hart expected faculty members to assume major clinical and teaching responsibilities and to pursue laboratory research. He recruited the founding members of the surgical faculty and established Duke’s surgery residency. Dr. Hart is also credited with originating the use of ultraviolet radiation to control airborne infections in surgical operating rooms – a technique that, ultimately, was widely accepted across the country.

J. Deryl Hart, M.D. 1930-1960

The emphasis Dr. Hart placed on achieving excellence in patient care and teaching by integrating research with development laid the foundation for an institution that remains one of the top medical centers in the country. His philosophy was central to the Department’s mission in 1930 and continues to be so today. Under the leadership of the successive chairs -- Drs. Clarence E. Gardner (1960-1964), David C. Sabiston, Jr. (1964-1994), and Robert W. Anderson (1994-2003) the model system of integrating the fundamental missions of academic medical centers: patient care, education, research and administration, was enhanced within the Department of Surgery at Duke. Dr. Gardner was Dr. Hart's first Chief Resident and continued on as a Duke faculty member after completing his surgical training.

Clarence Gardner, M.D. 1960-1964

Dr. David C. Sabiston, Jr., a North Carolina native, completed medical school and surgical training at Johns Hopkins Hospital under the mentorship of Dr. Alfred Blalock. Although his accomplishments were many during this time, he distinguished himself in the field of cardiovascular diseases. Notable among his academic achievements were his pioneering work in the surgical management of coronary artery disease and, while at Duke, groundbreaking work in the diagnosis and management of pulmonary embolism. Despite these significant efforts, Dr. Sabiston will be remembered most for his profound effect on surgical education both nationally and internationally. This is most evident when reviewing the list of successful graduates who have gone on to lead departments, divisions, and programs, and whose portraits adorn the hallways outside of the department offices.

David C. Sabiston, Jr., M.D. 1964-1994

6

Duke Surgery Department Chairmen

continued

Dr. Robert W. Anderson followed Dr. Sabiston as chairman and returned to the site of his surgical training. Social and economic influences were rapidly altering academic medicine in 1994. Dr. Anderson, an accomplished cardiothoracic surgeon with additional training in business administration, successfully led a department seeded as the epitome of traditional education and training, research, and clinical excellence while addressing the major changes in practice reimbursement that had occurred. This leadership solidified Duke’s fiscal stature and has facilitated a continued dedication to a tri-partite mission of clinical, educational, and investigational achievement.

Robert W. Anderson, M.D., M.B.A. 1994-2003

Dr. Jacobs was recruited to Duke in 2003 where he served as Chair until his departure in October 2012. Dr. Jacobs currently is the Executive Vice President, Provost and Dean of the School of Medicine at the University of Texas Medical Campus in Galveston. Over his nine years at Duke, Dr. Jacobs was highly committed to the success of all three missions within the Department of Surgery. He left Duke with the Department stronger than when he arrived and in a good position for his successor to continue the legacy of success that is Duke Surgery.

Danny O. Jacobs, M.D., M.P.H. 2003-2012

Dr. Allan D. Kirk was named Chair of the Department of Surgery at Duke University in May 2014. He also was named as the inaugural Surgeon-in-Chief for the Duke University Health System. Dr. Kirk received his M.D. from Duke University School of Medicine in 1987 and completed his Ph.D. in immunology at Duke in 1992. He completed his general surgery residency at Duke in 1995, and his multiorgan transplant fellowship at the University of Wisconsin in 1997. An accomplished scientist and surgeon, Dr. Kirk is recognized by his peers for his pioneering work in transplantation and for his outstanding ability to lead. Prior to returning to Duke, he served as a Commander in the United States Navy at the Naval Medical Research Institute, became the inaugural Chief of the Transplantation branch at the National Institutes of Health, and served as Vice Chair for Research for the Department of Surgery at Emory University. His commitment to rigorous education and training, innovative research, and the most advanced patient care make him an excellent leader for Duke Surgery.

Allan D. Kirk, M.D., Ph.D. 2014-present

7

History of Cardiothoracic Surgery at Duke

Dr. David C. Sabiston Jr. was one of the architects of the modern training program in cardiothoracic surgery. When he arrived at Duke in 1964, he established an integrated program in general and thoracic surgery, the model for the current integrated programs that have recently been approved by the American Board of Thoracic Surgery. Dr. Sabiston was a preeminent surgeon and surgical scientist, but many cite his most important accomplishment as the development of academic surgical training and his success in training academic surgeons. Over the years 1964-94, he trained 154 chief residents, of which 95 became cardiothoracic surgeons. Of these chief residents, 103 went on to academic positions, with 41 becoming either division chiefs or department chairmen. Finally, he was instrumental in the development of the careers of 4 subsequent Presidents of the American Association for Thoracic Surgeons. In 1994, Dr. Peter K. Smith was named as the Chief of the Division of Cardiothoracic Surgery. In conjunction with the Program Directors and Faculty, Dr. Smith has continued the tradition of clinical and academic excellence that was fostered by Dr. Sabiston. While, the Program has been progressive and dynamic, with many changes over the years (including the abolition of in-hospital call), the mission of the Division—to train academic thoracic surgeons—had been promoted. Specifically, 30 of the most recent 35 graduates from our traditional program have successfully attained a position in academic surgery. In the future, the Program will continue to dedicate itself to Dr. Sabiston’s tradition: the mission of training academic thoracic surgeons. Duke General Thoracic Surgery The Duke General Thoracic Surgery Program was one of the original Thoracic Track Training Programs, and we continue to lead in the training of academic general thoracic surgeons. The state of North Carolina has one of the nation’s highest incidences in both lung cancer and esophageal cancer, and Duke has the largest clinical Lung Cancer Surgery and Esophageal Cancer Surgery Programs in both the state and Southeast Region. Over the past 2 decades, the Program has also distinguished itself as a leader in minimally invasive thoracic surgery. Duke was the lead accrual site in the first multi-institutional clinical trial of thoracoscopic lobectomy, and our volume continues to be one of the highest in the country. Moreover, our clinical research program is unsurpassed—the majority of the faculty have advanced training in clinical research—and the program actively integrates our residents in clinical research, as evidenced by resident presentations at national meetings and publications. In addition to our minimally invasive lung cancer and esophageal cancer programs, we also have well-developed programs in robotics, benign esophageal disease, lung volume reduction, tracheal surgery, and interventional procedures (RFA, PDT, EMR, EBUS, EUS, laser, stents). Finally, as one of the largest programs in the Duke Cancer Institute, the Thoracic Oncology Program attracts patients from the Southeast and other regions in the country, as well as internationally. Lung Transplantation Program The Duke Lung Transplant Program was established in 1992 and has become one of the top lung transplant programs in the world. Since that time, over 1300 lung transplant have been performed. The program routinely performs more than 100 lung transplants per year and is projected to perform approximately 150 transplants this year. One-year survival is approximately 90% and is significantly better than expected (SRTR.ORG). The program has excellent outcomes in transplanting patients who have not historically been candidates for lung transplantation, such as people 70 and older, patients with cystic fibrosis whose lungs are colonized with resistant pathogens, patients with coronary artery and/or valvular heart disease, and critically ill people who require mechanical ventilation or ECMO (extracorporeal membrane oxygenation). The program has the highest transplant rate of any lung transplant program in the US. Patients have a median wait time of 12 days and mortality on the waitlist is uncommon. The primary focus of the program is on innovation that addresses the primary limitations in lung transplant: an inadequate supply of donor lungs, primary graft dysfunction and failure, and insufficient long-term survival of the patient and the lung allograft. Duke has been a pioneer in increasing the number of useable lungs including the use of ex vivo lung perfusion (EVLP). Translation of experimental data into the clinic has allowed Duke’s primary graft dysfunction rate to be one of the lowest in the country. Sentinel observations at Duke have led to the understanding of the importance of environmental exposures to lung allograft injury, particularly aspiration events related to gastric reflux, has fundamentally altered care of lung transplant recipients. Tolerance trials have been initiated. The first successfully tolerant lung transplant recipient using cadaveric lung and bone marrow is now over 3 years out from her lung transplant and off all immunosuppression for over 2 years. The Duke program is focused on exceptional clinical care, innovation and the training of physicians and surgeons to be leaders in lung transplantation.

8

Duke Cardiac Surgery The Cardiac Surgery program at Duke has a long and storied history beginning in the 1950’s with pioneering research in hypothermia which led to its universal adoption in the conduct of cardiopulmonary bypass. Coronary artery bypass grafting was introduced to our specialty by Dr. David C. Sabiston, Jr, and has been a cornerstone of our program. Two of our faculty (Wil Gay and Paul Ebert) developed and introduced cold potassium cardioplegia as the fundamental adjunct along with cardiopulmonary bypass for most cardiac surgical procedures performed today. Among many “firsts” achieved at Duke, valve replacement for endocarditis, valve resuspension in aortic dissection and the surgical treatment of cardiac arrhythmias stand out. More than 30,000 cardiac operations have been performed at Duke, with the current annual rate being more than 1200. Of interest to applicants, Duke’s cardiac volume has increased over the past 5 years as we have differentiated specialty programs that match the needs of future surgeons. During the 1990’s, over 75% of our procedures were isolated CABG. Today, that figure is less than 30%, but still amounts to 400-500 procedures per year. We feel that this is an appropriate number for today’s training needs, and still perform more than 90% of CABGs with cardiopulmonary bypass support as resident cases. The large number of isolated coronary bypass procedures has been replaced by equivalent numbers of valve, valve coronary, endovascular, aortic, cardiac/lung transplant and ventricular assist device procedures. We have several programs that are nationally and internationally recognized, and all of our programs are regional leaders. This change has been consistent with the changing demands of our specialty and there are no “gaps” in appropriate clinical training opportunities. Cardiac surgery is almost always performed for longevity benefit, and its efficacy has been fundamentally supported by extensive clinical research. We have continued that tradition with the award of the Cardiothoracic Surgical Research Network award from the NHLBI in 2006, with continued funding as a primary site through 2018. Associated with this, we have been awarded an NHLBI Clinical Skills Development site award that funds Master’s degree training in clinical research. Each year, we have two scholars enrolled in clinical research, and they actively work with our Thoracic Residents in clinical research projects. Thoracic residents are thus able to actively participate in clinical research with appropriate support. Among many examples, Duke has published extensively in the area of treatment selection in coronary artery disease from our databank on more than 60,000 patients who have had cardiac catheterization and/or cardiac surgery. This dataset is unique in having a medical therapy component, and has long term mortality outcome as the key endpoint for hypothesis testing. Duke Valve Surgery Program The Duke Valve Surgery Program performs approximately 400 valve procedures annually, including 250 AVR, 30 Bentall, 125 mitral repair, 75 MVR, 70 AVR/CAB, 40 mitral/CAB, 30 tricuspid, 50 maze procedures, 100 minimally invasive mitrals including robotics, 60 minithorc AVRs, 60 TAVR. Each resident finishes having performed and having competence in all of these standard open procedures, with numbers more than sufficient for thoracic or cardiac track boards. Residents have opportunity to perform more advanced minimally invasive procedures like robotic mitrals, mini-thoracotomy mitrals and AVRs, and TAVR based upon their interest and time spent on the service. A simulation laboratory and wet labs are being working into the residency to hone specific advanced technical skills. All residents finish with alternative cannulation, hybrid operating, and wire skills that will be needed for future procedures like percutaneous MVR and that are useful in high-risk open procedures like re-do cardiac surgery. Heart Transplant Program The Duke Heart transplant program was initiated in 1985. For the past decade, our volume has been consistently between 50 and 60 heart transplants per year. Duke is the largest heart transplant program in the southeast and usually one of the top five programs nationally for volume. Average wait times and survival outcomes are excellent and publically available on the SRTR registry website. Adult survival outcomes at one and three years post-transplant are better than expected national outcomes. Pediatric heart transplants are also performed at Duke with recent volumes ranging between 5-10 per year. Mechanical Circulatory Support Program The Duke MCS program has been in existence for approximately 15 years. Multiple types of devices for MCS are available at Duke for bridge to transplant, bridge to recovery and destination therapy. Implantable LVAD volumes

9

have exceeded transplant volumes at approximately 70 procedures per year. Duke was the leading enrolling site in the Heartware HVAD DT trial and the second leading enroller in the Heartmate II DT trial. Other clinical VAD trials which are active at Duke include: REVIVE IT, ROADMAP and the Recover Right Impella trial. Congenital Heart Surgery Program The Congenital Heart Surgery Program at Duke University Medical Center is a robust, nationally recognized clinical and research center. The annual congenital surgical volume includes over 250 pump cases and over 400 total cases per year, with approximately 85% being pediatric and 15% being adult congenital cases. We perform the entire spectrum of congenital heart operations. Our mortality is consistently lower, and our case complexity mix is consistently higher than the average reported by other centers. The program is supported by a dedicated 13 bed pediatric cardiac ICU in addition to the 16 bed PICU. We have a long history of contributions in both basic and clinical research in pediatric cardiac surgery. We have been a core center in the NHLBI Pediatric Heart Network, and participate in a number of multicenter trials. In addition, the Duke Clinical Research Institute is the data coordinating center for the STS Congenital Heart Database. Numerous graduates of the Duke Thoracic Surgery Residency have gone on to become congenital heart surgeons, including eight who are current chiefs of their respective divisions. The experience of the cardiothoracic surgery resident at Duke includes participation in all operative cases, management of the patients with the multi-disciplinary team in the ICU and on the wards, and participation in the weekly multi-specialty case conference that has been regarded as one of the most educational conferences in the program. At the current time we do not have a congenital heart surgery fellowship program. The operative experience for the resident is therefore undiluted and includes more than enough cases to satisfy all board requirements. The resident will gain experience as the operating surgeon on a variety of congenital heart defects, including re-operative cases. Overall the rotation provides a comprehensive overview of congenital heart surgery. Aortic Surgery Program The Duke Center for Aortic Disease was established in July of 2005 and has subsequently grown into one of the largest thoracic aortic surgery programs in the world performing over 200 major aortic operations annually, including more than 50 thoracic endovascular aortic repairs and over 100 cases utilizing deep hypothermic circulatory arrest each year. The Duke program is internationally recognized for pioneering work in the field of hybrid aortic repair with series of hybrid arch and thoracoabdominal repair among the largest in the world. Graduates of the Duke Cardiothoracic Training Program desiring to focus on Aortic Surgery during their 3rd year of training finish with extensive hands-on experience in all areas of thoracic aortic surgery including valve-sparing aortic root replacement, conventional Bentall and bio-Bentall root replacement, open and hybrid aortic arch replacement, endovascular and conventional open descending aortic replacement, as well as conventional and hybrid thoracoabdominal aortic aneurysm repair. Graduates of the program with an interest in Aortic Surgery also have the opportunity to spend time in the Aortic Disease Clinic where they gain valuable knowledge of pre- and post-operative evaluation and management of patients with thoracic aortic disease, including connective tissue disorders such as Marfan and Loeys-Dietz syndromes. Graduates also gain extensive experience in the interpretation of echocardiography and CT and MR angiography for the evaluation of aortic disease. The Duke Thoracic Aortic Surgery Database is a prospectively maintained database containing records on over 1200 patients undergoing thoracic aortic surgery at Duke since 2005, and the Aortic Program has published over 60 peer-reviewed manuscripts with more than 100 regional, national, and international presentations since 2005 on various topics in thoracic aortic disease. Residents in the Duke program are major participants in this research with numerous national presentations and published manuscripts based on data from this database. Duke is also a large referral center for transcatheter aortic valve replacement (TAVR) with high volume experience with both the commercially available Edwards Sapien and investigational Medtronic CoreValve devices, one of only a handful of centers in the U.S. with access to both devices, and currently ranks 3rd in overall enrollment in the Medtronic CoreValve trials. Current TAVR volumes at Duke are over 100 cases annually with further growth anticipated with the opening of the 2nd Duke Hybrid OR after the move to the Duke Medical Pavilion. All Duke Cardiac Surgery residents graduate with extensive experience in TAVR.

10

Training Program in Thoracic Surgery Currently, there are three training programs in Thoracic Surgery at the Duke University Medical Center: the Integrated program, the Joint Training Program (4/3 program for residents who have started their General Surgery training at Duke and wish to train in Thoracic Surgery), and the traditional program. These training programs are designed to develop academic cardiothoracic surgeons. At the completion of their training, residents will demonstrate proficiency in all clinical aspects of cardiothoracic surgery and will have extensive experience and training in clinical research. The traditional program, a 3-year program with 3 residents at each training level, provides for progressive responsibility and a balanced exposure to adult cardiac surgery, congenital cardiac surgery, and general thoracic surgery. The philosophy of the training program is predicated on the mentorship system, where each resident rotates on a service with 2-3 faculty members for 4 months, providing consistent, sustained relationships. Unique to our program, there are 2 VA hospital rotations, one in Durham and one in Asheville, where autonomy is optimized. Clinical Rotations in Cardiothoracic Surgery (rotations are 4 months in duration)

Year 1 Adult Cardiac (Duke)

General Thoracic (Duke)

Congenital Cardiac (Duke)

Year 2 Adult Cardiac (Duke)

General Thoracic (Duke)

Adult Cardiac and Thoracic (Durham VA)

Year 3 Chief Resident-Duke (Elective rotation)

Elective (Duke or Away)


Curriculum In addition to the clinical experience, a comprehensive didactic teaching schedule is emphasized, based on a 3-year defined curriculum including topics in medical knowledge, patient care, practice-based learning, systems-based practice, communication, and professionalism. The faculty and residents participate in a comprehensive conference schedule, designed to optimize clinical experience, didactic teaching, and interactive learning. General Thoracic Surgery Track Residents in the General Thoracic Surgery track are integrated in a didactic, clinical and investigational program that is designed to optimize the development of a career in Thoracic Surgical Oncology and General Thoracic Surgery. This program provides for 16-20 months of General Thoracic Surgery (out of 36 months), including robust experience in both the operating room and the outpatient clinics.

Year 1 General Thoracic (Duke)

Adult Cardiac (Duke)

Congenital Cardiac (Duke)

Year 2 General Thoracic (Duke)

Adult Cardiac (Duke)

Adult Cardiac and Thoracic (Durham VA)

Year 3 Chief Resident/Lung Transplant (Duke)



Academic and Professional Development Upon entering the Program, residents are assigned an advisor/mentor, who becomes integral to the clinical and academic development of each resident. The academic development of each of the residents in the training program is the responsibility of the mentor and the Program Director. In order to enhance education improve the national exposure, each resident has the opportunity to attend one national meeting annually, at the expense of the Division. Each resident attends one of the major academic meetings, such as the AATS and STS. In addition, each resident has the opportunity to attend an additional meeting, such as a technical course or review course. These opportunities are in addition to any meeting in which the resident is participating as a presenter. One of the most important features of the training program is the opportunity for elective rotations in the third year, in order to fully develop the clinical strengths and enhance the academic potential of each resident. In order to facilitate this process, the Division of Thoracic Surgery has established relationships with a number of other academic

11

programs nationally. The goal of the training program is the development of the complete academic Thoracic surgeon, competitive for all professional opportunities at the Assistant Professor level, with no requirement for future training. Clinical Research To promote the development of each resident as an academic surgeon, there is programmatic emphasis on excellence in clinical research. Some residents choose to participate in clinical research through the Duke Clinical Research Institute (DCRI), which houses one of the largest cardiovascular data banks in the world, as well as an array of professionals with expertise in clinical research, information technology, epidemiology, and biostatistics. Upon completion of the training program, residents have the opportunity to complete multiple projects, with publications in major peer-reviewed journals. In addition, residents have access to resources related to the American College of Surgeons Oncology Group (ACOSOG) and the Cancer and Leukemia Group B (CALGB). Thoracic Surgery Residency Educational Conferences (Duke Hospital)

Monday 6:30 PM Residents’ Teaching Conference

Tuesday 9:00 AM Lung Transplant Conference

Wednesday 6:00 AM Attending Rounds

Wednesday 6:45 AM M&M

Wednesday 7:30 AM Thoracic Surgery Grand Rounds

Wednesday 4:30 PM Multidisciplinary Thoracic Oncology Conference

Thursday 7:00 AM General Thoracic Surgery Conference

Friday 7:30 AM Pediatric Cath Conference Thoracic Surgery Residency Educational Conferences (Durham VA)

Wednesday 10:30 AM VA Cath/Indications Conference Work-Hours The schedule is designed to adhere to all RRC Duty Rules, including every other weekend off duty. There is NO IN-HOSPITAL call.

12

Clinical Programs

Adult Cardiac Surgery Myocardial Revascularization Valve Repair and Replacement Transcatheter Valve Replacement Minimally Invasive Cardiac Surgery

Surgery for Atrial Fibrillation Robotics

Aortic Surgery Surgery for Aneurysms, Dissections Stent Grafting

General Thoracic Surgery Lung Cancer Esophageal Cancer Mesothelioma Benign Esophageal Disease Minimally Invasive Thoracic Surgery Robotics

Lung Volume Reduction Surgery Tracheal Surgery EBUS, RFA, PDT

CT Screening

Surgery for Cardio-Pulmonary Failure

Heart Transplantation Ventricular Assist Pulmonary Transplantation ECMO

Congenital Cardiac Surgery Pediatric Congenital Adult Congenital

Affiliated Institutions

Duke University Medical Center

Consistently ranked as one of the top ten hospitals by US News & World Report, the 1,117-bed Duke University Hospital is a tertiary and quaternary care hospital. On its 210 acres, it is recognized as a model for hospitals of the future, with a Cancer Institute which opened in 2012 and a Medical Pavilion with state of the art operating rooms. The Medical Pavilion, which opened July 2013, is an eight-story building of approximately 580,000 square feet, and includes 16 new operating suites, 96 critical care beds and 64 intermediate care beds. The operating suites feature the latest in surgical technologies, as well as intraoperative CT and MRI scanners. The 64 new intermediate care beds allow for optimal transition of patients from intensive care beds to standard hospital rooms.

The Cardiothoracic Surgery Service draws patients from the across the Southeast, as well as from other national and international sites.

13

Durham Veterans Affairs Medical Center

The Duke training program is affiliated with the Durham VA Medical Center, a Deans' Committed Veterans Affairs Medical Center. This is a 274-bed general medical and surgical facility is located across the street from Duke Hospital. The Durham VA provides general and specialty medical, surgical, psychiatric inpatient and ambulatory services, and is a major referral center for veterans in North Carolina, southern Virginia, northern South Carolina, and eastern Tennessee.

There, residents conduct preoperative evaluation, operative procedures, and postoperative care on all patients. With supervision provided by the academic faculty of Duke University Medical Center, the rotations at the Durham VA provide a balanced exposure to cardiovascular and thoracic surgery.

14

Cardiovascular and Thoracic Surgery Faculty

15

DUMC Box 3442 Durham, NC 27710 [email protected]

Peter Smith, M.D. Professor of Surgery Title Division Chief, Cardiovascular and Thoracic Surgery Training MD, Duke University School of Medicine, North Carolina, 1977 Residency Cardiovascular Research, Duke University Medical Center, 1987 Teaching Scholar, AHA Clinician Scientist Awardee, Duke University Medical Center, 1980–83 Clinical Interests Adult cardiac surgery with emphasis on coronary artery disease and valvular heart surgery. Research Interests Dr. Smith is the principal investigator for the Duke site in the Cardiothoracic Surgery Clinical Trials Network (CTSN) and in recent years has focused on clinical research. Topics include comparing CABG alone to CABG with mitral repair for moderate ischemic mitral regurgitation, as well as FFR and angiographically guided CABG. An integration of clinical research, publications, and scholarship with the advancement of clinically effective thoracic surgery is the goal of his research activities.


Thomas D’Amico, M.D. Gary Hock Endowed Professor of Surgery

Title Vice-Chair of Surgery Chief, Section of General Thoracic Surgery Program Director, Thoracic Surgery

Training MD, Columbia University College of Physicians and Surgeons , New York, 1987

Residency Thoracic Surgery, Duke University Medical Center, 1987-1996

Fellowship Thoracic Oncology, Memorial Sloan-Kettering Cancer Center, 1996

Clinical Interests Lung and esophageal cancer; general thoracic and thorocoscopic surgery; minimally invasive thoracic surgery; thoracic oncology; lung volume reduction; photodynamic therapy (PDT); laser bronchoscopy; bronchial and esophageal stents; molecular biology of lung and esophageal cancer .

Research Interests Lung Cancer: (1) Role of molecular markers in the prognosis and therapy of lung cancer; (2) Genomic analysis lung cancer mutations. Esophageal Cancer: (1) Role of molecular markers in the prognosis and therapy of esophageal cancer; (2)Genomic analysis esophageal cancer mutations.

Cardiovascular and Thoracic Surgery Faculty Members

16

DUMC 3867 Durham, NC 27710 [email protected]

Mani A. Daneshmand, M.D. Assistant Professor of Surgery Training MD, Albany Medical College (New York), 2004 Residency General Surgery, Duke University Medical Center, 2004-2011 Thoracic Surgery, Duke University Medical Center, 2011-2013 Fellowship Cardiothoracic Surgical Research, Duke University Medical Center, 2006-2008 Clinical Interests Cardiac and lung transplantation, left ventricular assist devices, adult cardiac surgery, mitral valve surgery, surgical treatments for end-stage congestive heart failure, aortic valve surgery


Jeffrey G. Gaca, M.D. Associate Professor of Surgery Training M.D., Columbia University College of Physicians and Surgeons. New York, 1998 Residency General Surgery, Duke University Medical Center, 1998-2005 Thoracic Surgery, Duke University Medical Center, 2005-2008 Clinical Interests Adult cardiac surgery, thoracic aortic surgery, minimally invasive approaches to valvular heart disease.


Donald Glower, Jr., M.D. Professor of Surgery

Training M.D., Johns Hopkins University, Maryland, 1980

Residency Surgery, Duke University Medical Center, North Carolina, 1980-1987 Thoracic Surgery, Duke University Medical Center, North Carolina, 1987-1989

Clinical Interests Minimally invasive valve and coronary surgery; valve repair and replacement; robotic heart surgery; septal myectomy for hypertrophic obstructive cardiomyopathy; minimally invasive maze procedure for atrial fibrillation.

Research Interests Current clinical research projects examine the effects of patient characteristics and surgical technique in outcome after minimally invasive cardiac surgery, valve repair and replacement, and coronary artery bypass grafting. Prior work has examined the role of surgical therapy versus medical therapy in aortic dissection, load-independent means to quantify left and right ventricular function, and management of complex coronary disease.

17

DUMC Box 31071 Durham, N 27710 [email protected]

John Haney, M.D., M.P.H. Assistant Professor of Surgery Title Assistant Program Director, Thoracic Surgery MSII Core Course Director, Department of Surgery Training M.D., Duke University School of Medicine, 2004 Residency Surgery, Duke University Medical Center, North Carolina, 2004-2011 Thoracic Surgery, Duke University Medical Center, North Carolina, 2011-2014 Other Training M.P.H., Boston University, 2000 Clinical Interests Adult cardiac surgery including coronary artery revascularization and valve surgery; lung transplantation; extracorporeal life support therapies for cardiac and respiratory failure; ex-vivo lung perfusion; and surgical treatment of chronic thromboembolic pulmonary hypertension.


David H. Harpole, Jr. M.D. Professor of Surgery Associate Professor in Pathology Title: Vice Chief, Division of Surgical Services Training MD, University of Virginia School of Medicine, 1984 Residency General Surgery, Duke University Medical Center, 1984-1991 Thoracic Surgery, Duke University Medical Center, 1991-1993 Fellowship Thoracic Oncology, Dana Farber Cancer Institute, Harvard Medical School (Massachusetts), 1993-1995 Clinical Interests Thoracic oncology; general thoracic surgery; benign and malignant disease of the lung, esophagus, and mediastinum; advanced airway and thoracoscopic surgery; hyperhidrosis palmaris; mesothelioma. Research Interests Non-small cell lung cancer: (1) Evaluation of serum and tissue molecular biologic markers of recurrence in patients with a localized non-small cell lung cancer; (2) Molecular biologic staging of lymph nodes in patients with non-small cell lung cancer; (3) The evaluation of the clonality of metastatic tumors in patients with non-small cell lung cancer.

18


Matthew G. Hartwig, M.D. Associate Professor of Surgery Title Program Director, Thoracic Surgery Minimally Invasive Surgery Fellowship Surgical Director of Lung Transplantation Training MD, Duke University School of Medicine, 2001 Residency Surgery, Duke University Medical Center, 2001-2008 Thoracic Surgery, Duke University Medical Center, 2008-2011 Fellowship Thoracic Surgery, Research Fellow, Duke University Medical Center, 2003-2005 Clinical Interests Thoracic oncology with an emphasis on minimally invasive approaches to lung and esophageal cancer; video-assisted thoracic surgery (VATS) and robotic-assisted thoracic surgery (RATS); benign and malignant diseases of the lung, esophagus, mediastinum, and chest wall; surgical treatment of end-stage lung disease, including lung-volume reduction and lung transplantation; ex vivo lung perfusion; donation after cardiac death; extracorporeal life support for respiratory failure .


G. Chad Hughes, M.D. Associate Professor of Surgery Title Director, Aortic Surgery Program Training M.D., Duke University School of Medicine, North Carolina, 1995 Residency General Surgery, Duke University Medical Center, North Carolina, 1995-2002 Cardiothoracic Surgery, Duke University Medical Center, North Carolina, 2002-2005 Fellowship Thoracic Aortic Surgery, Hospital of the University of Pennsylvania, 2005 Clinical Interests Adult cardiac surgery, surgery of the thoracic aorta, including disorders of the aortic root, ascending aorta, aortic arch, descending and thoracoabdominal aorta; thoracic endovascular aortic repair (TEVAR); transcatheter aortic valve implantation (TAVR); aortic valve repair.

19


Jacob A. Klapper, M.D. Assistant Professor of Surgery Assistant Professor in Immunology Training M.D., Indiana University School of Medicine, 2003 Residency General Surgery, Indiana University School of Medicine, 2003 - 2011 Thoracic Surgery, Duke University Medical Center, North Carolina, 2011-2014 Other Training Research Fellow, Surgery Branch, National Cancer Institute, 2005-2008 Clinical Interests Thoracic oncology; general thoracic surgery; benign and malignant disease of the lung, esophagus, and mediastinum;


Shu Lin, M.D., Ph.D. Associate Professor of Surgery, Assistant Professor in Immunology Assistant Professor in Pathology Training M.D., Duke University School of Medicine, North Carolina, 1992 Residency General Surgery, Duke University Medical Center, North Carolina, 1992-2001 Thoracic Surgery, Duke University Medical Center, North Carolina, 2001-2004 Other Training PhD, Immunology, Duke University Medical Center, 2000 Clinical Interests Cardiopulmonary transplantation (heart, lung and heart-lung transplantation), transplant immunology, adult cardiac surgery including CABG and valvular surgery. Research Interests Two challenges of cardiopulmonary transplantation are the lack of consistent long-term graft survival and the shortage of donor organs. In searching for solutions to these problems, Dr. Lin’s laboratory studies: (1) Mechanisms underlying the chronic rejection, especially that of lung and heart-lung allografts; (2) Induction of immunologic tolerance to reduce the morbidity and improve the long-term survival of heart and lung transplantation; (3) Xenotransplantation, with the ultimate goal of alleviating the problem of donor organ shortage but the more immediate goal of gaining general knowledge about transplantation immunobiology.

20


Andrew Lodge, M.D. Associate Professor of Surgery Assistant Professor in Pediatrics Training MD, Duke University School of Medicine, 1993 Residency General Surgery, Duke University Medical Center, 1993-2000 Thoracic Surgery, Duke University Medical Center, 2000-2002 Fellowship Pediatric Cardiac Surgery, Children's Hospital of Philadelphia (Pennsylvania), 2002-2003 Clinical Interests Pediatric cardiac surgery, adult congenital heart disease, heart transplantation, ventricular assist devices. Research Interests Extracorporeal circulation Ventricular assist Clinical outcomes after congenital heart surgery


Carmelo A. Milano, M.D. Professor of Surgery Training MD, University of Chicago Pritzker School of Medicine (Illinois), 1990 Residency General Surgery, Duke University Medical Center, 1990-1992, 1994-1997 Cardiothoracic Surgery, Duke University Medical Center, 1997-1999 Fellowship Molecular Cardiology, Howard Hughes Medical Institute, Duke University, 1992-1994 Cardiac Transplant, Papworth Hospital (England), 1999 Clinical Interests Cardiac transplantation, left ventricular assist devices, adult cardiac surgery, mitral valve surgery, surgical treatments for end-stage congestive heart failure, aortic valve surgery

21


Ryan P. Plichta, M.D. Assistant Professor of Surgery Training MD, Loyola University Chicago Stritch School of Medicine, 2008 Residency General Surgery Residency, Surgery, Loyola University Chicago Stritch School of Medicine, 2008 – 2013 Cardiothoracic Surgery Residency, Surgery, Loyola University Chicago Stritch School of Medicine, 2013 - 2015 Fellowship Advanced Aortic And Endovascular Surgery Fellowship,, Cleveland Clinic, 2015 – 2016 Clinical Interests: Aortic surgery, TAVR, adult cardiac surgery


Jacob N. Schroder, M.D. Assistant Professor of Surgery Training MD, Georgetown University School of Medicine (Washington, DC), 2001 Residency General Surgery, Duke University Medical Center, 2001-2009 Thoracic and Cardiovascular Surgery, Duke University Medical Center, 2009-2012 Fellowship Cardiothoracic Surgery Research Fellow, Cardiothoracic Surgery, Duke University Medical Center, 2003-2006 Clinical Interests Cardiac transplantation, mechanical circulatory support devices and heart failure surgery, adult cardiac surgery, cardiothoracic surgical education


Betty C. Tong, M.D., M.H.S., M.S. Associate Professor of Surgery Title Associate Program Director, Thoracic Surgery Training MD, Duke University School of Medicine, 1999 MHS, The Johns Hopkins Bloomberg School of Public Health, 2009 Residency General Surgery, The Johns Hopkins Hospital, 1999-2005 Thoracic Surgery, Duke University Medical Center, 2005-2008 Clinical Interests Thoracic oncology including lung cancer and mesothelioma, esophageal cancer, and chest wall tumors; diseases of the mediastinum; pulmonary metastases; minimally invasive/video-assisted thoracic surgery; lung volume reduction; benign lung and chest conditions Research Interests Patient preferences and shared decision making Surgical education and learning

http://www.dukehealth.org/repository/dukehealth/2012/08/31/13/48/12/7351/SchroderJacob.jpg

22

Current Residents

23

Current Residents

Integrated Training Program

2017

Mohamed Algahim, MD*

Medical School: Northeastern Ohio University College of Medicine

Career Interest: Adult Cardiac Surgery

Email: [email protected]

*Dr. Algahim completed his PGY1 – 5 years at Medical College of Wisconsin

2021

Jatin Anand, MD

Medical School: University of Miami Leonard Miller School of Medicine



2023

Julie Doberne, MD, PhD

Medical School: Oregon Health Sciences University School of Medicine



mailto:[email protected]



24

Thoracic Surgery Integrated Research Fellowship

Muath Bishawi, MD, MPH

Medical School: State University of New York at Stony Brook

Career Interest: Cardiac Surgery


Traditional Training Program

2017

Christopher Scott, MD

Medical School: Univeristy of Virginia

Residency: General Surgery, University of Cincinnati

Career Interest: General Thoracic Surgery


Adam Williams, MD

Medical School: Univeristy of Miami

Residency: General Surgery, University of Miami






25

2018

Brittany Zwischenberger, MD

Medical School: University of Texas Southwestern Medical Center

Residency: General Surgery, University of Kentucky Medical Center



2019

Benjamin Bryner, MD, MS

Medical School: University of Michigan Medical School

Residency: General Surgery, University of Michigan

Career Interest: General Thoracic Surgery/Lung Transplantation


Joint Training Program

2017

Nicholas Andersen, MD

Medical School: Harvard Medical School

Residency: General Surgery, Duke University Medical Center

Career Interest: Congential Surgery





26

2018

Anthony Castleberry, MD, MMCI

Medical School: University of Pittsburgh School of Medicine


Career Interest: Cardiac Surgery


Jennifer Hanna, MD, MBA

Medical School: Duke University School of Medicine




2019

Asvin Ganapathi, MD

Medical School: Case Western Reserve University School of Medicine




Paul Speicher, MD, MHS

Medical School: Northwestern University Feinberg School of Medicine







27

2020

Jeffrey Keenan, MD

Medical School: University of Maryland School of Medicine




Chi-Fu Jeffrey Yang, MD

Medical School: Harvard Medical School




28

Resident Publications

29

Mohamed Algahim, MD

Refereed journals

1. Jain R, Algahim MF, Bajwa T, Khandheria B, O’Hair D, “Expanding options for native mitral valve stenosis in the extremely high risk surgical patient; Two cases treated with transcatheter mitral valve replacement,” Ann of Thor Surg, 2016 Mar; 101 (3): e75-e77.

2. Colwell EM, Algahim MF, Rao A, Gasparri MG Primary pulmonary leiomyosarcoma with invasion of the pulmonary vein-A case report, Int J Surg Case Rep. 2016;19:103-5

3. Boettcher BT, Irish SM, Algahim MF, Rokkas C, Plambeck C, Novalija J, Pagel PS;"Acute Severe Chest Pain in the Presence of known Coronary Artery Disease: New Myocardial Ischemia, Aortic Dissection, or some other Evolving Cardiovascular Catastrophe?" J Cardiothorac Vasc Anesth. 2015.

4. De Vry DJ, Poblocki JR, Algahim MF, Hossein Almassi G, Pagel PS. “Mechanism of Torrential Aortic Valve Insufficiency in Endocarditis: Leaflet Destruction, Restriction, Prolapse, or Perforation?” J Cardiothorac Vasc Anesth. 2015.

5. Algahim MF, LoveRB. “Donation after circulatory death: the current state and technical approaches to organ procurement,” Curr Opin Organ Transplant. 2015 Apr;20 (2):127-32

6. Algahim MF, Lux TR, Leichman JG, Taegtmeyer H, “Two contrasting outcomes of weight loss surgery: Positive impact on the heart, negative impact on the liver,” Case Reports in Internal Medicine 2.2 (2014): p1.

7. Carbone RG, Algahim MF, Rizzo S, Monselise A, RA Dart, Almassi GH, Gutterman DD, “Cardiovascular risk in patients without known cardiovascular disease,” Eur Rev Med Pharmacol Sci. 2014 Feb;18(3):365-73

8. Algahim MF, Almassi GH. “Current and emerging management options for patients with Morquio A Syndrome," Ther Clin Manag. 2013; 9:45-53.

9. Algahim MF, Sen S, Taegtmeyer H. “Bariatric Surgery to Unload the Stressed Heart: A Metabolic Hypothesis” Am J Physiol Heart Circ Physiol. 2012; 302:1539-45.

10. Algahim MF, Lux TR, Leichman JG, JBoyer AF, Miller CC, Laing ST, Kyle UG, and Taegtmeyer H. “Progressive decline of left ventricular mass two years after bariatric surgery” Am J Med. 2010; 123:549-55

11. Algahim MF, Yang PB, Burau KD, Swann AC, Dafny N. “Repetitive Ritalin Treatment Modulates the Diurnal Activity Pattern of Young SD Male Rats” Cent Nerv Syst Agents Med Chem. 2010; 10:247-57

12. Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC 3rd, Moody FG, Lux TR, Taegtmeyer H. “Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery” Am J Med. 2009; 122:435-42.

13. Algahim MF, Yang PB, Wilcox V, Bureau KD, Smolensky M, and Dafny N. “Prolonged methylphenidate treatment alters the behavioral diurnal activity pattern of adult male Sprague-Dawley rats” Pharmacol Biochem Behav. 2009; 92:939.

14. Ashrith G, Algahim MF, Taegtmeyer H. “Insulin resistance: marker or mediator?” Am J Med. 2009; 122(3):e13; author reply e15.

15. Harmancey R, Wright NR, Algahim MF, Wilson CR, Taegtmeyer H. “Obesogenic Western diet changes fatty acid composition in failing rat heart,” FASEB J. New Orleans, LA; 2009 23:793.4

16. Leichman JG, Wilson EB, Scarborough T, Aguilar D, Miller CC, Yu S, Algahim MF, Reyes M, Moody FG, and Taegtmeyer H. “Dramatic Reversal of Derangements in Muscle Metabolism and Left Ventricular Function After Bariatric Surgery” Am J Med. 2008; 121: 966 – 973.

17. Heinrich Taegtmeyer and Mohamed F. Algahim. “Obesity and Cardiac Metabolism in Women” JACC Cardiovasc Imaging; 2008; 1:434-435

BOOK CHAPTERS

1. Algahim MF, Love RB, Benjamin IJ, “Other Cardiac Topics” In: Andreoli & Carpenter’s Cecil Essentials of Medicine, 9th edition; Benjamin IJ (Ed), Elsevier Inc., Philadelphia PA, 2015.

2. Algahim MF, Yang PB, Wilcox, VT, Burau KD, Swann AC, Dafny N, “Chronic methylphenidate modulates the circadian activity pattern of adolescent SD male rats” In: Neurodevelopment Assessment Anomalies and Outcomes; F. Columbus (Ed), Nova Science Publishers Inc, Hauppauge, NY: Nova. 2009.

Jatin Anand, MD

Refereed journals

1. Mallidi HR, Anand J, Singh SK. Long-term mechanical circulatory support: A new disease state? J Thorac Cardiovasc Surg. 2015 Jul;150(1):e13-4. doi: 10.1016/j.jtcvs.2015.04.049. Epub 2015 May 7. PubMed PMID: 26126479.

http://www.ncbi.nlm.nih.gov/pubmed/26745312


http://www.europeanreview.org/wp/wp-content/uploads/365-373.pdf

http://www.europeanreview.org/wp/wp-content/uploads/365-373.pdf

http://www.ncbi.nlm.nih.gov/pubmed/19375553?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DefaultReportPanel.Pubmed_RVDocSum



30

2. Anand J, Singh SK, Antoun DG, Cohn WE, Frazier OH, Mallidi HR. Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future. Biomed Res Int. 2015;2015:849571. doi: 10.1155/2015/849571. Epub 2015 Oct 25. Review. PubMed PMID: 26583140; PubMed Central PMCID: PMC4637061.

3. Anand J, Singh SK, Hernández R, Parnis SM, Civitello AB, Cohn WE, Mallidi HR. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan;149(1):267-75, 278.e1. doi: 10.1016/j.jtcvs.2014.08.054. Epub 2014 Sep 10. PubMed PMID: 25312232.

4. Dathatri S, Gruberg L, Anand J, Romeiser J, Sharma S, Finnin E, Shroyer AL, Rosengart TK. Informed consent for cardiac procedures: deficiencies in patient comprehension with current methods. Ann Thorac Surg. 2014 May;97(5):1505-11; discussion 1511-2. doi: 10.1016/j.athoracsur.2013.12.065. Epub 2014 Mar 12. PubMed PMID: 24629303.

5. Mallidi HR, Anand J, Cohn WE. State of the art of mechanical circulatory support. Tex Heart Inst J. 2014 Apr 1;41(2):115-20. doi: 10.14503/THIJ-14-4143. eCollection 2014 Apr. Review. PubMed PMID: 24808767; PubMed Central PMCID: PMC4004468.

6. Anand J, R Mallidi H. The state of the art in heart transplantation. Semin Thorac Cardiovasc Surg. 2013 Spring;25(1):64-9. doi: 10.1053/j.semtcvs.2013.03.001. PubMed PMID: 23800530.

Book Chapters

1. Anand J, Sabe AA, Cohn WE. Off-Pump Coronary Artery Bypass Grafting and Transmyocardial Laser Revascularization. In: Selke FW, del Nido PJ, Swanson SL, eds. Sabiston and Spencer’s Surgery of the Chest, Volume II, 9th Edition. Philadelphia: Elsevier, 2016:1589-1602

2. Rosengart TK, Anand J. Acquired Heart Disease—Valvular. In: Townsend CM, Beauchamp RD, Evers BM, Mattox KL eds. Sabiston Textbook of Surgery: The Biologic Basis of Modern Surgical Practice, 20th Edition. Philadelphia: Elsevier, 2016

Nicholas Andersen, MD

Refereed journals

1. Benrashid E, Wang H, Andersen ND, Keenan JE, McCann RL, Hughes GC. Complimentary Roles of Open and Hybrid Approaches to Thoracoabdominal Aortic Aneurysm Repair. J Vasc Surg. J Vasc Surg. 2016 Jul 18. [EPub ahead of print].

2. Andersen ND, Hughes GC. Concomitant replacement of the ascending aorta is free—for some. J Thorac Cardiovasc Surg. 2016 Jun 27. [EPub ahead of print].

3. Andersen ND, Benrashid E, Daneshmand MA, Schroder JN, Gaca JG, Hughes GC. The Utility of the Aortic Dissection Team: Outcomes and Insights after a Decade of Experience. Ann Cardiothorac Surg. 2016 May;5(3):194-201.

4. Andersen ND. Isolated ascending aorta endografting: Another brush for the aortic reconstruction artist. J Thorac Cardiovasc Surg. 2016 Jun;151(6):1615-6.

5. Shah AA, Aftab M, Tchantchaleishvili V, Lapar D, Stephens EH, Walters D, DeNino WF, Odell D, Robich M, Cevasco M, Eilers AL, Gillaspie EA, Goldstone A, Malas T, Rice R, Shelstad R, Andersen ND. Characterizing the Operative Experience of Cardiac Surgery Trainees: What Are Residents Really Doing in the Operating Room? Ann Thorac Surg. 2016 Jun;101(6):2341-9.

6. Andersen ND. Certification in cardiothoracic surgical critical care: A distinction for some or for all? J Thorac Cardiovasc Surg. 2016 Jul;152(1):37-8.

7. Andersen ND. Active clearance technology to maintain chest tube patency: Practical, innovative, unproven. J Thorac Cardiovasc Surg. 2016 Mar;151(3):839-40.

8. Andersen ND. Antibiotic prophylaxis in cardiac surgery: If some is good, how come more is not better? J Thorac Cardiovasc Surg. 2016 Feb;151(2):598-9.

9. Ranney DN, Andersen ND, Jaquiss RD. Reimplantation of an Anomalous Left Innominate Artery with Kommerell Diverticulum Arising from a Right Aortic Arch. J Thorac Cardiovasc Surg. 2016 Feb;151(2):e37-9.

10. Benrashid E, Wang H, Keenan JE, Andersen ND, Meza JM, McCann RL, Hughes GC. Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair. J Vasc Surg. 2016 Feb;63(2):323-331.

11. Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, Welsby IJ, Hughes GC. Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2016 Feb;151(2):376-82.

31

12. Benrashid E, Wang H, Keenan JE, Andersen ND, Meza JM, McCann RL, Hughes GC. Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair. J Vasc Surg. 2015 Oct 27. pii: S0741-5214(15)01951-5.

13. Ranney DN, Andersen ND, Jaquiss RD. Reimplantation of an anomalous left innominate artery with Kommerell diverticulum arising from a right aortic arch. J Thorac Cardiovasc Surg. 2015 Oct 22. pii: S0022-5223(15)01990-X.

14. Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, Welsby IJ, Hughes GC. Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2015 Sep 28. pii: S0022-5223(15)01542-1.

15. Andersen ND. Parting ways with routine postoperative chest radiographs: Are we ready to cut the cord? J Thorac Cardiovasc Surg. 2015 Jul;150(1):230-1.

16. Williams JA, Hanna JM, Shah AA, Andersen ND, McDonald MT, Jiang YH, Wechsler SB, Zomorodi A, McCann RL, Hughes GC. Adult surgical experience with Loeys-Dietz syndrome. Ann Thorac Surg. 2015 Apr;99(4):1275-81.

17. Andersen ND, Ramachandran KV, Bao MM, Kirby ML, Pitt GS, Hutson MR. Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow. J Mol Cell Cardiol. 2015 Mar;80:1-9.

18. Andersen ND. Volatile anesthetics in cardiac surgery: renoprotective, cardioprotective, neither, or both? J Thorac Cardiovasc Surg. 2014 Dec;148(6):3137-8.

19. Andersen ND, Hanna JM, Ganapathi AM, Bhattacharya SD, Williams JB, Gaca JG, McCann RL, Hughes GC. Insurance status predicts acuity of thoracic aortic operations. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2082-6.

20. Andersen ND, Keenan JE, Ganapathi AM, Gaca JG, McCann RL, Hughes GC. Current Management and Outcome of Chronic Type B Aortic Dissection: Results with Open and Endovascular Repair since the Advent of Thoracic Endografting. Ann Cardiothorac Surg. 2014 May;3(3):264-74.

21. Andersen ND, Brennan JM, Zhao Y, Williams JB, Williams ML, Smith PK, Scarborough JE, Hughes GC. Insurance Status is Associated with Acuity of Presentation and Outcomes for Thoracic Aortic Operations. Circ Cardiovasc Qual and Outcomes. 2014 May;7(3):398-406.

22. Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, Hughes GC. Outcomes of Acute Type A Dissection Repair Before and After Implementation of a Multidisciplinary Thoracic Aortic Surgery Program. J J Am Coll Cardiol. 2014 May 6;63(17):1796-803.

23. Ganapathi AM, Hanna JM, Andersen ND, Gaca JG, McCann RL, Hughes GC. Comparison of Attachment Site Endoleak Rates in Dacron Versus Native Aorta Landing Zones Following Thoracic Endovascular Aortic Repair. J Vasc Surg. 2014 Apr;59(4):921-9.

24. Andersen ND, Hanna JM, Bhattacharya SD, Williams JB, Gaca JG, McCann RL, Hughes GC. Insurance Status Predicts Acuity of Thoracic Aortic Operations. J Thorac Cardiovasc Surg. 2014 Mar 19. pii: S0022-5223(14)00320-1.

25. James ML and Andersen ND (Co-first authors), Swaminathan M, Phillips-Bute B, Hanna JM, Smigla GR, Barfield ME, Bhattacharya SD, Williams JB, Gaca JG, Husain AM, Hughes GC. Predictors of Electrocerebral Inactivity with Deep Hypothermia. J Thorac Cardiovasc Surg. J Thorac Cardiovasc Surg. 2014 Mar;147(3):1002-7.

26. Hanna JM, Andersen ND, Ganapathi AM, McCann RL, Hughes GC. Five-Year Results for Endovascular Repair of Acute Complicated Type B Aortic Dissection. 2014 Jan;59(1):96-106.

27. Hughes GC, Andersen ND, McCann RL. Endovascular Repair of Chronic Type B Aortic Dissection with Aneurysmal Degeneration. Operative Techniques in Thoracic and Cardiovascular Surgery: A Comprehensive Atlas. Summer 2013(Vol. 18 | No. 2 | Pages 101-116).

28. van der Wilden G, Janjua S, Wedel S, Agarwal S, Shapiro M, Moorman D, Odom S, Andersen ND, Gates J, Frakes M, Chang Y, Velmahos G, Alam H, King D, de Moya M. Multi-institutional comparison of helicopter transfers directly to the operating room versus the pit stop in the Emergency Department. Am Surg. 2013 Sep;79(9):939-43.

29. Pradhan Nabzdyk L, Kuchibhotla S, Guthrie P, Chun M, Auster ME, Nabzdyk C, Deso S, Andersen N, Gnardellis C, LoGerfo FW, Veves A. Expression of Neuropeptides and Cytokines in a Rabbit Model of Diabetiic Neuroischemic Wound Healing. J Vasc Surg. 2013 Sep;58(3):766-75.

30. Hanna JM, Andersen ND, Aziz H, Shah AA, McCann RL, Hughes GC. Results with Selective Preoperative Lumbar Drain Placement for Thoracic Endovascular Aortic Repair. Ann Thorac Surg. 2013 Jun;95(6):1968-74.

31. Englum BR, Andersen ND, Husain AM, Mathew JP, Hughes GC. Degree of Hypothermia in Aortic Arch Surgery—Optimal Temperature for Cerebral and Spinal Protection: Deep Hypothermia Remains the Gold Standard in the Absence of Randomized Data. Ann Cardiothorac Surg 2013;2(2):184-193.

32. Turek JW and Andersen ND (Co-first authors), Lawson DS, Bonadonna D, Turley RS, Peters MA, Jaggers J, Lodge AJ. Outcomes Following Implementation of a Pediatric Rapid-Response Extracorporeal Membrane Oxygenation Program. Ann Thorac Surg. 2013 Jun;95(6):2140-6.

33. Chen X, Turley RS, Andersen ND, Desai BS, Glower DD. Minimally Invasive Edge-to-Edge Mitral Repair With or Without Artificial Chordae. Ann Thorac Surg. 2013 Apr;95(4):1347-53.

32

34. Andersen ND, Hughes GC. Reply to the editor. J Thorac Cardiovasc Surg. 2013 Jan;145(1):313-4. 35. Andersen ND and Barfield ME (Co-first authors), Hanna JM, Shah AA, Shortell CK, McCann RL, Hughes GC.

Intra-Thoracic Subclavian Artery Aneurysm Repair in the Thoracic Endovascular Aortic Repair Era. J Vasc Surg. 2013 Apr;57(4):915-25.

36. Ganapathi AM, Andersen ND, Prastein DJ, Rogers JG, Milano CA, McCann RL, Hughes GC. Endovascular Stent Grafting of a Left Ventricular Assist Device Outflow Graft Pseudoaneurysm. Circ Heart Fail. 2013 Jan;6(1):e16-8.

37. Andersen ND, Williams JB, Hanna JM, Shah AA, McCann RL, Hughes GC. Results With an Algorithmic Approach to Hybrid Repair of the Aortic Arch. J Vasc Surg. 2013 Mar;57(3):655-67.

38. Hughes GC, Andersen ND, McCann RL. Management of Acute Type B Aortic Dissection. J Thorac Cardiovasc Surg. J Thorac Cardiovasc Surg. 2013 Mar;145(3 Suppl):S202-7.

39. Hughes GC, Andersen ND, Hanna JM, McCann RL. Thoracoabdominal Aortic Aneurysm: Hybrid Repair Outcomes. Ann Cardiothorac Surg 2012;1(3):311-319.

40. Williams JB, Peterson ED, Zhao Y, O’Brien SM, Andersen ND, Miller DC, Chen EP, Hughes GC. Contemporary Results for Proximal Aortic Replacement in North America. J Am Coll Cardiol. 2012 Sep 25;60(13):1156-62.

41. Shah AA, Barfield ME, Andersen ND, Williams JB, Shah JA, Hanna JM, McCann RL, Hughes GC. Results of Thoracic Endovascular Aortic Repair Six Years After U.S. FDA Approval. Ann Thorac Surg. 2012 Nov;94(5):1394-9.

42. Bhasin M, Huang Z, Pradhan-Nabzdyk L, Malek J, LoGerfo PJ, Contreras M, Guthrie P, Csizmadia E, Andersen N, Kocher O, Ferran C, LoGerfo FW. Temporal Network Based Analysis of Cell Specific Vein Graft Transcriptome Defines Key Pathways and Hub Genes in Implantation Injury. PLoS One. PLoS One. 2012;7(6):e39123.

43. Andersen ND, Hughes GC. Reply to the editor. J Thorac Cardiovasc Surg. 2012 Jul;144(1):280-1. 44. Shah AA, Craig DM, Andersen ND, Williams JB, Bhattacharya SD, Shah SH, McCann RL, Hughes GC. Risk

Factors for 1-Year Mortality after Thoracic Endovascular Aortic Repair. J Thorac Cardiovasc Surg. 2012 Jun 12. [Epub ahead of print].

45. Andersen ND, DiBernardo LR, Linardic CM, Camitta MG, Lodge AJ. Recurrent Inflammatory Myofibroblastic Tumor of the Heart. Circulation. 2012 May 15;125(19):2379-81.

46. Hughes GC, Barfield ME, Shah AA, Williams JB, Kuchibhatla M, Hanna JM, Andersen ND, McCann RL. Staged Total Abdominal Debranching and TEVAR for Thoracoabdominal Aneurysm. J Vasc Surg. 2012 Sep;56(3):621-9.

47. Andersen ND and Bhattacharya SD (Co-first authors), Williams JB, Fosbol EL, Lockhart EL, Patel MB, Gaca JG, Welsby IJ, Hughes GC. Intraoperative Use of Low-Dose Recombinant Activated Factor VII During Thoracic Aortic Operations. Ann Thorac Surg. 2012 Jun;93(6):1921-8.

48. Andersen ND, Williams JB, Fosbol EL, Shah AA, Bhattacharya SD, Mehta RH, Hughes GC. Cardiac Catheterization Within One to Three Days of Proximal Aortic Surgery is Not Associated with Increased Postoperative Acute Kidney Injury. J Thorac Cardiovasc Surg. 2012 Jun;143(6):1404-10.

49. Williams JB, Andersen ND, Bhattacharya SD, Scheer E, Piccini JP, McCann RL, Hughes GC. Retrograde Ascending Aortic Dissection As An Early Complication of Thoracic Endovascular Aortic Repair. J Vasc Surg. 2012 May;55(5):1255-62.

50. Lima B, Williams JB, Bhattacharya SD, Shah AA, Andersen N, Gaca JG, Hughes GC. Results of Proximal Arch Replacement Using Deep Hypothermia for Circulatory Arrest: Is Moderate Hypothermia Really Justifiable? Am Surg. 2011 Nov;77(11):1438-44.

51. Andersen ND, Williams JB, Harrison JK, Hughes GC. Ascending-Descending Aortic Bypass with Valve-Sparing Root Replacement for Coarctation with Aortic Root Aneurysm. J Thorac Cardiovasc Surg. 2012 Feb;143(2):514-5.

52. Lima B, Williams JB, Bhattacharya SD, Shah AA, Andersen N, Wang A, Harrison JK, Hughes GC. Individualized Thoracic Aortic Replacement for the Aortopathy of Bicuspid Aortic Valve Disease. J Heart Valve Dis. 2011 Jul;20(4):387-95.

53. Andersen ND, Pal JD, Lodge AJ. Atrial Septal Defect Repair By Inversion of a Juxtaposed Left Atrial Appendage. Cardiol Young. 2012 Feb;22(1):103-5.

54. Andersen ND, Bhattacharya SD, Williams JB, McCann RL, Hughes GC. Mycotic Aneurysm of the Thoracoabdominal Aorta in a Child with End-Stage Renal Disease. J Vasc Surg. 2011 Oct;54(4):1161-3.

55. Lee TC, Andersen ND, Williams JB, Bhattacharya SD, McCann RL, Hughes GC. Results With A Selective Revascularization Strategy For Left Subclavian Artery Coverage During Thoracic Endovascular Aortic Repair. Ann Thorac Surg. 2011 Jul;92(1):97-103.

56. Williams JB, Phillps-Bute B, Bhattacharya SD, Shah AA, Andersen ND, Altintas B, Lima B, Smith PK, Hughes GC, Welsby IJ. Predictors of Massive Transfusion with Thoracic Aortic Procedures Involving Deep Hypothermic Circulatory Arrest. J Thorac Cardiovasc Surg. 2011 May;141(5):1283-8. Epub 2010 Dec 16.

57. Shrikhande GV, Scali ST, da Silva CG, Damrauer SM, Csizmadia E, Putheti P, Matthey M, Arjoon R, Patel R, Siracuse JJ, Maccariello ER, Andersen ND, Monahan T, Peterson C, Essayagh S, Studer P, Padilha Guedes R, Kocher O, Usheva A, Veves A, Kaczmarek E, Ferran C. O-Glycosylation Regulates Ubiquitination and Degradation of the Anti-Inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic ApoE-Null Mice. PLoS One. 2010 Dec 6;5(12):e14240.

33

58. Andersen ND and Chopra A (Co-first authors), Monahan TS, Malek, JY, Jain M, Pradhan L, Ferran C, LoGerfo FW. Endothelial Cells Are Susceptible to Rapid siRNA Transfection and Gene Silencing Ex Vivo. J Vasc Surg. 2010 Dec;52(6):1608-1615.

59. Andersen ND, DuBose J, Shah A, Lee T, Wechsler SB, Hughes GC. Thoracic Endografting in a Patient with Hereditary Hemorrhagic Telangiectasia Presenting with a Descending Thoracic Aneurysm. J Vasc Surg. 2010 Feb;51(2):468-70.

60. Pradhan L, Cai, X, Wu S, Andersen ND, Martin M, Malek J, Guthrie P, Veves A, LoGerfo FW. Gene Expression of Pro-Inflammatory Cytokines and Neuropeptides in Diabetic Wound Healing. J Surg Res. 2011 May 15;167(2):336-42.

61. Pradhan L, Nabzdyk, Andersen ND, LoGerfo FW, Veves A. Inflammation and Neuropeptides: The Connection in Diabetic Wound Healing. Expert Reviews in Molecular Medicine. 2009 Jan 13;11:e2

62. Monahan TS, Andersen ND, Martin MC, Malek JY, Shrikhande GV, Pradhan L, Ferran C, LoGerfo FW. MARCKS Silencing Differentially Affects Human Vascular Smooth Muscle and Endothelial Cell Phenotypes to Inhibit Neointimal Hyperplasia in Saphenous Vein. FASEB J. 2009 Feb;23(2):557-64.

63. Pradhan L, Andersen ND, Nabzdyk C, LoGerfo FW, Veves A. Wound Healing Abnormalities in Diabetes and New Therapeutic Interventions. U.S. Endocrine Disease 2007, Issue 1.

64. Pradhan L, Andersen ND, LoGerfo FW, Veves A. Molecular Targets for Promoting Wound Healing in Diabetes. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery, 2007, 1, 1-13.

65. Andersen ND, Monahan TS, Malek JY, Jain M, Daniel S, Caron LD, Pradhan L, Ferran C, LoGerfo FW. Comparison of Gene Silencing in Human Vascular Cells Using Small Interfering RNAs. J Am Coll Surg. 2007 Mar;204(3):399-408.

66. Monahan TS, Andersen ND, Panossian H, Kalish JA, Daniel S, Shrikhande GV, Ferran C, LoGerfo FW. A Novel Function for Cadherin 11/Osteoblast-Cadherin in Vascular Smooth Muscle Cells: Modulation of Cell Migration and Proliferation. J Vasc Surg. 2007 Mar;45(3):581-9.

67. Monahan TS, Phaneuf MD, Contreras MA, Andersen ND, Popescu-Vladimir A, Bide MJ, Dempsey DJ, Mitchell RN, Hamdan AD, LoGerfo FW. In Vivo Testing of an Infection-Resistant Annuloplasty Ring. J Surg Res. 2006;130(1):140-5.

Book Chapters

1. Andersen ND, Hughes GC. Intrathoracic Subclavian Artery Aneurysm Repair. In: Eskandari MK, Pearce WH,

Yao JS (eds). Current Vascular Surgery 2015. 1st ed. Shelton: People’s Medical Publishing House—USA; 2016:97-107. 2. Andersen ND. Hypoplastic Left Heart Syndrome. In: Lapar DJ, Mery CM, Turek JW (eds). TSRA Review of

Cardiothoracic Surgery. 2nd ed. Chicago: Thoracic Surgery Residents Association; 2015:377-381 3. Andersen ND. Cardiac Tumors. In: Lapar DJ, Mery CM, Turek JW (eds). TSRA Review of Cardiothoracic

Surgery. 2nd ed. Chicago: Thoracic Surgery Residents Association; 2015:291-294. 4. Andersen ND, Suhocki PV. Interventional Biliary Techniques. In: Blazer DG, Kuo PC, Pappas T, Clary BM

(eds). Contemporary Surgical Management of Liver, Biliary Tract, and Pancreatic Disease. 1st ed. Hackensack: World Scientific Publishing Co. Pte. Ltd.; 2014:363-368.

5. Turek JW, Andersen ND. Ventricular Septal Defect. In: Cantu E, Turek JW (eds). Case-Based Review of Cardiothoracic Surgery. 1st ed. Charleston: Fox & Locke Publishing, Inc; 2013:295-298.

6. Turek JW, Andersen ND. Aortic Coarctation. In: Cantu E, Turek JW (eds). Case-Based Review of Cardiothoracic Surgery. 1st ed. Charleston: Fox & Locke Publishing, Inc; 2013:299-304.

7. Andersen ND, Turek JW. Hypoplastic Left Heart Syndrome. In: Mery CM, Turek JW (eds). TSRA Review of Cardiothoracic Surgery. 1st ed. Chicago: Thoracic Surgery Residents Association; 2011:292-295.

8. Turek JW, Andersen ND. Cardiac Tumors. In: Mery CM, Turek JW (eds). TSRA Review of Cardiothoracic Surgery. 1st ed. Chicago: Thoracic Surgery Residents Association; 2011:223-225.

9. Andersen ND, Suhocki P. Interventional Biliary Techniques. Duke HPB Textbook. 10. Founding Co-Author, First Aid USMLERx Step 1 Qmax Online Test Bank. www.UsmleRx.Com 11. Founding Co-Author, First Aid Q & A for the USMLE Step 1. Eds. Le TT, Klein J, and Shivaram A. McGraw-Hill

Companies, Inc. 2007.

Muath Bishawi, MD, MPH Refereed journals

1. Phillips BT, Fourman MS, Bishawi M, Zegers M, O'Hea BJ, Ganz JC, Huston TL, Dagum AB, Khan SU, Bui DT. Are Prophylactic Postoperative Antibiotics Necessary for Immediate Breast Reconstruction? Results of a Prospective Randomized Clinical Trial. J Am Coll Surg. 2016 Jun;222(6):1116-24.

2. Almassi GH, Carr BM, Bishawi M, Shroyer AL, Quin JA, Hattler B, Wagner TH, Collins JF, Ravichandran P, Cleveland JC, Grover FL, Bakaeen FG; Veterans Affairs #517 Randomized On/Off Bypass (ROOBY) Study Group.

34

Resident versus attending surgeon graft patency and clinical outcomes in on- versus off-pump coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2015 Dec;150(6):1428-35.

3. McLarty AJ, Bishawi M, Yelika SB, Shroyer AL, Romeiser J. Surveillance of moderate-size aneurysms of the thoracic aorta. J Cardiothorac Surg. 2015 Feb 6;10:17.

4. Quin J, Lucke J, Hattler B, Gupta S, Baltz J, Bishawi M, Almassi GH, Grover FL, Collins J, Shroyer AL. Surgeon judgment and utility of transit time flow probes in coronary artery bypass grafting surgery. JAMA Surg. 2014 Nov;149(11):1182-7.

5. Phillips BT, Bishawi M, Dagum AB, Bui DT, Khan SU. A systematic review of infection rates and associated antibiotic duration in acellular dermal matrix breast reconstruction. Eplasty. 2014 Nov 11;14:e42. eCollection 2014.

6. Buscaglia JM, Karas J, Palladino N, Fakhoury J, Denoya PI, Nagula S, Bucobo JC, Bishawi M, Bergamaschi R. Simulated transanal NOTES sigmoidectomy training improves the responsiveness of surgical endoscopists. Gastrointest Endosc. 2014 Jul;80(1):126-32..

7. Shroyer AL, Hattler B, Wagner TH, Baltz JH, Collins JF, Carr BM, Almassi GH, Quin JA, Hawkins RB, Kozora E, Bishawi M, Ebrahimi R, Grover FL; VA #517 Randomized On/Off Bypass (ROOBY) Study Group.. Comparing Off-Pump and On-Pump Clinical Outcomes and Costs for Diabetic Cardiac Surgery Patients. Annals of Thoracic Surgery. 2014 Jul;98(1):38-44; discussion 44-5

8. Bishawi M, Foppa C, Bergamaschi R. Close but no cigar. Techniques in Coloproctology. 2014 Sep;18(9):857. 9. Bishawi M, Pryor AD. Should technical aptitude evaluation become part of resident selection for surgical

residency? Surgical Endoscopy. 2014 Jul 18. [Epub ahead of print] 10. Quin J, Luke J, Hattler B, Gupta S, Baltz J, Bishawi M, Almassi GH, Grover FL, Collins J, Shroyer AL. Surgeon

Judgment and Utility of Transit Time Flow Probes in Coronary Artery Bypass Grafting Surgery. JAMA Surgery. 2014 Sep 24. doi: 10.1001/jamasurg.2014.1891. [Epub ahead of print]

11. Bishawi M, Fakhoury M, Denoya P, Stein S, Bergamaschi R. Surgical Site Infection Rates: Open vs. Hand-Assisted Colorectal Resections. Tech Coloproctol. 2014 Apr;18(4):381-6.

12. Almassi GH, Shroyer AL, Collins JF, Hattler B, Bishawi M, Baltz JH, Ebrahimi R, Grover FL. Chronic Obstructive Pulmonary Disease Impact upon Outcomes: The Veterans Affairs Randomized On/Off Bypass Trial. Annals of Thoracic Surgery. 2013 Oct;96(4):1302-9.

13. Wagner TH, Hattler B, Bishawi M, Baltz JH, Collins JF, Quin JA, Grover FL, Shroyer AL; VA #517 Randomized On/Off Bypass (ROOBY) Study Group. On-pump versus off-pump coronary artery bypass surgery: cost-effectiveness analysis alongside a multisite trial. Annals of Thoracic Surgery. 2013 Sep;96(3):770-7.

14. Bishawi M, Moore WH, Bilfinger T. Severity of emphysema predicts location of lung cancer and 5-year survival for patients with NSCL stage I. Journal of Surgical Research. 2013 Sep;184(1):1-5.

15. Quin JA, Hattler B, Bishawi M, Baltz J, Gupta S, Collins JF, Grover FL, McDonald G, Shroyer AL. Impact of Lipid Lowering Medications and Low-Density Lipoprotein levels on 1-year Clinical Outcomes after Coronary Artery Bypass Grafting. JACS. 2013 Sep;217(3):452-60.

16. Bishawi M, Bernstein R, Boter M, Draughn D, Gould C, Hamilton C, Koziarski J. Mechanochemical ablation in patients with chronic venous disease: a prospective multicenter report. Phlebology. 2013 Jul 2;29(6):397-400.

17. Bishawi M, Shroyer AL, Rumsfeld J, Spertus J, Baltz J, Collins J, Quin J, Almassi H, Grover F, Hattler B. Changes in health-related quality of life in off-pump vs. on-pump cardiac surgery: VA ROOBY trial. Ann Thorac Surg. 2013 Jun;95(6):1946-51.

Book Chapters

1. Bishawi M, Halbreiener M, Rosengart T. Gene Therapy for CAD. Franco KL, Thourani VH (Eds.) Cardiothoracic Surgery Review. Lippincott Publishers, Philadelphia, 2012. 2011; Chapter 15: 164-166

2. Bishawi M, Rosengart TK. Biologic bypass. In: Moorjani N, Viola N, Ohri SK, editors. Key Questions in Cardiac Surgery. Castle Hill Barns, UK: TFM Publishing, 2010.

3. Rosengart TK, Bishawi M. Regenerating mechanical function in vivo with skeletal myoblasts. In: Cohen IS, Gaudette GR, editors. Regenerating the Heart: Stem Cells and the Cardiovascular System. New York: Humana, 2011.

Benjamin Bryner, MD

Refereed journals

1. Trahanas JM , Witer LJ , Alghanem F , Bryner B, Iyengar A , Hirschl JR , Hoenerhoff MJ , Potkay JA , Bartlett

RH , Rojas-Pena A , Owens GE , Bocks ML: “Achieving Twelve Hour Normothermic Ex situ Heart Perfusion: An Experience of Forty Porcine Hearts.” ASAIO Journal 62(2016):470-6. PMID: 27164040.

http://www.ncbi.nlm.nih.gov/pubmed?term=Pryor%20AD%5BAuthor%5D&cauthor=true&cauthor_uid=25034380

http://www.ncbi.nlm.nih.gov/pubmed?term=Wagner%20TH%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Hattler%20B%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Baltz%20JH%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Collins%20JF%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Quin%20JA%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Grover%20FL%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=Shroyer%20AL%5BAuthor%5D&cauthor=true&cauthor_uid=23916805

http://www.ncbi.nlm.nih.gov/pubmed?term=%22VA%20%23517%20Randomized%20On%2FOff%20Bypass%20%28ROOBY%29%20Study%20Group%22%5BCorporate%20Author%5D

http://www.ncbi.nlm.nih.gov/pubmed?term=%22VA%20%23517%20Randomized%20On%2FOff%20Bypass%20%28ROOBY%29%20Study%20Group%22%5BCorporate%20Author%5D

35

2. Ozer K, Rojas-Peña A, Mendias C, Bryner B, Toomasian C, Bartlett RH: “The Effect of Ex Situ Perfusion in a Swine Limb Vascularized Composite Tissue Allograft on Survival up to 24 Hours.” The Journal of Hand Surgery 41(2016):1;3-12. PMID: 26710728.

3. Witer L, Howard R, Trahanas J, Bryner B, Alghanem F, Hoffman H, Cornell M, Bartlett RH, Rojas-Peña A: “Large Animal Model of Pumpless Arteriovenous Extracorporeal CO2 Removal Using Room Air Via Subclavian Vessels.” ASAIO Journal 62(2015)1;110-113. PMID: 26461241.

4. Alghanem F, Davis R, Bryner B, Hoffman HR, Cornell MS, Trahanas J, Rojas-Peña A, Bartlett R: “The Implantable Pediatric Artificial Lung: Interim Report on the Development of an End-Stage Lung Failure Model.” ASAIO Journal 61(2015):4;453-8. PMID: 25905495.

5. Demos DS, Iyengar A, Bryner B, Gray B, Hoffman HR, Cornell MS, Wilkinson JE, Mazur DE, Bartlett RH, Punch JD, Rojas-Peña A: “Successful Porcine Renal Transplantation after 60 Minutes of Donor Warm Ischemia: Extracorporeal Perfusion and Thrombolytics." ASAIO Journal 61(2015):4;474-9. PMID: 25851315.

6. Ozer K, Rojas-Peña A, Mendias C, Bryner B, Toomasian C, Bartlett RH: “Ex-situ Limb Perfusion System to Extend Vascularized Composite Tissue Allograft Survival in Swine.” Transplantation 99(2015):10;2095-2101. PMID: 25929606.

7. Burney RE, Bryner B: “Safety and Long-Term Outcomes of Percutaneous Endoscopic Gastrostomy in Patients with Head and Neck Cancer.” Surgical Endoscopy 29(2015):12; 3685-3689. PMID: 25740644.

8. Teman NR; Thomas J; Bryner B; Haas CF; Haft JW; Park PK; Lowell MJ; Napolitano LM: “Inhaled Nitric Oxide to Improve Oxygenation for Safe Critical Care Transport of Adults With Severe Hypoxemia.” American Journal of Critical Care. 24(2015):2;110-7

9. Mychaliska GB, Bryner B, Dechert R, Kreutzman J, Becker M, Hirschl RB: “Safety and Efficacy of Perflubron-induced Lung Growth in Neonates with Congenital Diaphragmatic Hernia: Results of a Prospective, Randomized Trial.” Journal of Pediatric Surgery 50(2015):7;1083-87. PMID: 25799085.

10. Bryner B, Gray BW, Perkins E, Hoffman HR, Owens GE, Barks J, Rojas-Peña A, Bartlett RH, Mychaliska GB. “An Extracorporeal Artificial Placenta Supports Extremely Premature Lambs for One Week.” Journal of Pediatric Surgery 50(2015):1;44-49. PMID: 25598091.

11. Bryner B, Cooley E, Copenhaver W, Brierley K, Teman N, Landis D, Rycus P, Hemmila M, Napolitano L, Haft J, Park P, Bartlett R: “Two Decades’ Experience With Inter-Facility Transport on Extracorporeal Membrane Oxygenation.” Annals of Thoracic Surgery 98(2014):4;1363-1370. PMID: 25149055.

12. Teman NR, Demos DS, Bryner B, Faliks B, Fracz EM, Mazur DE, Rojas-Peña A, Bartlett RH, Haft JW: “In Vivo Testing of a Novel Blood Pump for Short-Term Extracorporeal Life Support.” Annals of Thoracic Surgery 98(2014):1;97-102. PMID: 24856794.

13. Davis R, Bryner B, Mychaliska GB: “A Paradigm Shift in the Treatment of Extreme Prematurity: The Artificial Placenta.” Current Opinion in Pediatrics 26(2014):3;370-6. PMID: 24786370.

14. Wright T, Filbrun A, Bryner B, Mychaliska GB: “Predictors of early lung function in patients with Congenital Diaphragmatic Hernia.” Journal of Pediatric Surgery -- American Academy of Pediatrics (AAP) Section on Surgery Edition 49(2014):6;882-885. PMID: 24888827.

15. Bryner B, Mychaliska GB: “ECLS for Preemies: The Artificial Placenta.” Seminars in Perinatology 38(2014):2;122-129. PMID: 24580768.

16. Waits S, Reames B, Krell R, Bryner B, Shih T, Obi A, Henke P, Minter RM, Englesbe M, Wong SL: “Development of Team Action Projects in Surgery (TAPS): A Multi-level Team-Based Approach to Teaching Quality Improvement.” Journal of Surgical Education 71(2014)2:166-168. PMID: 24602703.

17. Bryner B, Miskulin J, Smith C, Cooley E, Grams R, Bartlett RH, Annich G, Mychaliska GB: “Extracorporeal Life Support for the Acute Respiratory Distress Syndrome due to Severe Legionella Pneumonia.” Perfusion 29(2014):1;39-43. PMID: 23863490.

18. Bryner B, Smith C, Cooley E, Bartlett RH, Mychaliska GB: “Extracorporeal Life Support for Pancreatitis-Induced Respiratory Distress Syndrome.” Annals of Surgery 256(2012):6;1073-1077. PMID: 22824856.

19. Bryner B, West B, Drongowski R, Hirschl RB, Mychaliska GB, for the Congenital Diaphragmatic Hernia Study Group: “Congenital Diaphragmatic Hernia Requiring Extracorporeal Membrane Oxygenation: Does Timing of Repair Matter?” Journal of Pediatric Surgery – American Academy of Pediatrics (AAP) Section on Surgery Edition 44 (2009):6;1165-1171. PMID: 19524734.

20. Bryner B, Kim A, Khouri J, Drongowski R, Bruch S, Hirschl RB, Mychaliska GB: “Right-Sided Congenital Diaphragmatic Hernia: High Utilization of ECMO and High Survival.” Journal of Pediatric Surgery 44(2009):5;883-887. PMID: 19433162.

21. Gonzalez R, Bryner B, Teitelbaum DH, Hirschl RB, Drongowski R, Mychaliska GB: “Chylothorax After Congenital Diaphragmatic Hernia Repair.” Journal of Pediatric Surgery – AAP Section on Surgery Edition 44(2009):6:1181-1185. PMID: 19524736.

22. Kim A, Bryner B, Akay B, Hirschl RB, Mychaliska GB: “Thoracoscopic Repair of Congenital Diaphragmatic Hernia in Neonates: Lessons learned.” Journal of Laparoendoscopic & Advanced Surgical Techniques 19(2009):4;575-580. PMID 19670981.

36

23. Mychaliska GB, Bryner B, Nugent C, Barks J, Hirschl RB, McCrudden K, Chames M, Gomez-Fifer C, Servin MN, Chiravuri SD: “Giant Pulmonary Sequestration: The Rare Case Requiring the EXIT Procedure with Resection and ECMO.” Fetal Diagnosis and Therapy 25(2009):25;163-166. PMID: 19293587.

24. Bryner B, Saddawi-Konefka D, Gest T: “The Impact of Interactive, Computerized Educational Modules on Preclinical Medical Education.” Anatomical Sciences Education 1(2008):6; cover and pp. 247-251. PMID: 19109853.

Anthony Castleberry, MD Refereed journals

1. Castleberry AW, DeVore AD, Southerland KW, Meza JM, Irish WD, Rogers JG, Milano CA, and Patel CB. Assessing consequences of intra-aortic balloon counterpulsation vs. left ventricular assist devices at the time of heart transplantation. ASAIO J. 2016 May-Jun;62(3):232-9.

2. Castleberry AW, Englum BR, Snyder LD, Worni M, Osho AA, Gulack BC, Palmer SM, Davis RD, Hartwig MG. The Utility of Preoperative Six-Minute-Walk Distance in Lung Transplantation. Am J Respir Crit Care Med. 2015 Oct 1;192(7):843-52.

3. Gulack BC, Englum BR, Castleberry AW, Daneshmand MA, Smith PK, Perrault LP. Repair or observe moderate ischemic mitral regurgitation during coronary artery bypass grafting? Prospective randomized multicenter data. Ann Cardiothorac Surg. 2015 May;4(3):266-72.

4. Osho AA, Castleberry AW, Snyder LD, Ganapathi AM, Speicher PJ, Hirji SA, Stafford-Smith M, Daneshmand MA, Duane Davis R, Hartwig MG. Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. J Heart Lung Transplant. 2015 Apr;34(4):571-9.

5. Speicher PJ, Ganapathi AM, Englum BR, Gulack BC, Osho AA, Hirji SA, Castleberry AW, Snyder LD, Duane Davis R, Hartwig MG. Single-lung transplantation in the United States: what happens to the other lung? J Heart Lung Transplant. 2015 Jan;34(1):36-42.

6. Ganapathi AM, Speicher PJ, Castleberry AW, Englum BR, Osho AA, Davis RD, Hartwig MG. The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. Ann Thorac Surg. 2014 Dec;98(6):1922-8; discussion 1928-9.

7. Osho AA, Castleberry AW, Snyder LD, Palmer SM, Ganapathi AM, Hirji SA, Lin SS, Davis RD, Hartwig MG. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. Ann Thorac Surg. 2014 Dec;98(6):1914-20; discussion 1920-1.

8. Ganapathi AM, Speicher PJ, Englum BR, Castleberry AW, Migaly J, Hsu DS, Mantyh CR. Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit. Dis Colon Rectum. 2014 Dec;57(12):1341-8.

9. Osho AA, Castleberry AW, Snyder LD, Palmer SM, Stafford-Smith M, Lin SS, Duane Davis R, Hartwig MG. The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation. J Heart Lung Transplant. 2014 Dec;33(12):1248-54.

10. Ganapathi AM, Hanna JM, Schechter MA, Englum BR, Castleberry AW, Gaca JG, Hughes GC. Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: does it matter? A propensity-matched analysis. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2896-902.

11. Worni M, Castleberry AW, Gloor B, Pietrobon R, Haney JC, D'Amico TA, Akushevich I, Berry MF. Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008. Dis Esophagus. 2014 Sep-Oct;27(7):662-9.

12. Osho AA, Castleberry AW, Snyder LD, Ganapathi AM, Hirji SA, Stafford-Smith M, Lin SS, Davis RD, Hartwig MG. Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. Ann Thorac Surg. 2014 Jul;98(1):283-9; discussion 289-90.

13. Osho AA, Castleberry AW, Snyder LD, Palmer SM, Stafford-Smith M, Lin SS, Duane Davis R, Hartwig MG. The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation. J Heart Lung Transplant. 2014 Jun 30. pii: S1053-2498(14)01178-4.

14. Ganapathi AM, Hanna JM, Schechter MA, Englum BR, Castleberry AW, Gaca JG, Hughes GC. Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: Does it matter? A propensity-matched analysis. J Thorac Cardiovasc Surg. 2014 Apr 13. pii: S0022-5223(14)00438-3.

15. Castleberry AW, Williams JB, Daneshmand MA, Honeycutt E, Shaw LK, Samad Z, Lopes RD, Alexander JH, Mathew JP, Velazquez EJ, Milano CA, Smith PK. Surgical Revascularization is Associated with Maximal Survival in Patients With Ischemic Mitral Regurgitation: A 20-year Experience. Circulation. 2014 Jun 17;129(24):2547-56.








37

16. Zanotti G, Hartwig MG, Castleberry AW, Martin JT, Shaw SK, Williams JB, Lin SS, and Davis RD. Preoperative Mild-To-Moderate Coronary Artery Disease Does Not Affect Long-Term Outcomes Of Lung Transplantation. Transplantation. 2014 May 27;97(10):1079-85.

17. Reddi DM, Barbas AS, Castleberry AW, Rege AS, Vikraman DS, Brennan TV, Ravindra KV, Collins BH, Sudan DL, Lagoo AS, and Martin AE. Liver transplantation in a patient with hepatic failure from acute lymphoblastic leukemia. Pediatr Transplant. 2014 Mar;18(2):E57-63.

18. Castleberry AW, Martin JT, Osho AA, Hartwig MG, Hashmi ZA, Zanotti G, Shaw LK, Williams JB, Lin SS, Davis RD. Coronary Revascularization in Lung Transplant Recipients with Concomitant Coronary Artery Disease. Am J Transplant. 2013 Nov;13(11):2978-88.

19. Shah A, Chao KS, Østbye T, Castleberry AW, Pietrobon RS, Gloor B, Clary BM, White RR, Worni M. Trends in racial disparities in pancreatic cancer surgery. J Gastrointest Surg. 2013 Nov;17(11):1897-906.

20. Castleberry AW, Clary BM, Migaly J, Worni M, Ferranti JM, Pappas TN, Scarborough JE. Resident Education in the Era of Patient Safety: A nationwide analysis of outcomes and complications in resident-assisted oncologic surgery. Ann Surg Oncol. 2013 Nov;20(12):3715-24.

21. Castleberry AW, Hartwig MG, Whitson, BA. Extracorporeal membrane oxygenation post lung transplantation. Curr Opin Organ Transplant. 2013 Oct;18(5):524-30.

22. Worni M, Guller U, White RR, Castleberry AW, Pietrobon R, Cerny T, Gloor B, Koeberle D. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the SEER registry from 1988 to 2008. Pancreas. 2013 Oct;42(7):1157-63.

23. Castleberry AW, Worni M, Kuchibhatla M, Lin SS, Snyder LD, Shofer SL, Palmer SM, Pietrobon RS, Davis RD, and Hartwig MG. A Comparative Analysis of Bronchial Stricture Following Lung Transplantation in Recipients With and Without Early Acute Rejection. Ann Thorac Surg. 2013 Sep;96(3):1008-17.

24. Southerland KW, Castleberry AW, Ali AA, Williams JB, Daneshmand MA, Milano CA. Impact of Donor Cardiac Arrest on Heart Transplantation. Surgery. 2013 Aug;154(2):312-9.

25. Castleberry AW, Worni M, Osho AA, Snyder LD, Palmer SM, Peitrobon RS, Davis RD, Hartwig MG. The Use of Lung Allografts from Brain Death Donors After Cardiopulmonary Arrest and Resuscitation. Am J Respir Crit Care Med. 2013 Aug 15;188(4):466-73.

26. Castleberry AW, Hartwig MG, Whitson, BA. Extracorporeal membrane oxygenation post lung transplantation. Curr Opin Organ Transplant. Accepted July 2013 [Epub ahead of print].

27. Berry MF, Zeyer-Brunner J, Castleberry AW, Martin JB, Gloor B, Pietrobon R, D'Amico TA, Worni M. Treatment Modalities for T1N0 Esophageal Cancers: A comparative analysis of local therapy vs. surgical resection. J Thorac Oncol. Accepted 2013 Jun;8(6):796-802. doi: 10.1097/JTO.0b013e3182897bf1.

28. Shin J, Worni M, Castleberry AW, Pietrobon R, Omotosho PA, Silberberg M, Østbye T. The Application of Comorbidity Indices to Predict Early Postoperative Outcomes After Laparoscopic Roux-en-Y Gastric Bypass: A Nationwide Comparative Analysis of Over 70,000 Cases. Obes Surg. 2013 May;23(5):638-49.

29. Castleberry AW, Turley RS, Hanna JM, Hopkins TJ, Barbas AS, Worni M, Mantyh CR, Migaly J. A 10-Year Longitudinal Analysis of Surgical Management 6 for Acute Ischemic Colitis. J Gastrointest Surg. 2013 Apr;17(4):784-92.

30. Worni M, Castleberry AW, et al. Concomitant vascular reconstruction during pancreatectomy for malignant disease: A propensity score-adjusted, population-based trend analysis of 10,206 patients. JAMA Surg. 2013 Apr;148(4):331-8.

31. Barbas AS, Aparna R, Castleberry AW, Ellis MJ, Vikraman D, Ravindra K, Martin A, Brennan T, Collins B, and Sudan D. Posterior Reversible Encephalopathy Syndrome independently associated with both tacrolimus and sirolimus in a multivisceral transplant recipient. Am J Transplant. 2013 Mar;13(3):808-10.

32. Castleberry AW, White RR, De La Fuente SG, Clary BM, Blazer DG 3rd, McCann RL, Pappas TN, Tyler DS, Scarborough JE. The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: An analysis of the NSQIP database. Ann Surg Oncol. 2012 Dec;19(13):4068-77.

33. Castleberry AW and Hartwig MG. The Tradeoff of Utilizing Positive-Smoking Donor Lungs. Semin Thorac Cardiovasc Surg. 2012 Autumn;24(3):151-2.

34. Castleberry AW, Grannis FW. What is a reasonable cost to refute a preposterous hypothesis? Br J Cancer. 2010 Feb 2;102(3):627-8.

35. Castleberry AW, Smith D, Anderson C, Rotter AJ, Grannis FW Jr. Cost of a Five-Year Lung Cancer Survivor: Symptomatic tumor identification vs. proactive CT screening. Br J Cancer. 2009 Sep 15;101(6):882-96.

36. Castleberry AW, Geller DA, Tsung A. The pineapple upside-down liver cake (case report of a ruptured hepatic adenoma in a pelvic liver congenitaly displaced secondary to an omphalocele). Hepatology. 2009 Jun;49(6):2113-4.

37. Richard SD, Krivak TC, Castleberry A, et al. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. Gynecol Oncol. 2008 Apr;109(1):43-8.

38

Julie Doberne, MD, PhD

Refereed journals

1. Moren A, Cook M, McClain M, Doberne J, Kiraly L, Perkins RS, Kwong K. A pilot curriculum in international surgery for medical students. J Surg Educ. 2015 Jul-Aug;72(4):e9-e14. doi: 10.1016/j.jsurg.2015.04.027. PubMed PMID: 26073480.

2. Broberg C, McLarry J, Mitchell J, Winter C, Doberne J, Woods P, Burchill L, Weiss J. Accuracy of administrative data for detection and categorization of adult congenital heart disease patients from an electronic medical record. Pediatr Cardiol. 2015 Apr;36(4):719-25. doi: 10.1007/s00246-014-1068-2. Epub 2014 Nov 27. PubMed PMID: 25428778.

3. Redd TK, Doberne JW, Lattin D, Yackel TR, Eriksson CO, Mohan V, Gold JA, Ash JS, Chiang MF. Variability in Electronic Health Record Usage and Perceptions among Specialty vs. Primary Care Physicians. AMIA Annu Symp Proc. 2015 Nov 5;2015:2053-62. eCollection 2015. PubMed PMID: 26958305; PubMed Central PMCID: PMC4765603.

4. Doberne JW, He Z, Mohan V, Gold JA, Marquard J, Chiang MF. Using High-Fidelity Simulation and Eye Tracking to Characterize EHR Workflow Patterns among Hospital Physicians. AMIA Annu Symp Proc. 2015 Nov 5;2015:1881-9. eCollection 2015. PubMed PMID: 26958287; PubMed Central PMCID: PMC4765617.

5. Hornberger J, Doberne J, Chien R. Laboratory-developed test--SynFRAME: an approach for assessing laboratory-developed tests synthesized from prior appraisal frameworks. Genet Test Mol Biomarkers. 2012 Jun;16(6):605-14. doi:10.1089/gtmb.2011.0177. Epub 2012 Feb 2. PubMed PMID: 22300513.

6. Klang SH, Hammerman A, Liebermann N, Efrat N, Doberne J, Hornberger J. Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization. Value Health. 2010 Jun-Jul;13(4):381-7. doi: 10.1111/j.1524-4733.2010.00724.x. Epub 2010 Apr 15. PubMed PMID: 20412544.

Asvin Ganapathi, MD

Refereed journals

1. Hartwig MG, Ganapathi AM, Osho AA, Hirji SA, Englum BR, Speicher PJ, Palmer SM, Davis RD, Snyder LD. Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time. Am J Transplant. 2016 May 27. doi: 10.1111/ajt.13892. [Epub ahead of print] PubMed PMID: 27233085.

2. Gulack BC, Nussbaum DP, Keenan JE, Ganapathi AM, Sun Z, Worni M, Migaly J, Mantyh CR. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone. Dis Colon Rectum. 2016 Apr;59(4):299-305. doi: 10.1097/DCR.0000000000000546. PubMed PMID: 26953988; PubMed Central PMCID: PMC4785825.

3. Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D'Amico TA, Berry MF. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. Ann Surg. 2016 Mar 15. [Epub ahead of print] PubMed PMID: 26982688.

4. Nussbaum DP, Adam MA, Youngwirth LM, Ganapathi AM, Roman SA, Tyler DS, Sosa JA, Blazer DG 3rd. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma. Ann Surg Oncol. 2016 Mar;23(3):1026-33. doi: 10.1245/s10434-015-4937-x. Epub 2015 Nov 5. PubMed PMID: 26542590.

5. Keenan JE, Wang H, Ganapathi AM, Englum BR, Kale E, Mathew JP, Husain AM, Hughes GC. Electroencephalography During Hemiarch Replacement With Moderate Hypothermic Circulatory Arrest. Ann Thorac Surg. 2016 Feb;101(2):631-7. doi: 10.1016/j.athoracsur.2015.08.002. Epub 2015 Oct 17. PubMed PMID: 26482779.

6. Schechter MA, Shah AA, Englum BR, Williams JB, Ganapathi AM, Davies JD, Welsby IJ, Hughes GC. Prolonged postoperative respiratory support after proximal thoracic aortic surgery: Is deep hypothermic circulatory arrest a risk factor? J Crit Care. 2016 Feb;31(1):125-9. doi: 10.1016/j.jcrc.2015.10.021. Epub 2015 Nov 6. PubMed PMID: 26700606.

7. Englum BR, Ganapathi AM, Speicher PJ, Gulack BC, Snyder LD, Davis RD, Hartwig MG. Impact of donor and recipient hepatitis C status in lung transplantation. J Heart Lung Transplant. 2016 Feb;35(2):228-35. doi: 10.1016/j.healun.2015.10.012. Epub 2015 Oct 9. PubMed PMID: 26615769; PubMed Central PMCID: PMC4747827.

8. Schechter MA, Ganapathi AM, Englum BR, Speicher PJ, Daneshmand MA, Davis RD, Hartwig MG. Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation. Transplantation. 2016 Jan 20. [Epub ahead of print] PubMed PMID: 26910331.

9. Englum BR, Ganapathi AM, Schechter MA, Harrison JK, Glower DD, Hughes GC. Changes in Risk Profile and Outcomes of Patients Undergoing Surgical Aortic Valve Replacement From the Pre- to Post-Transcatheter Aortic

39

Valve Replacement Eras. Ann Thorac Surg. 2016 Jan;101(1):110-7. doi: 10.1016/j.athoracsur.2015.06.083. Epub 2015 Sep 16. PubMed PMID: 26384440; PubMed Central PMCID: PMC4689657.

10. Speicher PJ, Englum BR, Ganapathi AM, Nussbaum DP, Mantyh CR, Migaly J. Robotic Low Anterior Resection for Rectal Cancer: A National Perspective on Short-term Oncologic Outcomes. Ann Surg. 2015 Dec;262(6):1040-5. doi: 10.1097/SLA.0000000000001017. PubMed PMID: 25405559.

11. Gulack BC, Ganapathi AM, Speicher PJ, Meza JM, Hirji SA, Snyder LD, Davis RD, Hartwig MG. What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis? Ann Thorac Surg. 2015 Nov;100(5):1826-33. doi: 10.1016/j.athoracsur.2015.05.008. Epub 2015 Jul 23. PubMed PMID: 26210946; PubMed Central PMCID: PMC4630142.

12. Speicher PJ, Wang X, Englum BR, Ganapathi AM, Yerokun B, Hartwig MG, D'Amico TA, Berry MF. Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer. Dis Esophagus. 2015 Nov-Dec;28(8):788-96. doi: 10.1111/dote.12285. Epub 2014 Sep 12. PubMed PMID: 25212528; PubMed Central PMCID: PMC4362812.

13. Englum BR, Ganapathi AM, Hughes GC. Reply: To PMID 25301369. Ann Thorac Surg. 2015 Oct;100(4):1508. doi: 10.1016/j.athoracsur.2015.03.091. PubMed PMID: 26434467.

14. Ganapathi AM, Englum BR, Keenan JE, Schechter MA, Wang H, Smith PK, Glower DD, Hughes GC. Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? Ann Thorac Surg. 2015 Aug;100(2):550-9. doi: 10.1016/j.athoracsur.2015.02.067. Epub 2015 May 16. PubMed PMID: 25986098.

15. Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd. Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas. Ann Surg. 2015 Jul;262(1):163-70. doi: 10.1097/SLA.0000000000000840. PubMed PMID: 25185464; PubMed Central PMCID: PMC4345136.

16. Keenan JE, Vavalle JP, Ganapathi AM, Wang H, Harrison JK, Wang A, Hughes GC. Factor VIIa for Annulus Rupture After Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2015 Jul;100(1):313-5. doi: 10.1016/j.athoracsur.2014.09.063. PubMed PMID: 26140778.

17. Ganapathi AM, Speicher PJ, Englum BR, Perez A, Tyler DS, Zani S. Gangrenous cholecystitis: a contemporary review. J Surg Res. 2015 Jul;197(1):18-24. doi: 10.1016/j.jss.2015.02.058. Epub 2015 Mar 4. PubMed PMID: 25937567.

18. Nussbaum DP, Speicher PJ, Gulack BC, Keenan JE, Ganapathi AM, Englum BR, Tyler DS, Blazer DG 3rd. Management of 1- to 2-cm Carcinoid Tumors of the Appendix: Using the National Cancer Data Base to Address Controversies in General Surgery. J Am Coll Surg. 2015 May;220(5):894-903. doi: 10.1016/j.jamcollsurg.2015.01.005. Epub 2015 Jan 22. PubMed PMID: 25840530.

19. Ganapathi AM, Hirji SA, Wang A, Patel CB, Gaca JG, Schroder JN. Bridge to long-term mechanical circulatory support with a left ventricular assist device: novel use of transcatheter aortic valve replacement. Ann Thorac Surg. 2015 Apr;99(4):e91-3. doi: 10.1016/j.athoracsur.2014.12.087. PubMed PMID: 25841859.

20. Speicher PJ, Englum BR, Ganapathi AM, Onaitis MW, D'Amico TA, Berry MF. Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small-cell lung cancer. Eur J Cardiothorac Surg. 2015 Apr;47(4):636-41. doi: 10.1093/ejcts/ezu270. Epub 2014 Jul 8. PubMed PMID: 25005840; PubMed Central PMCID: PMC4366575.

21. Osho AA, Castleberry AW, Snyder LD, Ganapathi AM, Speicher PJ, Hirji SA, Stafford-Smith M, Daneshmand MA, Duane Davis R, Hartwig MG. Determining eligibility for lung transplantation: A nationwide assessment of the cutoff glomerular filtration rate. J Heart Lung Transplant. 2015 Apr;34(4):571-9. doi: 10.1016/j.healun.2014.09.035. Epub 2014 Oct 2. PubMed PMID: 25524142.

22. Nussbaum DP, Speicher PJ, Ganapathi AM, Englum BR, Keenan JE, Mantyh CR, Migaly J. Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base. J Gastrointest Surg. 2015 Jan;19(1):124-31; discussion 131-2. doi: 10.1007/s11605-014-2614-1. Epub 2014 Aug 5. PubMed PMID: 25091847; PubMed Central PMCID: PMC4336173.

23. Speicher PJ, Ganapathi AM, Englum BR, Gulack BC, Osho AA, Hirji SA, Castleberry AW, Snyder LD, Duane Davis R, Hartwig MG. Single-lung transplantation in the United States: what happens to the other lung? J Heart Lung Transplant. 2015 Jan;34(1):36-42. doi: 10.1016/j.healun.2014.08.018. Epub 2014 Aug 28. PubMed PMID: 25305097; PubMed Central PMCID: PMC4339113.

24. Speicher PJ, Englum BR, Ganapathi AM, Mulvihill MS, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF. Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma. J Thorac Oncol. 2015 Jan;10(1):181-8. doi: 10.1097/JTO.0000000000000384. PubMed PMID: 25490005.

25. Ganapathi AM, Speicher PJ, Castleberry AW, Englum BR, Osho AA, Davis RD, Hartwig MG. The effect of prior pneumonectomy or lobectomy on subsequent lung transplantation. Ann Thorac Surg. 2014 Dec;98(6):1922-8; discussion 1928-9. doi: 10.1016/j.athoracsur.2014.06.042. Epub 2014 Oct 17. PubMed PMID: 25443000.

26. Osho AA, Castleberry AW, Snyder LD, Palmer SM, Ganapathi AM, Hirji SA, Lin SS, Davis RD, Hartwig MG. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. Ann Thorac Surg. 2014 Dec;98(6):1914-20; discussion 1920-1. doi: 10.1016/j.athoracsur.2014.06.036. Epub 2014 Oct 17. PubMed PMID: 25442999.

40

27. Englum BR, Pavlisko EN, Mack MC, Ganapathi AM, Schechter MA, Hanna JM, Hughes GC. Pseudoaneurysm formation after medtronic freestyle porcine aortic bioprosthesis implantation: a word of caution. Ann Thorac Surg. 2014 Dec;98(6):2061-7. doi: 10.1016/j.athoracsur.2014.06.062. Epub 2014 Oct 7. PubMed PMID: 25301369; PubMed Central PMCID: PMC4336162.

28. Hughes GC, Ganapathi AM, Keenan JE, Englum BR, Hanna JM, Schechter MA, Wang H, McCann RL. Thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection. Ann Thorac Surg. 2014 Dec;98(6):2092-7; discussion 2098. doi: 10.1016/j.athoracsur.2014.06.066. Epub 2014 Oct 1. PubMed PMID: 25282168; PubMed Central PMCID: PMC4330190.

29. Ganapathi AM, Speicher PJ, Englum BR, Castleberry AW, Migaly J, Hsu DS, Mantyh CR. Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit. Dis Colon Rectum. 2014 Dec;57(12):1341-8. doi: 10.1097/DCR.0000000000000245. PubMed PMID: 25379998; PubMed Central PMCID: PMC4336178.

30. Ganapathi AM, Hanna JM, Schechter MA, Englum BR, Castleberry AW, Gaca JG, Hughes GC. Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: does it matter? A propensity-matched analysis. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2896-902. doi: 10.1016/j.jtcvs.2014.04.014. Epub 2014 Apr 13. PubMed PMID: 24908350; PubMed Central PMCID: PMC4336168.

31. Andersen ND, Hanna JM, Ganapathi AM, Bhattacharya SD, Williams JB, Gaca JG, McCann RL, Hughes GC. Insurance status predicts acuity of thoracic aortic operations. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2082-6. doi: 10.1016/j.jtcvs.2014.03.013. Epub 2014 Mar 19. PubMed PMID: 24725770; PubMed Central PMCID: PMC4322755.

32. Ganapathi AM, Englum BR, Schechter MA, Vavalle JP, Harrison JK, McCann RL, Hughes GC. Role of cardiac evaluation before thoracic endovascular aortic repair. J Vasc Surg. 2014 Nov;60(5):1196-203. doi: 10.1016/j.jvs.2014.05.029. Epub 2014 Jun 25. PubMed PMID: 24973286; PubMed Central PMCID: PMC4336174.

33. Langan EM 3rd, Ganapathi AM. Discussion. J Vasc Surg. 2014 Nov;60(5):1203. doi: 10.1016/j.jvs.2014.05.030. Epub 2014 Jun 25. PubMed PMID: 24973285.

34. Schechter MA, Joseph JT, Krishnamoorthy A, Finet JE, Ganapathi AM, Lodge AJ, Milano CA, Patel CB. Efficacy and durability of central oversewing for treatment of aortic insufficiency in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2014 Sep;33(9):937-42. doi: 10.1016/j.healun.2014.04.017. Epub 2014 May 9. Erratum in: J Heart Lung Transplant. 2014 Nov;33(11):1202. Finet, J Emanuel [corrected to Finet, JE]. PubMed PMID: 24997496.

35. Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Keenan JE, Stinnett SS, Kirsch DG, Tyler DS, Blazer DG 3rd. The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. Surg Oncol. 2014 Sep;23(3):155-60. doi: 10.1016/j.suronc.2014.07.001. Epub 2014 Jul 23. Review. PubMed PMID: 25085344; PubMed Central PMCID: PMC4322682.

36. Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer. J Thorac Oncol. 2014 Aug;9(8):1195-201. doi: 10.1097/JTO.0000000000000228. PubMed PMID: 25157773; PubMed Central PMCID: PMC4145610.

37. Speicher PJ, Ganapathi AM, Englum BR, Vaslef SN. Laparoscopy is safe among patients with congestive heart failure undergoing general surgery procedures. Surgery. 2014 Aug;156(2):371-8. doi: 10.1016/j.surg.2014.03.003. Epub 2014 Mar 14. PubMed PMID: 24947641; PubMed Central PMCID: PMC4346558.

38. Osho AA, Castleberry AW, Snyder LD, Ganapathi AM, Hirji SA, Stafford-Smith M, Lin SS, Davis RD, Hartwig MG. Assessment of different threshold preoperative glomerular filtration rates as markers of outcomes in lung transplantation. Ann Thorac Surg. 2014 Jul;98(1):283-9; discussion 289-90. doi: 10.1016/j.athoracsur.2014.03.010. Epub 2014 May 1. PubMed PMID: 24793682; PubMed Central PMCID: PMC4332517.

39. Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, Hughes GC. Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. J Am Coll Cardiol. 2014 May 6;63(17):1796-803. doi: 10.1016/j.jacc.2013.10.085. Epub 2014 Jan 8. PubMed PMID: 24412454; PubMed Central PMCID: PMC4159705.

40. Andersen ND, Keenan JE, Ganapathi AM, Gaca JG, McCann RL, Hughes GC. Current management and outcome of chronic type B aortic dissection: results with open and endovascular repair since the advent of thoracic endografting. Ann Cardiothorac Surg. 2014 May;3(3):264-74. doi: 10.3978/j.issn.2225-319X.2014.05.07. PubMed PMID: 24967165; PubMed Central PMCID: PMC4052409.

41. Ganapathi AM, Andersen ND, Hanna JM, Gaca JG, McCann RL, Hughes GC. Comparison of attachment site endoleak rates in Dacron versus native aorta landing zones after thoracic endovascular aortic repair. J Vasc Surg. 2014 Apr;59(4):921-9. doi: 10.1016/j.jvs.2013.10.086. Epub 2013 Dec 19. PubMed PMID: 24360582.

42. Speicher PJ, Ganapathi AM, Englum BR, Onaitis MW, D'Amico TA, Berry MF. Survival in the elderly after pneumonectomy for early-stage non-small cell lung cancer: a comparison with nonoperative management. J Am Coll Surg. 2014 Mar;218(3):439-49. doi: 10.1016/j.jamcollsurg.2013.12.005. Epub 2013 Dec 12. PubMed PMID: 24559956; PubMed Central PMCID: PMC3934839.

41

43. Ganapathi AM, Englum BR, Hanna JM, Schechter MA, Gaca JG, Hurwitz LM, Hughes GC. Frailty and risk in proximal aortic surgery. J Thorac Cardiovasc Surg. 2014 Jan;147(1):186-191.e1. doi: 10.1016/j.jtcvs.2013.09.011. Epub 2013 Oct 30. PubMed PMID: 24183336; PubMed Central PMCID: PMC4336171.

44. Hanna JM, Andersen ND, Ganapathi AM, McCann RL, Hughes GC. Five-year results for endovascular repair of acute complicated type B aortic dissection. J Vasc Surg. 2014 Jan;59(1):96-106. doi: 10.1016/j.jvs.2013.07.001. Epub 2013 Oct 1. PubMed PMID: 24094903.

45. Atkins BZ, Hashmi ZA, Ganapathi AM, Harrison JK, Hughes GC, Rogers JG, Milano CA. Surgical correction of aortic valve insufficiency after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013 Nov;146(5):1247-52. doi: 10.1016/j.jtcvs.2013.05.019. Epub 2013 Jul 16. PubMed PMID: 23870154.

46. Rajagopal K, Daneshmand MA, Patel CB, Ganapathi AM, Schechter MA, Rogers JG, Milano CA. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013 May;145(5):1373-9. doi: 10.1016/j.jtcvs.2012.11.066. Epub 2013 Jan 8. PubMed PMID: 23312101.

47. Ganapathi AM, Andersen ND, Prastein DJ, Hashmi ZA, Rogers JG, Milano CA, McCann RL, Hughes GC. Endovascular stent grafting of a left ventricular assist device outflow graft pseudoaneurysm. Circ Heart Fail. 2013 Jan;6(1):e16-8. doi: 10.1161/CIRCHEARTFAILURE.112.971861. PubMed PMID: 23322880.

48. Piacentino V 3rd, Ganapathi AM, Stafford-Smith M, Hsieh MK, Patel CB, Simeone AA, Rogers JG, Milano CA. Utility of concomitant tricuspid valve procedures for patients undergoing implantation of a continuous-flow left ventricular device. J Thorac Cardiovasc Surg. 2012 Nov;144(5):1217-21. doi: 10.1016/j.jtcvs.2012.07.064. Epub 2012 Aug 29. PubMed PMID: 22938779.

49. Ganapathi AM, Westmoreland T, Tyler D, Mantyh CR. Bevacizumab-associated fistula formation in postoperative colorectal cancer patients. J Am Coll Surg. 2012 Apr;214(4):582-8; discussion 588-90. doi: 10.1016/j.jamcollsurg.2011.12.030. Epub 2012 Feb 8. PubMed PMID: 22321523.

50. Piacentino V 3rd, Troupes CD, Ganapathi AM, Blue LJ, Mackensen GB, Swaminathan M, Felker GM, Stafford-Smith M, Lodge AJ, Rogers JG, Milano CA. Clinical impact of concomitant tricuspid valve procedures during left ventricular assist device implantation. Ann Thorac Surg. 2011 Oct;92(4):1414-8; discussion 1418-9. doi: 10.1016/j.athoracsur.2011.05.084. PubMed PMID: 21958790.

Book Chapters

1. Ganapathi AM, Tyler DS, and Mosca PJ(2011). Challenging Problems in the Surgical Management of Melanoma, Current Management of Malignant Melanoma, Ming Y. Cao (Ed.). ISBN: 978-953-307-264-7, InTech.

2. Ganapathi AM, Lodge AJ(2013). Surgical Considerations for Congenital Heart Defects, Caffey’s Pediatric Diagnostic Imaging, 12th Ed, Brian D. Coley (Ed.). ISBN: 000-0323081762, Saunders.

3. Ganapathi AM, Lagoo S (2012). Biliary Anatomy and Anatomical Variants, Contemporary Surgical Management of Liver, Biliary Tract, and Pancreatic Disease, Dan G Blazer, Paul C Kuo, Theodore Pappas, Bryan Clary (Ed.). ISBN: 978-9814293051, World Scientific Publishing Company.

Jennifer Hanna, MD, MBA

Refereed journals

1. Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, Welsby IJ, Hughes GC. Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2016 Feb;151(2):376-82. doi: 10.1016/j.jtcvs.2015.08.079. Epub 2015 Sep 28. PubMed PMID: 26428473.

2. Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, Welsby IJ, Hughes GC. Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 2015 Sep 28. pii: S0022-5223(15)01542-1.

3. Wang H, Hanna JM, Ganapathi A, Keenan JE, Hurwitz LM, Vavalle JP, Kiefer TL, Wang A, Harrison JK, Hughes GC. Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement. Am J Cardiol. 2015 Jun 1;115(11):1568-73.

4. Williams JA, Hanna JM, Shah AA, Andersen ND, McDonald MT, Jiang YH, Wechsler SB, Zomorodi A, McCann RL, Hughes GC. Adult surgical experience with Loeys-Dietz syndrome. Ann Thorac Surg. 2015 Apr;99(4):1275-81.

5. Hanna JM, Erhunmwunsee L, Berry M, D'Amico T, Onaitis M. The prognostic importance of the number of dissected lymph nodes after induction chemoradiotherapy for esophageal cancer. Ann Thorac Surg. 2015 Jan;99(1):265-9.

6. Englum BR, Pavlisko EN, Mack MC, Ganapathi AM, Schechter MA, Hanna JM, Hughes GC. Pseudoaneurysm formation after medtronic freestyle porcine aorticbioprosthesis implantation: a word of caution. Ann Thorac Surg. 2014 Dec;98(6):2061-7.

42

7. Hughes GC, Ganapathi AM, Keenan JE, Englum BR, Hanna JM, Schechter MA, Wang H, McCann RL. Thoracic endovascular aortic repair for chronic DeBakey IIIb aortic dissection. Ann Thorac Surg. 2014 Dec;98(6):2092-7; discussion 2098.

8. Ganapathi AM, Hanna JM, Schechter MA, Englum BR, Castleberry AW, Gaca JG, Hughes GC. Antegrade versus retrograde cerebral perfusion for hemiarch replacement with deep hypothermic circulatory arrest: does it matter? A propensity-matched analysis. J Thorac Cardiovasc Surg. 2014 Dec;148(6):2896-902.

9. Andersen ND, Hanna JM, Ganapathi AM, Bhattacharya SD, Williams JB, Gaca JG, McCann RL, Hughes GC. Insurance status predicts acuity of thoracic aortic operations. J Thorac Cardiovasc Surg. 2014 Nov;148(5):2082-6.

10. Hanna JM, Turley R, Castleberry A, Hopkins T, Peterson AC, Mantyh C, Migaly J. Surgical management of complex rectourethral fistulas in irradiated and nonirradiated patients. Dis Colon Rectum. 2014 Sep;57(9):1105-12.

11. Hanna JM, Peterson AC, Mantyh C. Rectourethral fistulas in the cancer survivor. Curr Opin Urol. 2014 Jul;24(4):382-8.

12. Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, Hughes GC. Outcomes of acute type a dissection repair before and after implementation of a multidisciplinary thoracic aortic surgery program. J Am Coll Cardiol. 2014 May 6;63(17):1796-803.

13. Andersen ND, Hanna JM, Barfield ME, and Hughes GC. Insurance Status Predicts Acuity of Thoracic Aortic Operations. J Thorac Cardiovasc Surg 2014: doi: 10.1016/j.jtcvs.2014.03.013. [Epub ahead of print].

14. Haney JC, Hanna JM, Berry MF, Harpole DH, D’Amico TA, Tong BC, Onaitis MW. Differential prognostic significance of extralobar and intralobar nodal metastases in patients with surgically resected stage II non-small cell lung cancer. J Thorac Cardiovasc Surg 2014;147:1164-8.

15. Hanna JM, Peterson AC, Mantyh C. Rectourethral fistulas and the cancer survivor. Curr Opin Urol 2014:24(4);382-8.

16. Hanna JM, Onaitis MW. Robotic benign esophageal procedures. Thorac Surg Clin 2014;24(2):223-9. 17. Hanna JM, Turley RS, Castleberry AW, Hopkins TJ, Webster GW, Mantyh CR, and Migaly J. Surgical

management of complex rectourethral fistulas in irradiated and non-irradiated patients. Dis Colon Rectum 2014:57(9); 1105-12.

18. Andersen ND, Ganapathi AM, Hanna JM, Williams JB, Gaca JG, and Hughes GC. Outcomes of Acute Type A Dissection Repair Before and After the Implementation of a Multidisciplinary Thoracic Aortic Surgery Program. J Am Coll Cardiol 2014;63(17):1796-803.

19. James ML, Andersen ND, Swaminathan M, Phillips-Bute B, Hanna JM, Smigla GR, Barfield ME, Bhattacharya SD, Williams JB, Gaca JG, Husain AM, Hughes GC. Predictors of electrocerebral inactivity with deep hypothermia. J Thorac Cardiovasc Surg 2014;147(3):1002-7.

20. Ganapathi AM, Andersen ND, Hanna JM, Gaca JG, McCann RL, Hughes GC. Comparison of attachment site endoleak rates in Dacron versus native aorta landing zones after thoracic endovascular aortic repair. J Vasc Surg 2013;59(4):921-9.

21. Hanna JM, Berry M, D’Amico TA. Contraindications of VATS lobectomy and determinants of conversion to open. J Thorac Dis 2013:5(Suppl 3):S182-S189.

22. Hanna JM, Andersen ND, Ganapathi AM, McCann RL, Hughes GC. Five-Year Results for Endovascular Repair of Acute Complicated Type B Aortic Dissection. J Vasc Surg 2014;59(1):96-106.

23. Hanna JM, Onaitis MW. Cell of origin of lung cancer. J Carcinog 2013: 12:6. 24. Hanna JM, Blazer DG, Mosca PJ. Overview of Palliative Surgery: Principles and Priorities. J Palliative Care

Med 2012;2(7):1-6. 25. Hughes GC, Andersen ND, Hanna JM, McCann RL. Thoracoabdominal aortic aneurysm: hybrid repair

outcomes. Ann Cardiothorac Surg 2012;1(3):311-319. 26. Hanna JM and Onaitis MW. Technique of Video-Assisted Thoracoscopic Chest Wall Resection. Op Tech Thor

CV Surg;17(4)280-91. 27. Shah AA, Barfield ME, Andersen ND, Williams JB, Shah JA, Hanna JM, McCann RL, and Hughes GC. Results

of Thoracic Endovascular Aortic Repair Six Years after U.S. FDA Approval. Ann Thor Surg 2012;94(5):1394-9. 28. Hanna, JM, Andersen ND, Aziz H, Shah AA, McCann RL, and Hughes GC. Results with selective preoperative

lumbar drain placement for thoracic endovascular aortic repair. Ann Thor Surg 2013;95(6):1968-75. 29. Andersen ND, Barfield ME, Hanna JM, Shah AA, Shortell CK, McCann RL, and Hughes GC. Intra-thoracic

Subclavian Artery Aneurysm Repair in the Thoracic Endovascular Era. J Thorac Cardiovasc Surg 2013:57(4):915-25.

30. Andersen ND, Williams, JB, Hanna JM, Shah AA, McCann RL, and Hughes GC. Results with an Algorithmic Approach to Hybrid Repair of the Aortic Arch. J Vasc Surg 2013;57(3):655-67.

31. Villamizar N, Darrabie M, Hanna JM, Onaitis M, Tong B, D’Amico T, Berry M. Impact of T status and N status on outcomes after thoracoscopic lobectomy for lung cancer. J Thorac Cardiovasc Surg 2013;145(2):514-20.

32. Castleberry AW, Turley RS, Hanna JM, Hopkins TJ, Barbas AS, Worni M, Mantyh CR, Migaly J. A 10-Year Longitudinal Analysis of Surgical Management for Acute Ischemic Colitis. J Gastrointest Surg 2013;17(4):784-92.

43

33. Hughes GC, Barfield ME, Shah, AA, Williams JB, Kuchibhatla M, Hanna JM, Anderson ND, McCann RL. Staged Total Abdominal Debranching and TEVAR for Thoracoabdominal Aneurysm. J Vasc Surg 2012;56(3):621-9.

34. Hanna JM, Onaitis MW. Human Lung Stem Cells: Has the Future Arrived? Semin Thorac Cardiovasc Surg 2011 Winter: 23(4): 259-60.

35. Hanna JM, Simiele E, Lawson DC, Tyler D. Conflict of interest issues pertinent to Veterans Affairs Medical Centers. J Vasc Surg 2011 Sept; 54 (3 Suppl): 50S-54S.

36. Tong BC, Hanna JM, Toloza EM, Onaitis MW, D’Amico TA, Harpole DH, and Burfiend WR. Outcomes of Video-Assisted Thoracoscopic Decortication. Ann Thorac Surg 2010 Jan; 89 (1): 220-225.

37. Berry MG, Hanna JM, Onaitis MW, Tong BC, Burfiend WR, Harpole DH, and D’Amico TA. Risk Factors for Morbidity After Lobectomy for Lung Cancer in Elderly Patients. Ann Thorac Surg 2009 Oct; 88(4): 1093-1099.

38. Grabowski H, Moe J, and Hanna JM. (2008, April 1). Impact of Economic, Regulatory and Patent Policies on Innovation in Cancer Chemoprevention. http://cancerprevres.aacrjournals.org.

Book chapters

1. Hanna JM, Onaitis MW, D’Amico TA (2016). Lung Cancer: Minimally Invasive Approaches. In Sabiston & Spencer Surgery of the Chest 9th ed. (pp. 318-326). Philadelphia, PA: Elsevier, Inc.

Jeffrey Keenan, MD

Refereed journals

1. Keenan JE, Schechter MA, Bonadonna DK, Bartz RR, Milano CA, Schroder JN, et al. Early Experience with a Novel Cannulation Strategy for Left Ventricular Decompression during Nonpostcardiotomy Venoarterial ECMO. ASAIO J. 2016;62(3):e30-4. Epub 2016/01/07. doi: 10.1097/MAT.0000000000000333. PubMed PMID: 26735555.

2. Gulack BC, Nussbaum DP, Keenan JE, Ganapathi AM, Sun Z, Worni M, et al. Surgical Resection of the Primary Tumor in Stage IV Colorectal Cancer Without Metastasectomy Is Associated With Improved Overall Survival Compared With Chemotherapy/Radiation Therapy Alone. Diseases of the colon and rectum. 2016;59(4):299-305. Epub 2016/03/10. doi: 10.1097/DCR.0000000000000546. PubMed PMID: 26953988; PubMed Central PMCID: PMC4785825.

3. Keenan JE, Wang H, Ganapathi AM, Englum BR, Kale E, Mathew JP, et al. Electroencephalography During Hemiarch Replacement With Moderate Hypothermic Circulatory Arrest. The Annals of thoracic surgery. 2015. Epub 2015/10/21. doi: 10.1016/j.athoracsur.2015.08.002. PubMed PMID: 26482779.

4. Benrashid E, Wang H, Keenan JE, Andersen ND, Meza JM, McCann RL, et al. Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair. Journal of vascular surgery. 2015. Epub 2015/11/01. doi: 10.1016/j.jvs.2015.09.004. PubMed PMID: 26518097.

5. Hanna JM, Keenan JE, Wang H, Andersen ND, Gaca JG, Lombard FW, et al. Use of human fibrinogen concentrate during proximal aortic reconstruction with deep hypothermic circulatory arrest. The Journal of thoracic and cardiovascular surgery. 2015. Epub 2015/10/03. doi: 10.1016/j.jtcvs.2015.08.079. PubMed PMID: 26428473.

6. Gulack BC, Englum BR, Lo DD, Nussbaum DP, Keenan JE, Scarborough JE, et al. Leukopenia is associated with worse but not prohibitive outcomes following emergent abdominal surgery. The journal of trauma and acute care surgery. 2015;79(3):437-43. Epub 2015/08/27. doi: 10.1097/TA.0000000000000757. PubMed PMID: 26307878.

7. Sun Z, Shenoi MM, Nussbaum DP, Keenan JE, Gulack BC, Tyler DS, et al. Feeding jejunostomy tube placement during resection of gastric cancers. The Journal of surgical research. 2015. Epub 2015/08/08. doi: 10.1016/j.jss.2015.07.014. PubMed PMID: 26248478.

8. Keenan JE, Speicher PJ, Nussbaum DP, Adam MA, Miller TE, Mantyh CR, et al. Improving Outcomes in Colorectal Surgery by Sequential Implementation of Multiple Standardized Care Programs. Journal of the American College of Surgeons. 2015;221(2):404-14 e1. Epub 2015/07/25. doi: 10.1016/j.jamcollsurg.2015.04.008. PubMed PMID: 26206639.

9. Keenan JE, Vavalle JP, Ganapathi AM, Wang H, Harrison JK, Wang A, et al. Factor VIIa for Annulus Rupture After Transcatheter Aortic Valve Replacement. The Annals of thoracic surgery. 2015;100(1):313-5. Epub 2015/07/05. doi: 10.1016/j.athoracsur.2014.09.063. PubMed PMID: 26140778.

10. Gulack BC, Englum BR, Rialon KL, Talbot LJ, Keenan JE, Rice HE, et al. Inequalities in the use of helmets by race and payer status among pediatric cyclists. Surgery. 2015;158(2):556-61. Epub 2015/06/06. doi: 10.1016/j.surg.2015.02.025. PubMed PMID: 26044110.

44

11. Ganapathi AM, Englum BR, Keenan JE, Schechter MA, Wang H, Smith PK, et al. Long-Term Survival After Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter? The Annals of thoracic surgery. 2015. Epub 2015/05/20. doi: 10.1016/j.athoracsur.2015.02.067. PubMed PMID: 25986098.

12. Nussbaum DP, Speicher PJ, Gulack BC, Keenan JE, Ganapathi AM, Englum BR, et al. Management of 1- to 2-cm Carcinoid Tumors of the Appendix: Using the National Cancer Data Base to Address Controversies in General Surgery. Journal of the American College of Surgeons. 2015;220(5):894-903. Epub 2015/04/05. doi: 10.1016/j.jamcollsurg.2015.01.005. PubMed PMID: 25840530.

13. Wang H, Hanna JM, Ganapathi A, Keenan JE, Hurwitz LM, Vavalle JP, et al. Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement. The American journal of cardiology. 2015;115(11):1568-73. Epub 2015/04/08. doi: 10.1016/j.amjcard.2015.02.060. PubMed PMID: 25846765.

14. Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Keenan JE, Stinnett SS, et al. The effect of neoadjuvant radiation therapy on perioperative outcomes among patients undergoing resection of retroperitoneal sarcomas. Surgical oncology. 2014;23(3):155-60. Epub 2014/08/03. doi: 10.1016/j.suronc.2014.07.001. PubMed PMID: 25085344.

15. Nussbaum DP, Speicher PJ, Ganapathi AM, Englum BR, Keenan JE, Mantyh CR, et al. Laparoscopic versus open low anterior resection for rectal cancer: results from the national cancer data base. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2015;19(1):124-31; discussion 31-2. Epub 2014/08/06. doi: 10.1007/s11605-014-2614-1. PubMed PMID: 25091847; PubMed Central PMCID: PMC4336173.

16. McCoy CC, Englum BR, Keenan JE, Vaslef SN, Shapiro ML, Scarborough JE. Impact of specific postoperative complications on the outcomes of emergency general surgery patients. The journal of trauma and acute care surgery. 2015;78(5):912-9. Epub 2015/04/25. doi: 10.1097/TA.0000000000000611. PubMed PMID: 25909409.

17. Keenan JE, Gulack BC, Nussbaum DP, Green CL, Vaslef SN, Shapiro ML, et al. Optimal timing of tracheostomy after trauma without associated head injury. The Journal of surgical research. 2015. Epub 2015/05/16. doi: 10.1016/j.jss.2015.03.072. PubMed PMID: 25976854.

18. Hughes GC, Ganapathi AM, Keenan JE, Englum BR, Hanna JM, Schechter MA, et al. Thoracic Endovascular Aortic Repair for Chronic DeBakey IIIb Aortic Dissection. The Annals of thoracic surgery. 2014. Epub 2014/10/06. doi: 10.1016/j.athoracsur.2014.06.066. PubMed PMID: 25282168.

19. Keenan JE, Speicher PJ, Thacker JK, Walter M, Kuchibhatla M, Mantyh CR. The Preventive Surgical Site Infection Bundle in Colorectal Surgery: An Effective Approach to Surgical Site Infection Reduction and Health Care Cost Savings. JAMA surgery. 2014. Epub 2014/08/28. doi: 10.1001/jamasurg.2014.346. PubMed PMID: 25163027.

20. Andersen ND, Keenan JE, Ganapathi AM, Gaca JG, McCann RL, Hughes GC. Current management and outcome of chronic type B aortic dissection: results with open and endovascular repair since the advent of thoracic endografting. Annals of cardiothoracic surgery. 2014;3(3):264-74. Epub 2014/06/27. doi: 10.3978/j.issn.2225-319X.2014.05.07. PubMed PMID: 24967165; PubMed Central PMCID: PMC4052409.

21. Keenan JE, Turley RS, McCoy CC, Migaly J, Shapiro ML, Scarborough JE. Trials of nonoperative management exceeding 3 days are associated with increased morbidity in patients undergoing surgery for uncomplicated adhesive small bowel obstruction. The journal of trauma and acute care surgery. 2014;76(6):1367-72. Epub 2014/05/24. doi: 10.1097/TA.0000000000000246. PubMed PMID: 24854302.

22. Fayek SA, Keenan J, Haririan A, Cooper M, Barth RN, Schweitzer E, et al. Ureteral stents are associated with reduced risk of ureteral complications after kidney transplantation: a large single center experience. Transplantation. 2012;93(3):304-8. Epub 2011/12/20. doi: 10.1097/TP.0b013e31823ec081. PubMed PMID: 22179401.

23. Temmerman ST, Ma CA, Zhao Y, Keenan J, Aksentijevich I, Fessler M, et al. Defective nuclear IKKalpha function in patients with ectodermal dysplasia with immune deficiency. The Journal of clinical investigation. 2012;122(1):315-26. Epub 2011/12/14. doi: 10.1172/JCI42534. PubMed PMID: 22156202; PubMed Central PMCID: PMC3248277.

24. Lopez-Granados E, Keenan JE, Kinney MC, Leo H, Jain N, Ma CA, et al. A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Human mutation. 2008;29(6):861-8. Epub 2008/04/17. doi: 10.1002/humu.20740. PubMed PMID: 18412279; PubMed Central PMCID: PMC3179847.

25. Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. Journal of molecular biology. 2007;369(2):498-511. Epub 2007/04/20. doi: 10.1016/j.jmb.2007.03.066. PubMed PMID: 17442341; PubMed Central PMCID: PMC1976284.

45

Christopher Scott, MD

Refereed journals

1. Scott CD, Harpole DH. The Biology of Pulmonary Metastasis. Thorac Surg Clin. 2016 Feb;26(1):1-6. doi: 10.1016/j.thorsurg.2015.09.001. Review. PMID:26611504

2. Klebanoff CA, Scott CD, Leonardi AJ, Yamamoto T, Ramaswamy M, Cruz AC, Ouyang C, Roychoudhuri R, Ji Y, Eil RL, Sukumar M, Crompton JG, Palmer DC, Borman ZA, Clever D, Yu Z, Muranski P, Liu H, Wang E, Marincola FM, Gros A, Gattinoni L, Rosenberg SA, Siegel RM, Restifo NP (2016). Memory T cell-driven differentiation of naïve cells impairs adoptive immunotherapy. J Clin Invest. 2016 Jan;126(1):318-34. doi: 10.1172/JCI81217. Epub 2015 Dec 14. PMID: 26657860

Book Chapters

1. Scott CD, Guitron J (2012). Principles of Thoracic Surgical Oncology in Thoracic Oncology. Newell K, ed. Wiley-Blackwell, New Jersey.

2. Scott CD, Onaitis MO (2015). Robotic Esophagectomy: Results and Discussion in Atlas of Minimally Invasive Surgery for Lung and Esophageal Cancer. Wang J and Ferguson M, eds. Springer, Philadelphia.

Paul Speicher, MD, MHS

Refereed journals

1. Gulack BC, Jeffrey Yang CF, Speicher PJ, Yerokun BA, Tong BC, Onaitis MW, D'Amico TA, Harpole DH Jr, Hartwig MG, Berry MF. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016 Sep 1. pii: S0003-4975(16)30739-1.

2. Speicher PJ, Fitch ZW, Gulack BC, Yang CF, Tong BC, Harpole DH, D'Amico TA, Berry MF, Hartwig MG. Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016 Sep;102(3):884-94.

3. Yerokun BA, Sun Z, Jeffrey Yang CF, Gulack BC, Speicher PJ, Adam MA, D'Amico TA, Onaitis MW, Harpole DH, Berry MF, Hartwig MG. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. Ann Thorac Surg. 2016 Aug;102(2):416-23.

4. Lidsky ME, Sun Z, Nussbaum DP, Adam MA, Speicher PJ, Blazer DG 3rd. Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers. Ann Surg. 2016 Jul 15. [Epub ahead of print] PubMed PMID: 27429020.

5. Sun Z, Kim J, Adam MA, Nussbaum DP, Speicher PJ, Mantyh CR, Migaly J. Minimally Invasive Versus Open Low Anterior Resection: Equivalent Survival in a National Analysis of 14,033 Patients With Rectal Cancer. Ann Surg. 2016

6. Jun;263(6):1152-8. 7. Yang CF, Meyerhoff RR, Mayne NR, Singhapricha T, Toomey CB, Speicher PJ, Hartwig MG, Tong BC, Onaitis

MW, Harpole DH Jr, D'Amico TA, Berry MF. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer. Eur J Cardiothorac Surg. 2016

8. Jun;49(6):1615-23. 9. Hartwig MG, Ganapathi AM, Osho AA, Hirji SA, Englum BR, Speicher PJ, Palmer SM, Davis RD, Snyder LD.

Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time. Am J Transplant. 2016 May 27.

10. Yang CF, Chan DY, Speicher PJ, Gulack BC, Wang X, Hartwig MG, Onaitis MW, Tong BC, D'Amico TA, Berry MF, Harpole DH. Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. J Clin Oncol. 2016 Apr 1;34(10):1057-64.

11. Yang CJ, Yan BW, Meyerhoff RR, Saud SM, Gulack BC, Speicher PJ, Hartwig MG, D'Amico TA, Harpole DH, Berry MF. Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma. Clin Lung Cancer. 2016 Mar 17. pii: S1525-7304(16)30031-6.

12. Speicher PJ, Englum BR, Ganapathi AM, Wang X, Hartwig MG, D'Amico TA, Berry MF. Traveling to a High-volume Center is Associated With Improved Survival for Patients With Esophageal Cancer. Ann Surg. 2016 Mar 15. [Epub ahead of print] PubMed PMID: 26982688.

13. Yang CF, Sun Z, Speicher PJ, Saud SM, Gulack BC, Hartwig MG, Harpole DH Jr, Onaitis MW, Tong BC, D'Amico TA, Berry MF. Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. Ann Thorac Surg. 2016 Mar;101(3):1037-42.

14. Javidfar J, Speicher PJ, Hartwig MG, D'Amico TA, Berry MF. Impact of Positive Margins on Survival in Patients Undergoing Esophagogastrectomy for Esophageal Cancer. Ann Thorac Surg. 2016 Mar;101(3):1060-7.

46

15. Englum BR, Ganapathi AM, Speicher PJ, Gulack BC, Snyder LD, Davis RD, Hartwig MG. Impact of donor and recipient hepatitis C status in lung transplantation. J Heart Lung Transplant. 2016 Feb;35(2):228-35.

16. Schechter MA, Ganapathi AM, Englum BR, Speicher PJ, Daneshmand MA, Davis RD, Hartwig MG. Spontaneously Breathing Extracorporeal Membrane Oxygenation Support Provides the Optimal Bridge to Lung Transplantation. Transplantation. 2016 Jan 20. [Epub ahead of print] PubMed PMID: 26910331.

17. Speicher PJ, Gu L, Gulack BC, Wang X, D'Amico TA, Hartwig MG, Berry MF. Sublobar Resection for Clinical Stage IA Non-small-cell Lung Cancer in the United States. Clin Lung Cancer. 2016 Jan;17(1):47-55.

18. Sun Z, Shenoi MM, Nussbaum DP, Keenan JE, Gulack BC, Tyler DS, Speicher PJ, Blazer DG 3rd. Feeding jejunostomy tube placement during resection of gastric cancers. J Surg Res. 2016 Jan;200(1):189-94.

19. Speicher PJ, Englum BR, Ganapathi AM, Nussbaum DP, Mantyh CR, Migaly J. Robotic Low Anterior Resection for Rectal Cancer: A National Perspective on Short-term Oncologic Outcomes. Ann Surg. 2015 Dec;262(6):1040-5

20. Gulack BC, Ganapathi AM, Speicher PJ, Meza JM, Hirji SA, Snyder LD, Davis RD, Hartwig MG. What Is the Optimal Transplant for Older Patients With Idiopathic Pulmonary Fibrosis? Ann Thorac Surg. 2015 Nov;100(5):1826-33.

21. Sun Z, Kim J, Adam MA, Nussbaum DP, Speicher PJ, Mantyh CR, Migaly J. Minimally Invasive Versus Open Low Anterior Resection: Equivalent Survival in a National Analysis of 14,033 Patients With Rectal Cancer. Ann Surg. 2015 Oct 22.

22. Gulack BC, Yang CJ, Speicher PJ, Meza JM, Gu L, Wang X, D'Amico TA, Hartwig MG, Berry MF. The impact of tumor size on the association of the extent of lymph node resection and survival in clinical stage I non-small cell lung cancer. Lung Cancer. 2015 Oct 14. pii: S0169-5002(15)30080-5.

23. Englum BR, Rialon KL, Speicher PJ, Gulack B, Driscoll TA, Kreissman SG, Rice HE. Value of surgical resection in children with high-risk neuroblastoma. Pediatr Blood Cancer. 2015 Sep;62(9):1529-35.

24. Keenan JE, Speicher PJ, Nussbaum DP, Adam MA, Miller TE, Mantyh CR, Thacker JK. Improving Outcomes in Colorectal Surgery by Sequential Implementation of Multiple Standardized Care Programs. J Am Coll Surg. 2015 Aug;221(2):404-14.e1.

25. Lane WO, Cramer CK, Nussbaum DP, Speicher PJ, Gulack BC, Czito BG, Kirsch DG, Tyler DS, Blazer DG 3rd. Analysis of perioperative radiation therapy in the surgical treatment of primary and recurrent retroperitoneal sarcoma. J Surg Oncol. 2015 Aug;112(4):352-8.

26. Sun Z, Shenoi MM, Nussbaum DP, Keenan JE, Gulack BC, Tyler DS, Speicher PJ, Blazer DG 3rd. Feeding jejunostomy tube placement during resection of gastric cancers. J Surg Res. 2015 Jul 16. pii: S0022-4804(15)00795-7.

27. Yang CJ, Gulack BC, Gu L, Speicher PJ, Wang X, Harpole DH, Onaitis MW, D'Amico TA, Berry MF, Hartwig MG. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Jul 2. pii: S0022-5223(15)01090-9.

28. Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Englum BR, Kirsch DG, Tyler DS, Blazer DG 3rd. Long-term Oncologic Outcomes After Neoadjuvant Radiation Therapy for Retroperitoneal Sarcomas. Ann Surg. 2015 Jul;262(1):163-70

29. Sun Z, Nussbaum DP, Speicher PJ, Czito BG, Tyler DS, Blazer DG 3rd. Neoadjuvant radiation therapy does not increase perioperative morbidity among patients undergoing gastrectomy for gastric cancer. J Surg Oncol. 2015 Jul;112(1):46-50

30. Ganapathi AM, Speicher PJ, Englum BR, Perez A, Tyler DS, Zani S. “Gangrenous cholecystitis: A contemporary review”. J Surg Res. 2015;197(1):18-24.

31. Englum BR, Rialon KL, Speicher PJ, Gulack B, Driscoll TA, Kreissman SG, Rice HE. “Value of Surgical Resection in Children with High-Risk Neuroblastoma”. Pediatr Blood Cancer. 2015;62(9):1529-35.

32. Meyerhoff RR, Yang CJ, Speicher PJ, Gulack BC, Hartwig MG, D’Amico TA, Harpole DH, Berry MF. “Impact of mesothelioma histologic subtype on outcomes in the SEER database”. J Surg Res. 2015;196(1):23-32.

33. Speicher PJ, Gu L, Wang X, Hartwig MG, D’Amico TA, Berry MF. “Adjuvant chemotherapy after lobectomy for T1-2N0 non-small cell lung cancer: are the guidelines supported?” J Natl Compr Canc Netw. 2015;13(6):755-61.

34. Nussbaum DP, Speicher PJ, Gulack BC, Keenan JE, Ganapathi AM, Englum BR, Tyler DS, Blazer DG III. “Management of 1-2 Centimeter Carcinoid Tumors of the Appendix: Using the National Cancer Data Base to Address Controversies in General Surgery”. J Am Coll Surg. 2015;220(5):894-903.

35. Rialon KL, Speicher PJ, Ceppa EP, Rendell T, Vaslef SN, Beaven A, Tyler DS, Blazer DG. "Outcomes Following Splenectomy in Patients with Myeloid Neoplasms". J Surg Onc 2015;111(4):389-95. Osho AA, Castleberry AW, Snyder LD, Ganapathi AM, Speicher PJ, Hirji SA, Stafford-Smith M, Daneshmand MA, Davis RD, Hartwig MG. “Determining Eligibility for Lung Transplantation: A Nationwide Assessment of The Cutoff Glomerular Filtration Rate”. J Heart Lung Transplant. 2014;34(4):571-9.

36. Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB. “Chemotherapeutic agents

47

subvert tumor immunity by generating platelet-activating factor agents”. Cancer Res. 2014;74(23):7069-78.

37. Ganapathi AM, Speicher PJ, Englum BR, Castleberry AW, Migaly J, Hsu DS, Mantyh CR. “Adjuvant chemotherapy for T1 node positive colon cancers provides significant survival benefit”. Dis Col Rectum. 2014;57(12):1341-8.

38. Speicher PJ, Englum BR, Ganapathi AM, Mulvihill MS, Hartwig MG, Onaitis MW, D’Amico TA, Berry MF. “Adjuvant Chemotherapy is Associated with Improved Survival After Esophagectomy without Induction Therapy for Node-positive Adenocarcinoma”. J Thor Oncol. 2015;10(1):181-8.

39. Speicher PJ, Ganapathi AM, Englum BR, Gulack BC, Osho AA, Hirji SA, Castleberry AW, Snyder LD, Davis RD, Hartwig MG. “Single Lung Transplantation in the United States: What Happens to the Other Lung?” J Heart Lung Transplant. 2015;34(1):36-42.

40. Nussbaum DP, Speicher PJ, Gulack BC, Hartwig MG, Onaitis MW, D'Amico TA, Berry MF. “Defining the Role for Adjuvant Chemotherapy Following Lobectomy for Typical Bronchopulmonary Carcinoid Tumors”. Ann Thorac Surg. 2014;23(3):155-60.

41. Lidksy ME, Antoun G, Speicher PJ, Adams B, Turley RS, Augustine C, Tyler DS, Ali-Osman F. “Mitogen-activated protein kinase hyper-activation and enhanced NRAS expression drive acquired vemurafenib resistance in V600E BRAF melanoma cells”. J Biol Chem. 2014;289(40):27714-26.

42. Nussbaum DP, Speicher PJ, Gulack BC, Ganapathi AM, Keenan JE, Kirsch DG, Tyler DS, Blazer DG III. “The Effect of Neoadjuvant Radiation Therapy on Perioperative Outcomes Among Patients Undergoing Resection of Retroperitoneal Sarcomas Surgical Oncology”. Surg Oncol. 2014;23(3):155-60.

43. Beasley GM, Speicher P, Augustine CK, Dolber PC, Peterson BL, Mosca PJ, Royal R, Ross M, Zager JS, Tyler DS. “A Multi-center Phase I Dose Escalation Trial to Evaluate Safety and Tolerability of Intra-arterial Temozolomide for Patients with Advanced Extremity Melanoma Using Normothermic Isolated Limb Infusion”. Ann Surg Oncol. 2015;22(1):287-94.

44. Nussbaum DP, Penne K, Stinnett SS, Speicher PJ, Cocieru A, Blazer DG III, Zani S, Clary BM, Tyler DS, White RR. “A Standardized Care Plan Is Associated with Shorter Hospital Length of Stay in Patients Undergoing Pancreaticoduodenectomy”. J Surg Res. 2015;193(1):237-45.

45. Nussbaum DP, Zani S, Penne K, Speicher PJ, Stinnett SS, Clary BM, White RR, Pappas TN, Tyler DS, Blazer DG III. “Feeding Jejunostomy Tube Placement in Patients Undergoing Panctreaticoduodenectomy: An Ongoing Dilemma”. J Gastrointest Surg. 2014;18(10):1752-9.

46. Ganapathi AM, Speicher PJ, Castleberry AW, Englum BR, Osho AA, Davis RD, Hartwig MG. “The Effect of Prior Pneumonectomy or Lobectomy on Subsequent Lung Transplantation”. Ann Thorac Surg. 2014;98(6):1922-9.

47. Adam MA, Speicher P, Pura J, Dinan MA, Reed SD, Roman SA, Sosa JA. “Robotic Thyroidectomy for Cancer in the United States: Patterns of Use and Short-term Outcomes”. Ann Surg Onc. 2014;21(12):3859-64.

48. Speicher PJ, Englum BR, Ganapathi AM, Onaitis MW, D'Amico TA, Berry MF. “Outcomes after treatment of 17,378 patients with locally advanced (T3N0-2) non-small cell lung cancer”. Eur J Cardiothorac Surg. 2014;47(4):636-41.

49. Speicher PJ, Meriwether CH, Tyler DS. “Regional therapies for in-transit disease”. Surg Oncol Clin N Am. 2015;24(2):309-322.

50. Speicher PJ, Nussbaum DP, White RR, Zani S, Mosca PJ, Blazer DG III, Clary BM, Pappas TN, Tyler DS, Perez A. “Defining the Learning Curve for Team-based Laparoscopic Pancreaticoduodenectomy” Ann Surg Oncol. 2014;21(12):4014-9.

51. Speicher PJ, Ganapathi AM, Englum BR, Hartwig MG, Onaitis MW, D’Amico TA, Berry MF. “Induction Therapy Does Not Improve Survival for Clinical Stage T2N0 Esophageal Cancer”. J Thorac Oncol. 2014;9:1195-1201.

52. Barbas AS, Speicher PJ, Clary BM. “Hepatic and pancreatic resection in patients with end-stage renal disease: A propensity analysis”. HPB. 2014;16(11):1016-22.

53. Speicher PJ, Ganapathi AM, Englum BR, Vaslef SN. "Laparoscopy Is Safe Among Patients with Congestive Heart Failure Undergoing General Surgery Procedures". Surgery. 2014;156(2):371-8.

54. Keenan JE, Speicher PJ, Thacker JKM, Walter M, Kuchibhatla M, Mantyh CR. "The Preventative Surgical Site Infection Bundle in Colorectal Surgery: An Effective Approach for Surgical Site Infection Reduction and Healthcare Cost Savings". JAMA Surgery. 2014;149(10):1045-52.

55. Speicher PJ, Barbas AS, Mureebe L. “Open versus endovascular repair of ruptured abdominal aortic aneurysms”. Ann Vasc Surg. 2014;28(5):1249-57.

56. Speicher PJ, Nussbaum DP, Scarborough JE, Zani S, White RR, Blazer DG III, Mantyh CR, Tyler DS, Clary BM. "Wound classification reporting in HPB surgery: can a single word change public perception of institutional performance?" HPB. 2014;16(12):1068-73.

48

57. Jiang BS, Beasley GM, Speicher PJ, Mosca PJ, Morse MA, Hanks B, Salama A, Tyler DS. "Immunotherapy Following Regional Chemotherapy Treatment of Advanced Extremity Melanoma". Ann Surg Onc. 2014;21(8):2525-31.

58. Nussbaum DP, Penne K, Speicher PJ, Stinnett SS, Perez A, White RR, Clary BM, Tyler DS, Blazer DG III. “The Role of Clinical Care Pathways: An Experience with Distal Pancreatectomy”. J Surg Res. 2014;190(1):64-71.

59. Speicher PJ, Goldsmith ZG, Nussbaum DP, Turley RS, Peterson AC, Mantyh CR. "Ureteral stenting in laparoscopic colorectal surgery". J Surg Res. 2014;190(1):98-103.

60. Li GZ, Speicher PJ, Lidsky ME, Darrabie MD, Scarborough JE, White RR, Turley RS, Clary BM. “Hepatic Resection for Hepatocellular Carcinoma: Do Contemporary Morbidity and Mortality Rates Demand a Transition to Ablation as First-Line Treatment?” J Am Coll Surg. 2014;218(4):827-34.

61. Speicher PJ, Ganapathi AM, Englum BR, Onaitis MW, D'Amico TA, Berry MF. "Survival in the Elderly Following Pneumonectomy for Early Stage Non-Small Cell Lung Cancer: A Comparison with Non- operative Management”. J Am Coll Surg. 2014;218(3):439-49.

62. Beasley GM, Speicher PJ, Sharma K, Seigler H, Salama AKS, Mosca PJ, Tyler DS. “Efficacy of Repeat Sentinel Lymph Node Biopsy for Patients who Develop Recurrent Melanoma”. J Am Coll Surg. 2014;218(4):686-92.

63. Lidsky ME, Speicher PJ, Turley RS, Barbas AS, Clary BM. "Does the Presence of Coronary Artery Disease Impact Perioperative Outcomes Following Partial Hepatectomy?" J Gastrointest Surg. 2014;18(4):709-18.

64. Lidsky ME, Speicher PJ, Jiang BS, Tsutsui M, Tyler DS. "Isolated limb infusion as a model to test new agents to treat metastatic melanoma". J. Surg. Oncol. 2014;109(4):357-65.

65. Speicher PJ, Turley RS, Sloane JL, Mantyh CR, Migaly J. “Pelvic Exenteration for the Treatment of Locally Advanced Colorectal and Bladder Malignancies in the Modern Era.” J Gastrointest Surg. 2014;18(4):782-8.

66. Speicher PJ, Ligh C, Scarborough JE, Thacker JK, Mantyh CR, Turley RS, Migaly J. “A simple scoring system for risk-stratifying rectal cancer patients prior to radical resection.” Tech Coloproctol. 2014;18(5):459-65.

67. Speicher PJ, Beasley G, Jiang B, Lidsky M, Palmer G, Scarbrough P, Mosca P, Dewhirst M, Tyler D. “Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma.” Ann Surg Onc. 2014;21(5):1435-40.

68. Speicher PJ, Englum BR, Jiang B, Pietrobon R, Mantyh CR, Migaly J. “The impact of laparoscopic versus open approach on reoperation rate after segmental colectomy: a propensity analysis.” J Gastrointest Surg. 2014;18(2):378-84.

69. Elfenbein DM, Scarborough JE, Speicher PJ, Scheri RP. “Comparison of laparoscopic versus open adrenalectomy: results from ACS-NSQIP.” J Surg Res. 2013;184:216-20.

70. Speicher PJ, Lagoo S, Galanos A, Pappas TN, Scarborough JE. “Expectations and outcomes in geriatric patients with do-not-resuscitate orders undergoing emergent surgical management of bowel obstruction.” JAMA Surg. 2013;148(1):23-28.

71. Speicher PJ, Aziz H, Bhattacharya S, Baerman K. “Septic Thrombophlebitis of the Superior Mesenteric 72. Vein: An Unusual Complication of Appendicitis.” Am Surg. 2013;79(1):31-2. 73. Turner JP, Rodriguez HE, Daskin MS, Mehrotra S, Speicher P, DaRosa DA. “Overcoming obstacles

to resident-patient continuity of care.” Annals of Surgery. 2012;255(4):618-622. 74. Rodriguez H, Turner JP, Speicher P, Daskin MS, Darosa D. “A model for evaluating resident

education with a focus on continuity of care and educational quality.” J Surg Educ. 2010;67(6):352-8. Book chapters 1. Speicher P, Rodriguez HE. Infectious Aortitis. In: Yao JST, Pearce WH, Eskandari M, Morasch M, Matsumura

(eds): Vascular Surgery: Therapeutic Strategies. Shelton, CT: PMPH-USA, 2010; 409-420. ISBN 978-1-60795-055-4.

2. Rodriguez HE, Speicher P. Balloon Angioplasty and Stenting of Peripheral Arterial Lesions. In: Yao JST, Pearce WH (eds): Atlas of Vascular Surgery, 6th edition. Shelton, CT: PMPH-USA, 2013. ISBN 978-1-60795-021-9.

3. Speicher P, Tyler D, Mosca P. Management of In-transit Malignant Melanoma. In: Duc (ed): Melanoma-From Early Detection to Treatment. InTech 2013: 255-274. ISBN 978-953-51-0961-7.

4. Speicher PJ, Barbas AS, Li GZ, Tyler DS. Duodenal Stump Blowout. In: Pawlik, Merchant, Maithel (eds): Gastrointestinal Surgery: Management of Complex Perioperative Complications. New York: Springer, 2015. ISBN 978-1-4939-2223-9

5. Speicher PJ, Lagoo-Deenadayalan SA. The Approach to Reoperations in the Geriatric Population. In: Mizrahi, Reissman, Polk (eds). Reoperative Abdominal Surgery. London: JP Medical Publishers, 2014. ISBN-13: 978-1907816550

49

Adam Williams, MD

Refereed journals

1. Williams AR, Wang A, Kim H, Milano CA. Resection of Carcinoid Tumor Metastatic to the Right Ventricle and Tricuspid Valve. Ann Thorac Surg. 2015 Dec;100(6):2348-50. doi: 10.1016/j.athoracsur.2015.02.108. PubMed PMID: 26652531.

2. Suncion VY, Ghersin E, Fishman J, Zambrano JP, Karantalis V, Mandel NS, Nelson KH, Gerstenblith G, Difede DL, Breton E, Sitammagari KK, Schulman IH, Taldone S, Williams AR, Sanina C, Johnston P, Brinker JA, Altman PA, Mushtaq M, Trachtenberg B, Mendizabal A, Tracy M, Da Silva J, McNiece I, Lardo A, George RT, Hare JM, Heldman A. Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally? An analysis from the POSEIDON randomized clinical trial. Circ Res 2014;114:1292-1301.

3. Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR, Suncion VY, McNiece IK, Ghershin E, Soto V, Lopera G, Miki R, Willens H, Hendel R, Mitrani R, Pattany P, Feigenbaum G, Oskouei B, Byrnes J, Lowery MH, Sierra J, Pujol MV, Delgado C, Gonzalez PJ, Rodriguez J, Bagno LL, Rouy D, Altman P, Wong C, da Silva J, Anderson E, Schwartz R, Mendizabal A, Hare JM. Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: The TAC-HFT randomized trial. JAMA 2014;311(1):62-73.

4. Williams AR, Zambrano JP, Guerra D, Mather JP, Carvalho D, McCall F, Rodriguez JE, Valdes D, McNiece I, Heldman AW, Hare JM. Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. Journal American Heart Assoc 2013;2:e140.

5. Williams AR, Hatzistergos K, Addicott B, McCall F, Carvalho D, Suncion V, Morales A, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and restore cardiac function after myocardial infarction. Circulation 2013;127:213-23

Chi-Fu Jeffrey Yang, MD

Refereed journals

1. Yang CF, Hartwig MG, Berry MF, D’Amico TA. Large clinical databases for the study of lung cancer: Making

up for the failure of randomized trials. Journal of Thoracic and Cardiovascular Surgery 2016; 151(3):626-8. PMID: 26432720

2. Gulack BC, Yang CF, Babatunde Y, Tong BC, Onaitis MW, D’Amico TA, Harpole DH, Berry MF, Hartwig, MG. A Risk Score to Assist Selecting Lobectomy versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer. Annals of Thoracic Surgery 2016. [Epub ahead of print]. PMID: 27592602

3. Speicher PJ, Fitch ZW, Gulack BC, Yang CF, Harpole DH, D’Amico TA, Berry MF, Hartwig MG. Induction Chemotherapy for cN1 Non-small Cell Lung Cancer Is Not Associated with Improved Survival. Annals of Thoracic Surgery 2016; 102(3):884-94. PMID: 27476819

4. Yang CF, Meyerhoff R, Mayne N, Wang HH, Hirji S, Tong BC, Onaitis MW, Hartwig MG, Harpole DH, D’Amico TA, Berry MF. Outcomes of Major Lung Resection After Induction Therapy for Non-small Cell Lung Cancer in Elderly Patients. Annals of Thoracic Surgery 2016; 102(3):962-70. PMID: 27234579

5. Pershing NL, Yang CF (co-first author), Xu, MM, Counter, CM. Treatment with the nitric oxide synthase inhibitor L-NAME provides a survival advantage in a mouse model of Kras mutation-positive, non-small cell lung cancer. Oncotarget 2016. [Epub ahead of print]. PMID: 27285753

6. Yerokun BA, Sun Z, Yang CF, Gulack BC, Speicher PJ, Adam MA, D’Amico TA, Onaitis MW, Harpole DH, Berry MF, Hartwig MG. Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis. Annals of Thoracic Surgery 2016; 102(2):416-23. PMID: 27157326

7. Yang CF, Yan B, Gulack BC, Speicher P, Meyerhoff RR, Hartwig MG, D’Amico TA, Harpole DH, Berry MF. Impact of Age on Long-term Outcomes of Surgery for Malignant Pleural Mesothelioma. Clinical Lung Cancer 2016. [Epub ahead of print]. PMID: 27236386

8. Yang CF, Kumar A, Gulack BC, Mulvihill MS, Hartwig MG, D’Amico TA, Berry MF. Long-term Outcomes after Lobectomy for Non-Small Cell Lung Cancer when Unsuspected pN2 Disease is Found: A National Cancer Data Base Analysis. Journal of Thoracic and Cardiovascular Surgery 2016; 151(5):1380-8. PMID: 26874598

9. Yang CF, Adil SM, Anderson KL, Meyerhoff RR, Turley RS, Hartwig MG, Harpole DH, Tong BC, Onaitis MW, D’Amico TA, Berry MF. Impact of patient selection and treatment strategies on outcomes after lobectomy for biopsy-proven stage IIIA pN2 non-small cell lung cancer. European Journal of Cardiothoracic Surgery 2016; 49(6):1607-13. PMID: 26719403

50

10. Yang CF, Meyerhoff RR, Mayne NR, Singhapricha T, Toome CB, Speicher PJ, Hartwig MG, Tong BC, Onaitis MW, Harpole DH, D’Amico TA, Berry MF. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer. European Journal of Cardiothoracic Surgery 2016; 49(6):1615-23. PMID: 26719408

11. Yang CF, Chan DY, Speicher PJ, Gulack BC, Wang X, Hartwig MG, Onaitis MW, Tong BC, D’Amico TA, Berry MF, Harpole DH. Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer. Journal of Clinical Oncology 2016, 34(10):1057-64. PMID: 26786925

12. Yang CF, Sun Z, Speicher PJ, Saud SM, Gulack BC, Hartwig MG, Harpole DH, Onaitis MW, Tong BC, D’Amico TA, Berry MF. Use and Outcomes of Minimally Invasive Lobectomy for Stage I Non-Small Cell Lung Cancer in the National Cancer Data Base. Annals of Thoracic Surgery 2016; 101(3):1037-42. PMID: 26822346

13. Gulack BC, Yang CF, Speicher PJ, Meza JM, Gu L, Wang X, D’Amico TA, Hartwig MG, Berry MF. The Impact of Tumor Size on the Association of the Extent of Lymph Node Resection and Survival in Clinical Stage I Non-Small Cell Lung Cancer. Lung Cancer 2015; 90(3):554-60. PMID: 26519122

14. Yang CF, Gulack BC, Gu L, Speicher PJ, Wang X, Harpole DH, Onaitis MW, D’Amico TA, Berry MF, Hartwig MG. Adding Radiation to Induction Chemotherapy Does Not Improve Survival of Patients With Operable Clinical N2 Non-Small Cell Lung Cancer. Journal of Thoracic and Cardiovascular Surgery 2015, 150(6):1484-92. PMID: 26259994

15. Berry M, Yang CF, Hartwig MG, Tong BC, Harpole DH, D’Amico TA, Onaitis MW. Impact of Pulmonary Function on Long-term Survival After Lobectomy for Stage I Non-small Cell Lung Cancer. Annals of Thoracic Surgery 2015; 100(1):271-6. PMID: 25986099

16. Meyerhoff RR, Yang CF [co-first author], Speicher PJ, Gulack BC, Hartwig MG, D’Amico TA, Harpole DH, Berry MF. Impact of Mesothelioma Histologic Subtype on Outcomes in the Surveillance, Epidemiology, and End Results database. Journal of Surgical Research 2015; 196(1):23-32. PMID: 25791825

17. Yang CF, Meyerhoff RR, Stephens SS, Singhapricha T, Toomey CB, Anderson KL, Kelsey C, Harpole DH, D'Amico TA, Berry, MF. Long-term outcomes of lobectomy for non-small cell lung cancer after definitive radiation treatment. Annals of Thoracic Surgery 2015; 99(6):1914-20. PMID: 25886806

18. Yang CF, D’Amico TA. Open, Thoracoscopic and Robotic Segmentectomy for Lung Cancer. Annals of Cardiothoracic Surgery 2014; 3(2):142-52. PMID: 24790837

19. Yang CF, D’Amico TA. Thoracoscopic Segmentectomy for Lung Cancer. Annals of Thoracic Surgery 2012; 94(2):668-81, PMID: 22748648

20. Lu PJ, Yang CF [co-first author], Wu MY, Hung CH, Chan MY, Hsu TC. Wave Intensity Analysis of Para-aortic Counterpulsation. American Journal of Physiology Heart Circulatory Physiology 2011; 302(7):1481-91. PMID: 22227124

21. Lu PJ, Yang CF [co-first author], Lin B, Hung CH, Chan MY, Hsu TC. Wave Energy Patterns of Counterpulsation: A Novel Approach Using Wave Intensity Analysis. Journal of Thoracic and Cardiovascular Surgery 2011; 142(5):1205-13,

22. Yang CF, Duro D, Zurakowski D, Lee M, Jaksic T, Duggan C. High Prevalence of Micronutrient Deficiencies in Patients with Intestinal Failure: A longitudinal study. Journal of Pediatrics 2011, 159(1):39-44. PMID: 21324480.

23. Lu PJ, Lin PJ, Yang CF, Hung CH, Chan MY, Hsu TC. Hemodynamic and Metabolic Effects of Para- versus Intra-aortic Counterpulsatile Circulation Supports. Journal of the American Society for Artificial Internal Organs 2011, 57(1):19-25. PMID: 20980912

24. Duro D, Fitzgibbons S, Valim C, Yang CF, Zurakowski D, Dolan M, Bechard L, Yu YM, Duggan C, Jaksic T. [13C]-Methionine Breath Test to Assess Intestinal Failure Associated Liver Disease. Pediatric Research 2010; 68(4):349-54. PMID: 20581744

25. Yang CF, Lee M, Valim C, Hull MA, Zhou J, Jones BA, Gura K, Collier S, Lo C, Duggan C, Jaksic T. Persistent Alanine Aminotransferase Elevations in Patients with Parenteral Nutrition Associated Liver Disease. Journal of Pediatric Surgery 2009; 44(6):1084-1088. PMID: 19524721

26. Yang CF, Gray PB, Zhang J, Pope HG Jr. Second to Fourth Digit Ratios, Sex Differences, and Behavior in Chinese Men and Women. Social Neuroscience 2009; 4(1):49-59. PMID: 18633837

27. Yang CF, Hooven CK, Boynes M, Gray PB, Pope HG Jr. Testosterone Levels and Mental Rotation Performance in Chinese Men. Hormones and Behavior 2007; 51(3):373-378. PMID: 17292367

28. Gray PB, Yang CF [co-first author], Pope HG Jr. Fathers Have Lower Salivary Testosterone Levels Than Unmarried Men and Married Non-fathers In Beijing, China. Proceedings of the Royal Society of London Biological Sciences 2006; 273:333-339. PMID: 16543176

29. Yang CF, Gray PB, Pope HG Jr. Male Body Image in Taiwan versus the West: Yanggang Zhiqi 30. meets the Adonis Complex. American Journal of Psychiatry 2005; 162(2):263-269. PMID: 15677589

51

Brittany Zwischenberger, MD

Refereed journals

1. Zwischenberger BA, D’Amico TA, Tong BC. How I teach a thoracoscopic lobectomy. Annals of Thoracic Surgery. 2016; 101(3):846-849. PMID: 26897185

2. Zwischenberger BA, Tzeng CW, Ward ND, Zwischenberger JN, Martin JT. Venous thromboembolism (VTE) prophylaxis for esophagectomy: a survey of practice patterns among thoracic surgeons. Annals of Thoracic Surgery. 2016;101(2):489-94. PMID: 26409709

3. Zwischenberger BA, Kister NL, Zwischenberger JB, Martin JT. Laparoscopic, robot-assisted diaphragm plication: a case series. Annals Thoracic Surgery. 2016;101(1):369-71. PMID: 26694286

4. Tharrappel JC, Harris JW, Zwischenberger BA, Levy SM, Puleo DA, Roth JS. Doxycycline shows dose-dependent changes in hernia repair strength after mesh repair. Surgical Endoscopy. August 12, 2015. E-pub ahead of print. PMID:26264696

5. Starr M, Takahashi H, Okamura D, Zwischenberger BA, Mrazek A, Ueda J, Stromberg A, Evers B, Esmon C, and Saito H. Increased coagulation and suppressed generation of activated protein C in aged mice during intra-abdominal sepsis. American Journal of Physiology-Heart and Circulatory Physiology. 2015;308(2):H83-91. PMID: 25380813

6. Kister NL, Zwischenberger BA, Martin JT, Zwischenberger JB. Development and clinical use of an artificial lung. Curr Surg Rep 2014 Oct; 2(10):68. DOI 10.1007/s40137-014-0068-8

7. Davenport DL, Zwischenberger BA, Xenos ES. Analysis of 30-day readmission after aorto-iliac and infrainguinal revascularization using the ACS NSQIP dataset. Journal of Vascular Surgery. 2014;60(5):1266-74. PMID: 24973287

8. Zwischenberger BA, Vargas HD. Toxic colitis with megacolon in a patient with malrotation: a case report. The American Surgeon. American Surgeon. 2014 Dec;80(12):E356-8. PMID: 25513909

9. Martin JT, Zwischenberger BA, Fabian T. Malignant pleural mesothelioma: treatment options and novel therapies. Journal of Cancer Therapy. 2014; 5(1); 60-66.

10. Carmichael SP, Zwischenberger BA, Bernard AC. Late reoperation for retained gallstone following laparoscopic cholecystectomy. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 2014 Feb;24(1):e27-8. PMID: 24487171

11. Zwischenberger BA & Xenos ES. Drug-eluting stents in critical limb ischemia (CLI): a systematic review of long-term outcomes. Italian Journal of Vascular and Endovascular Surgery. 2013 Sept; 20(3):147-50.

12. Zwischenberger BA, Beasley MM, Davenport DL, Xenos ES. Meta-analysis of the correlation between Chronic Cerebrospinal Venous Insufficiency (CCSVI) and multiple sclerosis. Vascular and Endovascular Surgery. 2013 Nov; 47(8):620-624. PMID: 24005191.

13. Totten C, Tharappel JC, Harris JW, Zwischenberger BA, Roth JS. Doxycycline alters collagen composition following ventral hernia repair. Accepted to Surgical Endoscopy July, 26 2016.

14. Zwischenberger BA, Jacobe HJ. A systematic review of morphea treatments and therapeutic algorithm. Journal of the American Academy of Dermatology. 2011 Nov; 65(5):925-41. PMID: 21645943

15. Zwischenberger BA, Boren T. Placental site trophoblastic tumor presenting as a friable cervical mass. European Journal of Gynaecological Oncology. 2010 Nov; 31(5):570-2. PMID: 21061804

16. Zwischenberger BA, Moore BJ, Luber SD, Dallo FJ. Etiology of uncompleted exercise stress testing following emergency department chest pain evaluation. The American Journal of Emergency Medicine. 2011 May; 29(4):427-431. PMID: 20825836

17. Zwischenberger BA, Clemson LA, Zwischenberger JB. Artificial lung: progress and prototypes. Expert Review of Medical Devices. 2006 Jul; 3(4):485-497. PMID: 16866645

Book chapters 1. Zwischenberger BA, Martin JT, Zwischenberger JB. Barotrauma and Inhalation Injuries. In: Shileds TW,

LoCicero III J, Reed CE, Feins, RH. Shield’s General Thoracic Surgery. In press. 2. Zwischenberger BA, Lynch J, Zwischenberger JB. Mechanical support of the failing lung (respiratory assist

device). In: Franco KL, Thourani VH, eds. Cardiothoracic Surgery Review. Philidelphia, PA: Lippincott Williams & Wilkins, 2012, ch. 279.

3. Zwischenberger BA, Pandya AG, Guitart J. Cutaneous T-cell Lymphoma: Mycosis Fungoides and Sezary Syndrome. In: Rigel DS, ed. Cancer of the Skin, 2nd Edition. London, UK: Elsevier Inc., 2011, pp. 217-230.

4. Zwischenberger BA, Clemson L, Lynch J, Zwischenberger J. ECMO to Artificial Lungs: Advances in Long-term Pulmonary Support. In: Mongero LB, Beck JR, eds. On Bypass: Advanced Perfusion Techniques. Totowa, NJ: Humana Press, 2008, pp. 251-278.

52

Resident Presentations at

National Meetings (last 4 years)

53

Society of Thoracic Surgeons: January 2013

• Dr. Matthew Schechter: Outcomes Following Implantable Left Ventricular Assist Device Replacement Procedures

International Symposium on Regional Cancer Therapies: February 2013

• Dr. Paul Speicher: A novel method of assessing real-time changes in melanoma tumor hypoxia and blood flow during regional chemotherapy”.

World Congress of Paediatric Cardiology and Cardiac Surgery: April 2013

• Dr. Asad Shah: Management and Outcome of Isolated Partial Anomalous Pulmonary Venous Connection from the Left Upper Lobe

International Society for Heart and Lung Transplant: May 2013

• Dr. Anthony Castleberry: Utility of Six-Minute Walk Distance in Predicting Outcomes after Lung Transplant: A Nationwide Survival Analysis

• Dr. Anthony Castleberry: Socioeconomic Disparities Associated with Medication Non-Adherence Following Lung Transplantation in Adult Recipients

• Dr. Anthony Castleberry: Mortality Differences after Heart Transplantation in Patients Bridged with Balloon Pumps vs. Left Ventricular Assist Devices

American Association for Thoracic Surgery: May 2013

• Dr. Mani Daneshmand: Midterm Outcomes with Continuous Flow Left Ventricular Assist Devices for Destination Therapy

• Dr. Mani Daneshmand: Treatment Strategies for Ischemic Mitral Regurgitation: A 20-year Experience American Transplant Congress: May 2013

• Dr. Anthony Castleberry: Lung Transplant with Allografts from Donors with a History of Smoking: A Nationwide Analysis of Usage and Outcomes

• Dr. Anthony Castleberry: The Utility of Six-Minute Walk Distance in Predicting Waitlist Mortality for Lung Transplant Candidates

European Society of Thoracic Surgeons: May 2013

• Dr. Benjamin Wei: The Impact Of Pulmonary Hypertension On Morbidity And Mortality Following Major Lung Resection

International Society for Minimally Invasive Cardiothoracic Surgery: June 2013

• Dr. Jennifer Hanna: Flat Learning Curve for Robotic Lobectomy in a Video-Assisted Thoracoscopic • Dr. Paul Tang: Right Mini-thoracotomy versus Median Sternotomy for Mitral Surgery in Patients with

Chronic Renal Impairment, a Propensity Matched Study

Society of Vascular Surgery: June 2013

• Dr. Matthew Schechter: Frailty Does Not Increase Risk in Thoracic Endovascular Aortic Repair

Western Thoracic Surgery Association: June 2013

• Dr. Asvin Ganapathi: Modeling Frailty and Risk in Proximal Aortic Surgery • Dr. Jack Haney: Differential Prognostic Significance of Extralobar and Intralobar Nodal Metastases in

Patients with Surgically Resected Stage II Non-small Cell Lung Cancer

54

Southern Thoracic Surgical Association: November 2013

• Dr. Asvin Ganapathi: Antegrade Versus Retrograde Cerebral Perfusion for Hemi-Arch Replacement Utilizing DHCA: Does it Matter? A Propensity-Matched Analysis

• Dr. James Meza: The Perceived Bias Against Integrated Cardiothoracic Surgery Residency Applicants During their General Surgery Interviews: Are We Hurting a Generation of Strong Candidates?

• Dr. Jennifer Hanna: The Prognostic Importance of the Number of Dissected Lymph Nodes after Induction Chemoradiation for Esophageal Cancer

• Dr. Jennifer Hanna: Thoracic Endovascular Aortic Repair for Chronic DeBakey Type IIIb Aortic Dissection

American Heart Association Scientific Sessions: November 2013

• Dr. Nicholas Andersen: Ca2+ Signaling is Required for Cardiomyocyte Hypertrophy During Chamber Development Independent of Contraction or Blood Flow

• Muath Bishawi: Postoperative Atrial Fibrillation Impacts One Year Clinical Outcomes and Costs: The VA ROOBY Trial.


• Dr. Nicholas Andersen: Adult Surgical Experience with Loeys-Dietz Syndrome. Society of Thoracic Surgeons 50th Annual Meeting, January 25-29, 2014, Orlando, Florida.

• Dr. Nicholas Andersen: RiaSTAP® Use to Increase Fibrinogen Levels During Thoracic Aortic Surgery Involving Deep Hypothermic Circulatory Arrest

• Muath Bishawi: Off Pump vs On-Pump Impact on Diabetic Patients’ Clinical Outcomes and Costs. • Dr. Asad Shah: Early Surgical Experience with Loeys-Dietz Syndrome • Dr. Paul Speicher: Outcomes after treatment of locally advanced (T3N0-2) Non-Small Cell Lung Cancer: a

population-based study of 17,378 patients • Dr. Jennifer Hanna: Adult Surgical Experience with Loeys-Dietz Syndrome • Dr. Jennifer Hanna: RiaSTAP® Use to Increase Fibrinogen Levels During Thoracic Aortic Surgery Involving

Deep Hypothermic Circulatory Arrest • Dr. Jennifer Hanna: Catastrophic immunologic reaction and pseudoaneurysm formation after Medtronic

Freestyle Stentless Procine Aortic Bioprosthetic implantation: a word of caution • Dr. Asvin Ganapathi: The Effect of Prior Pneumonectomy or Lobectomy on Subsequent Lung

Transplantation Southern Association for Vascular Surgery Meeting : January 2014

• Dr. Asvin Ganapathi: Role of Cardiac Evaluation Prior to Thoracic Endovascular Aortic Repair Academic Surgical Congress: February 2014

• Dr. Jennifer Hanna: Connective Tissue Growth Factor (CTGF/CCN2) is a Direct Transcriptional Target of SOX2 and Regulator of Integrin Alpha 5, Bone Morphogenetic Protein 7, and Collagen I Alpha 1 Expression in Squamous Cell Lung Cancer

• Dr. Paul Speicher: Congestive Heart Failure and the Role of Laparoscopy in General Surgery • Dr. Asvin Ganapathi: A Contemporary Review of Gangrenous Cholecystitis: Analysis of Outcomes Using

NSQIP • Dr. Asvin Ganapathi: Is A Priori Staging of Bilateral Lung Transplant the Optimal Surgical Approach for

High-Risk Patients with Interstitial Lung Disease? Annual Meeting of the International Society for Heart and Lung Transplantation: April 2014

• Dr. Paul Speicher: Single Lung Transplantation in the United States: What Happens to the Other Lung? Aortic Symposium: April 2014

• Dr. Asad Shah: Outcomes of Elderly Patients Undergoing Proximal Aortic Surgery using Deep Hypothermic Circulatory Arrest: Prohibitive Risk or Equivalent Outcomes to Younger Patients?

• Dr. Asad Shah: Prolonged Postoperative Respiratory Support after Proximal Thoracic Aortic Surgery: Is Deep Hypothermic Circulatory Arrest a Risk Factor?

55

American Society of Clinical Oncology: May 2014

• Dr. Paul Speicher: Adjuvant Chemotherapy is Associated with Improved Survival After Esophagectomy without Induction Therapy for Node-positive Adenocarinoma

World Transplant Congress: July 2014

• Dr. Anthony Castleberry: Graft and Patient Survival Following Kidney Transplantation in Previous Lung Transplant Recipients.

AATS FACTS-Care 11th Annual Conference, CVT Critical Care: October 2014

• Dr. Judson Williams: Central venous pressure after coronary artery bypass surgery: Does it predict postoperative mortality or renal failure? John W. Kirklin CT Resident & Fellow Research Award

The American College of Surgeons Clinical Congress: October 2014

• Dr. Paul Speicher: Outcomes for locally advanced T1- T3N1M0 esophageal cancer: the impact of traveling to a high volume center for treatment

Southern Thoracic Surgical Association: November 2014

• Dr. Asvin Ganapathi: Long-Term Survival Following Bovine Pericardial Versus Porcine Stented Bioprosthetic Aortic Valve Replacement: Does Valve Choice Matter?


• Dr. Asad Shah: Understanding Why Residents May Inaccurately Log Their Role in Operations: A Look at the 2013 In-Training Exam Survey.

• Dr. Asad Shah: Predictors of Career Choice Among Cardiothoracic Surgery Trainees. Presented at the Society of Thoracic Surgeons Annual Meeting.

• Dr. Asad Shah: A Decade of Change: Training and Career Paths of Cardiothoracic Surgery Residents 2003-2014.

• Dr. Jeffrey Keenan: Characterization of Intraoperative Electroencephalography during Aortic Hemiarch Replacement with Moderate Hypothermic Circulatory Arrest.

American College of Cardiology Annual Meeting: March 2015

• Dr. Asad Shah: The Fate of Tricuspid Regurgitation after Repair of Pre-Tricuspid Valve Left-to-Right Shunts. • Dr. Asad Shah: Gender and Cardiothoracic Surgery Training: Specialty Interests, Satisfaction, and Career

Pathways. American Association for Thoracic Surgery: April 2015

• Dr. Nicholas Andersen: Does Moderate Hypothermia Really Carry Less Bleeding Risk than Deep Hypothermia for Circulatory Arrest: A Propensity-Matched Comparison in Hemiarch Replacement.

• Dr. Jeffrey Keenan: Does Moderate Hypothermia Really Carry Less Bleeding Risk than Deep Hypothermia For Circulatory Arrest? A Propensity-Matched Comparison in Hemiarch Replacement.

Society for Vascular Surgery: June 2015

• Dr. Nicholas Andersen: Hybrid Repair of the Aortic Arch: Long-Term Outcomes After a Decade of Intervention.

• Dr. Muath Bishawi: Resident versus attending surgeon patency and clinical outcomes in on- versus off-pump coronary artery bypass surgery.

European Conference on General Thoracic Surgery: June 2015

56

• Dr. Chi-Fu Yang: Impact of Patient Selection and Treatment Strategies on Outcomes After Lobectomy for Biopsy-Proven Stage IIIA pN2 Non-Small Cell Lung Cancer.

• Dr. Chi-Fu Yang: Performing Sublobar Resection Instead of Lobectomy Compromises the Survival of Stage I Non-small Cell Lung Cancer in Patients 80 years of Age and Older.

American Association for Thoracic Surgery International Coronary Congress: August 2015

• Dr. Judson Williams: Glycemic Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: Clinical Features, Predictors, and Outcomes.

World Conference on Lung Cancer: September 2015

• Dr. Chi-Fu Yang: Survival after Surgery for pN1 and pN2 Small Cell Lung Cancer: A Comparison with Surgical Treatment of Non-Small Cell Lung Cancer.

• Dr. Chi-Fu Yang: Right-sided vs Left-side Pneumonectomy after Induction Therapy for Non-Small Cell Lung Cancer.

• Dr. Chi-Fu Yang: Long-term Survival after Surgery for Pathologic N1 and N2 Small Cell Lung Cancer: A Comparison with Nonoperative Management.

• Dr. Chi-Fu Yang: Wedge Resection vs Segmentectomy for Patients with T1A N0 Non-small Cell Lung Cancer. AATS FACTS-Care 12th Annual Conference, CVT Critical Care: October 2015

• Dr. Jeff Javidfar: Standardized CT ICU Handover. John W. Kirklin CT Resident & Fellow Research Award Southern Thoracic Surgical Association: November 2015

• Dr. Asad Shah, Dr. Nicholas Andersen: Characterizing the Operative Experience of Cardiothoracic Surgery Residents in the United States: What are residents really doing in the operating room?

• Dr. Chi-Fu Yang: Outcomes of Major Lung Resection After Induction Therapy for Non-small Cell Lung Cancer in Elderly Patients.

Southern Association for Vascular Surgery: January 2016

• Dr. Nicholas Andersen: An Integrated Approach to Thoracoabdominal Aortic Aneurysm Repair: Complimentary Roles of Open and Hybrid Approaches


• Dr. Asad Shah: An Overlooked Tool to Address Mitral Regurgitation at the Time of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy.

• Dr. Paul Speicher: Induction Chemotherapy for cN1 Non-small Cell Lung Cancer Is Not Associated with Improved Survival.

American Association for Thoracic Surgery: May 2016

• Dr. Muath Bishawi: Treatment of Ischemic MR with a rigid, undersized ring yeilds excellent reccurence free rate.

International Society for Heart and Lung Transplantation: May 2016

• Dr. Muath Bishawi: Incidence and outcomes after stroke on rotary flow ventricular assist device support. Western Thoracic Surgical Association: June 2016

• Comparison of Right Ventricle-Pulmonary Artery Shunt Position in the Norwood Procedure: An Analysis of the Pediatric Heart Network Public Database.

57

Summary of Graduates

Positions of Recent Residents

Year Resident First Position Academic

2016 Jeffrey Javidfar Emory University Academic

Asad Shah Rex Healthcare No

Judson Williams WakeMed No

2015 Loretta Erhunmwunsee City of Hope Academic

Matthew Gaudet Ochsner Academic

Alexander Iribarne Dartmouth-Hitchcock Academic

2014 John “Jack” Haney Duke Academic

Jacob Klapper Medical University South Carolina Academic

Paul Tang Duke Academic

2013 Mani Daneshmand Duke Academic

Chad Johnson US Navy Academic

Ben Wei University of Alabama, Birmingham Academic

2012 Keshava Rajagopal University of Maryland Academic

Jacob Schroder Duke Academic

Jason Williams US Air Force/UC Davis Academic

2011 Mimi Ceppa Indiana University Academic

Matthew Hartwig Duke Academic

Anthony Lemaire UMDNJ Academic

2010 Edward Cantu University of Pennsylvania Academic

Teng Lee University of Maryland Academic

Joseph Turek Children’s’ Hospital PA Academic

2009 Berry, Mark Duke Academic

Pal, Jay U. Texas-San Antonio Academic

Williams, Matthew Louisville Academic

2008 Jeff Gaca Duke Academic

58

Cyrus Parsa Duke Academic

Betty Tong Duke Academic

2007 Zane Atkins Air Force; Durham VA Academic

Sitaram Emani Boston Children’s Academic

Mark Onaitis Duke Academic

2006 Shankha Biswas Riverside, CA No

Shari Meyerson University of Arizona Academic

David White Duke Academic

2005 Chad Hughes Duke Academic

Jeff Martin Columbia, SC No

Ash Shah Johns Hopkins Academic

2004 William Burfeind Duke Academic

Paul Chai Tampa, FL No

Shu Lin Duke Academic

2003 Kimberly Gandy Wisconsin-Milwaukee Academic

Cleveland Lewis Goshen, NJ No

2002 Allen Kypson East Carolina Academic

Andy Lodge Duke Academic

Larkin Daniels Mobile, Alabama No

59

Duke Graduate Medical Education

Employment & Benefits ⋅ Employment Requirements ⋅ Requirement and Standards ⋅ Stipends ⋅ Sample Agreement of

Appointment

⋅ Program and GME Benefits

60

Employment Requirements

The qualifications for membership to the Associate Medical Staff (Graduate Medical Trainee) eligibility are as follows:

• Graduates of medical schools in the United States and Canada accredited by the Liaison Committee on Medical Education (LCME).

• Graduates of colleges of osteopathic medicine in the United States accredited by the American Osteopathic Association (AOA).

• Graduates of medical schools outside the United States and Canada who meet one of the following qualifications:

o Have received a currently valid certificate from the Educational Commission for Foreign Medical Graduates (ECFMG) or

o Have a full and unrestricted license to practice medicine in a U.S. licensing jurisdiction. • Graduates of medical schools outside the United States who have completed a Fifth Pathway program

provided by an LCME‐accredited medical school • Have a North Carolina Full State License or Resident Training License (RTL). (see: Medical License) • Official Medical School Transcript with conferred or graduated • A completed Postgraduate Training Verification Form (if applicable) • Current ACLS/BLS/PALS certification (see: ACLS/BLS/PALS Certification Policy) • Proof of identity and US Employment Eligibility (I‐9) via E-Verify (See: I‐9 Form Policy) including SS Card • Health Record Clearance, which includes drug screening (See: the Drug Testing Policy) • A signed Agreement of Appointment (Contract)

o The signed Graduate Medical Education Agreement of Appointment; is not effective, and employment will not commence, until all credentialing documents have been received and approved by the Office of GME and all requirements for hire have been satisfied.

• Application for Appointment, which requires: o 2 Reference forms o Criminal Background Check (includes EPLS & OIG check) o National Practitioner Databank check o ECFMG check (for International Medical Graduates)

• Completion of several payroll forms which include: o Duke Insurance Beneficiary Form o Health/Dental/Vision Enrollment Form o Reimbursement Accounts Enrollment Form (if applicable) o Acknowledgment Form o Foreign National Form (if applicable)

• Completion of all required Online Safety Training Modules and GME Learning Modules (See: Online Safety Training Modules and GME Modules) (Completed after Hire)

• USMLE (or equivalent) Transcript o Document passing scores in the first two parts of appropriate medical licensure examinations

(USMLE Step I, Step 2CK and Step 2CS (if applicable), COMLEX, or equivalent Canadian examinations, etc.). After 24 months of post graduate training passing of all three parts of the licensing examinations must be provided.

o This policy applies to all graduate medical trainees whether United States or International Medical School graduates. Programs have the right to impose more stringent requirements, but not less than those contained in this policy. An Agreement of Appointment will not be valid without satisfying this requirement. (*USMLE statement if trainee has not passed Step 3)

• Attend Institutional Orientation

A trainee may begin his/her clinical duties when he/she has met the above GME requirements.

61

Requirements and Standards

Essential Abilities Requirements/Technical Standards

A. Introduction

All candidates for any of the Duke Graduate Medical Education programs must meet the criteria necessary to successfully complete the program. To achieve the optimal educational experience and to maintain patient safety, trainees are required to participate in all phases of the training program. The study of medicine and its specialties and subspecialties is not a pure intellectual exercise. Rather a specific minimum set of observation, communication, motor, intellectual/conceptual, integrative and quantitative abilities, behavioral and social attributes and ethical and legal standards are needed to be a successful intern, resident or fellow. To be successful, one must progress with increasing independence throughout the program and by the time of program completion must be capable of competent and independent practice in that field. Essential abilities and characteristics required for the completion of the training program consist of certain minimum physical and cognitive abilities and sufficient mental and emotional stability to complete the entire training program. Trainees must possess all of the requirements defined as technical standards listed in the six categories below, which in conjunction with individual program qualification criteria constitute the training program. Although these standards serve to delineate the necessary physical and mental abilities of all candidates, they are not intended to deter any candidate for whom reasonable accommodation will allow the fulfillment of the complete training program. Candidates with questions regarding technical standards are encouraged to contact Dr George Jackson/Dr. Carol Epling in Employee/Occupational Health and Wellness immediately to begin to address what types of reasonable accommodations may be considered for development to achieve these standards. Candidates with questions about Duke’s reasonable accommodation process may contact Barbara Briner, Coordinator, Employment and Public Reasonable Accommodations with the Disability Management System at 919-684-8247.

Individual programs may require more stringent or more extensive abilities as appropriate to the requirements for training in that specialty and in certain specialties one or more of these technical standards may be more or less essential.

Candidates are encouraged to contact individual Duke Programs in which they are interested to see if additional expectations apply.

Programs that do not oversee all of the services required by their own discipline must work closely with other program directors with authority over services on which their trainees will be required to rotate. This is necessary in order to obtain copies of their most recent technical standards and ensure trainees meet technical standards in all areas required for completion of their program.

B. TECHNICAL STANDARDS I. Observation:

a. Observe materials presented in the learning environment including, but not limited to, audiovisual presentations, written documents, tissues and gross organs in the normal and pathologic state and diagnostic images.

b. Accurately and completely observe patients both at a distance and directly and assess findings.

c. Obtain a medical history and perform a complete physical examination in order to integrate findings based on these observations and to develop an appropriate diagnostic and treatment plan.

II. Communication: a. Communicate effectively, efficiently, accurately, respectfully and sensitively with patients,

their families and members of the health care team. b. Perceive non-verbal communications, including facial expression, body language and

affect. c. Respond appropriately to emotions communicated verbally and none verbally.

62

d. Synthesize accurately and quickly large volumes of medical information from different types of written forms and formats, electronic medical records, both typed and hand written, that constitutes medical history.

e. Record information accurately and clearly and communicate effectively in English with other health care professionals in a variety of patient settings including a variety of hand written and computerized record systems.

III. Motor Function: a. Elicit information from patients and perform physical examinations and diagnostic

maneuvers, at a minimum via palpitation, auscultation, and percussion. b. Carry out diagnostic maneuvers required by the specialty (e.g. positioning patients,

coordinating gross and fine motor movements). c. Respond to emergency situations in a timely manner and provide general and emergency

care necessitating the coordination of gross and fine motor movements, equilibrium and sensation.

d. Adhere to universal precaution measures and meet safety standards applicable to inpatient and outpatient settings and other clinical activities.

e. Manipulate equipment and instruments to perform basic laboratory tests and procedures as required to attain residency goals (e.g. stethoscope, central site sets, ultrasound etc).

IV. Intellectual/Conceptual, Integrative, & Quantitative Abilities: a. Perform calculations necessary to solve quantitative problems as required by patient care

and testing needs. b. Collect, organize, prioritize, analyze, synthesize and assimilate large amounts of

technically detailed and complex information in a timely fashion and with progressive independence. This information will be presented in a variety of educational and clinical settings including lectures, small group discussions and individual clinical settings.

c. Analyze, integrate, and apply this information for problem solving and decision-making in an appropriate and timely manner for the clinical situation.

d. Comprehend and learn factual knowledge from readings and didactic presentations. e. Apply knowledge and reasoning to solve problems as outlined by the curriculum. f. Recognize, comprehend and draw conclusions about three dimensional spatial

relationships and logical, sequential relationships among events. g. Formulate and test hypotheses that enable effective and timely problem solving in

diagnosis and treatment of patients in a variety of clinical modalities. h. Develop habits for lifelong learning.

V. Behavioral and Social Attributes: a. Possess and demonstrate the maturity and emotional stability required for full use of

intellectual skill, exercise good judgment, and have the ability to complete all responsibilities attendant to the diagnosis and care of patients.

b. Develop a mature, sensitive and effective relationship with patients and colleagues. c. Tolerate work hours consistent with ACGME duty standards, function effectively under

stress, and display flexibility and adaptability to changing environments during training and patient care including call, sustained work up to 30 hours at a stretch and up to 80 hours/week of clinical work or the specialty-specific duty hours.

d. Function in the face of uncertainty and ambiguity in rapidly changing circumstances. e. Behave in an ethical and moral manner consistent with professional values and standards. f. Exhibit sufficient interpersonal skills, knowledge, and attitudes to interact positively and

sensitively with people from all parts of society, racial and ethnic backgrounds, and belief systems.

g. Cooperate with others and work collaboratively as a team member. h. Demonstrate insight into personal strengths and weaknesses. i. Seek the advice of others when appropriate. j. Be punctual, present at all assignments when expected or notify superiors. k. Complete work including documentation and dictations in a timely manner l. Acknowledge conflicts of interest, mistakes and adverse outcomes and cooperate in their

resolution. m. Remain awake and alert for assigned duty periods and teaching activities within duty

hours and abide by rules and policies. VI. ETHICAL AND LEGAL STANDARDS:

a. Candidates must meet the legal standards to be licensed to practice medicine in the State of North Carolina. As such, candidates for admission must acknowledge and provide written explanation of any felony offense or disciplinary action taken against them prior to matriculation in any Duke GME Program.

63

b. Should the intern, resident or fellow be convicted of any felony offense, or any offense that puts medical licensure at risk, while in a GME Program, he/she agrees to immediately notify the Program Director and the GME Office as to the nature of the conviction.

c. Failure to disclose prior or new offenses can lead to disciplinary action that may include dismissal.

C. PROCESS Program directors recognize their responsibilities to verify that at program completion, trainees are capable of competent and independent practice with in the specialty or subspecialty. To do so, trainees will have to have demonstrated competencies that include knowledge, attitudes, and skills which equip them to function in a broad variety of clinical situations.

Duke Graduate Medical Education has an institutional commitment to provide equal opportunities for qualified interns, residents and fellows with disabilities who apply for admission to any of the Duke GME programs. Duke GME is a leader in diversity and individual rights, with a strong commitment to full compliance with state and federal laws and regulations (including the Rehabilitation Act of 1973, and the Americans with Disabilities Act of 1990.)

A “qualified person with a disability” is an individual with a disability who meets the academic and technical standards requisite to admission or participation in GME programs, with or without reasonable accommodations.

Admitted candidates with disabilities are reviewed individually, on a case-by-case basis, with a complete and careful consideration of all the skills, attitudes and attributes of each candidate to determine whether they can satisfy the standards with or without any reasonable accommodations.

An accommodation is not reasonable if it poses a direct threat to the health or safety of patients, self and/or others, if making it requires a substantial modification in an essential element of the program, if it lowers GME program standards, or possesses an undue administrative or financial burden. As noted above, except in rare circumstances, the use by the candidate of a third party (e.g., an intermediary) to perform any of the functions described in the Technical Standards set forth above would constitute an unacceptable substantial modification.

Admission to any of Duke’s GME programs is conditional on the candidate’s having the willingness and ability to satisfy the technical standards, with or without reasonable accommodation.

Admitted candidates who have a disability and need accommodations should initiate discussions with the Program Director as soon as the offer of admission is received and accepted. It is the responsibility of a candidate with a disability to provide sufficiently current information documenting the general nature and extent of his/her disability, and the functional limitations proposed to be accommodated. GME reserves the right to request new or additional information.

Evaluating and facilitating effort by the candidate, are the Duke Program Director, Employee/Occupational Health (EOHW) and Wellness, and the Disability Management System. Should a candidate have or develop a condition that would place patients, the candidate or others at risk or that may affect his/her need for accommodation, an evaluation with EOHW may be necessary. As in initial assessments, a complete and careful reconsideration of all the skills, attitudes and attributes of each candidate will be performed.

Duke GME Programs, program directors and selection committees are responsible for adhering to these technical standards and process during the selection of interns, residents and fellows. When an individual enters a Graduate Medical Education Training program it is expected that all necessary accommodations will be detailed and agreed to by the program before (s) he begins training.

If you have any questions about this document or whether you meet the technical standards described above, please contact Dr. George Jackson or Dr. Carol Epling and Occupational and Employee Health or Duke GME.

http://www.dukehealth.org/physicians/george_w_jackson

http://www.dukehealth.org/physicians/carol_a_epling

http://www.hr.duke.edu/eohw/

http://gme.duke.edu/

http://gme.duke.edu/

64

Stipends

2016 – 2017 2015 – 2016 Stipend Level & Amount Stipend Level & Amount

1 53,580.00 1 52,284.00

2 55,764.00 2 54,408.00

3 57,912.00 3 56,508.00

4 60,276.00 4 58,812.00

5 62,604.00 5 61,080.00

6 65,088.00 6 63,504.00

7 67,404.00 7 65,760.00

8 69,768.00 8 68,076.00

9 72, 216.00 9 70,464.00

10 74,700.00 10 72,888.00

11 77,280.00 11 75,396.00

12 79,944.00 12 78,000.00

69

Program Benefits

Meetings The cardiothoracic residents will be sponsored to attend one Academic Meeting (AATS, STS, ACS, AHA, WTSA or ACC) annually at the expense of the Division and one course. The academic meeting schedule is created in July. No more than 3 CT residents from Duke Hospital rotations (including only 1 CT2 resident) may attend a given meeting. Except when specified, travel for meetings should include a Saturday evening, in order to obtain the most reasonable airline fares. Vacations Each resident is allotted two (2) one-week vacations during the academic year, the first week July-December, and the second week Jan-June. The week must be requested in advance to avoid conflicts with scientific meetings and other vacations. Each “one-week” vacation actually extends from Saturday morning after clinical responsibilities are met and ends the following Monday morning at 6 AM. Vacation schedules must be approved in advance by Dr. D’Amico. FMLA / Disability Leave The Family and Medical Leave Act (FMLA) entitles a covered employee to take up to 84 days of unpaid leave in a 12-month period for the birth or adoption of a child, or the "serious health condition" of the employee or the employee's child, spouse, or parent. If at all possible, the resident must make the request for FMLA and all associated paperwork prior to the precipitating event. The resident must inform the Program Director and the Program Coordinator at the earliest awareness of such a need. For FMLA approval, the resident should seek consultation with the EOHS, or ask his/her treating clinician to send documentation of an FMLA qualifying condition and recommendation for time away to the EOHS. The EOHS will then communicate the approval of the leave to the program director. FMLA can be taken in a full block or in smaller increments as determined by the clinician who provides care in conjunction with the EOHS or his/her designee. Call Rooms Call rooms are located on 3200 and DMP 7W. Showers are located in the DMP 7W call suite. Meals • Grill – Monday, Tuesday, Thursday, Friday, Saturday

o Grilled Chicken Sandwiches o Hamburgers & Cheeseburgers o Veggie Burgers o Turkey Burgers o Daily Grill Specials

• Grill – Wednesday and Sunday – Breakfast Menu o Fried or Scrambled Eggs, Omelets and Breakfast Sandwiches o Waffles & Pancakes o Bacon, Sausage, Grits, Home Fries, and Biscuits.

• Soup – Two Daily Selections • Grab-and-Go Items 1. Fresh Sushi 2. Yogurt & Parfaits 3. Salads & Sandwiches 4. Prepackaged Snacks 5. Specialty Juices & Drinks 6. Desserts All other convenience items will be available for sale as well.

Subway and Starbucks in the North Atrium are open 24 hours.

residency program in cardiothoracic surgery · the training program in thoracic surgery ......

Documents